STUDYID,SUBJID,RAND,TREATXT,TRTCD,PCREFID,CNTNRID,PCDT,PCTM,VISIT,PCTPT,PCORRES,PCORRESU,PKACOM,PKCOML,PCSPEC,PKTERM,PCCAT,PCNAM,PCANMETH,PCMETHOD,PCLLOQ,PCLLOQU,PCSPID,ASSAYRUN,ASSAYDT
C1071022,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,11:30,CYCLE1_DAY1,0 H,<0.500,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 12,1RSYC,26-Oct-21
C1071022,10681001,1,PF-06863135,T,6514526668,6.51453E+11,20210209,18:45,CYCLE1_DAY1,6 H,551.5015416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 13,11RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,9:12,CYCLE1_DAY8,0 H,28.55176842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 14,11RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6514526671,6.51453E+11,20210216,16:30,CYCLE1_DAY8,6 H,553.0651071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 15,12RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6514526673,6.51453E+11,20210223,11:20,CYCLE1_DAY15,0 H,96.12690263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 16,1RSYC,26-Oct-21
C1071022,10681001,1,PF-06863135,T,6514526675,6.51453E+11,20210302,10:08,CYCLE1_DAY22,0 H,8.956746211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 17,1RSYC,26-Oct-21
C1071022,10681001,1,PF-06863135,T,6514526676,6.51453E+11,20210309,11:00,CYCLE2_DAY1,0 H,591.2359222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 18,1RSYC,26-Oct-21
C1071022,10681001,1,PF-06863135,T,6515768046,6.51577E+11,20210406,14:04,CYCLE3_DAY1,0 H,671.1376259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 19,12RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6515337610,6.51534E+11,20210504,12:00,CYCLE4_DAY1,0 H,512.8213742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 20,12RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6517472556,6.51747E+11,20210727,13:56,CYCLE7_DAY1,0 H,769.9594254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 21,12RSYC,2-Nov-21
C1071022,10681001,1,PF-06863135,T,6517472564,6.51747E+11,20211102,11:09,CYCLE10_DAY1,0 H,253.3442651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 678,64RSYC,3-May-22
C1071022,10681001,1,PF-06863135,T,6518807395,6.51881E+11,20220111,11:36,CYCLE13_DAY1,0 H,567.8575903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1611,97RSYC,12-May-22
C1071022,10681001,1,PF-06863135,T,6518807393,6.51881E+11,20220405,11:49,CYCLE16_DAY1,0 H,702.3735691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1921,123RSYC,29-Jul-22
C1071022,10681001,1,PF-06863135,T,6521317289,6.52132E+11,20221213,11:17,CYCLE25_DAY1,0 H,344.8471962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2127,139RSYC,22-Mar-23
C1071022,10681001,1,PF-06863135,T,6521699933,6.5217E+11,20230307,10:43,CYCLE28_DAY1,0 H,154.882052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2202,141RSYC,17-May-23
C1071022,10681001,1,PF-06863135,T,6523611270,6.52361E+11,20230810,11:51,END_OF_TRT,,457.1409285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2288,147RSYC,29-Feb-24
C1071022,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,11:00,CYCLE1_DAY1,0 H,305.2009695,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 22,1RSYC,26-Oct-21
C1071022,10681002,2,PF-06863135,T,6514526669,6.51453E+11,20210302,18:30,CYCLE1_DAY1,6 H,108.5414603,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 23,11RSYC,2-Nov-21
C1071022,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,9:31,CYCLE1_DAY8,0 H,649.5109832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 24,11RSYC,2-Nov-21
C1071022,10681002,2,PF-06863135,T,6514526670,6.51453E+11,20210309,17:31,CYCLE1_DAY8,6 H,760.3649085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 25,12RSYC,2-Nov-21
C1071022,10681002,2,PF-06863135,T,6514526672,6.51453E+11,20210316,9:56,CYCLE1_DAY15,0 H,839.1310532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 26,1RSYC,26-Oct-21
C1071022,10681002,2,PF-06863135,T,6515768043,6.51577E+11,20210323,10:05,CYCLE1_DAY22,0 H,872.4370429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 27,1RSYC,26-Oct-21
C1071022,10681002,2,PF-06863135,T,6515784458,6.51578E+11,20210330,10:29,CYCLE2_DAY1,0 H,2.321519186,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 28,1RSYC,26-Oct-21
C1071022,10681002,2,PF-06863135,T,6515784461,6.51578E+11,20210427,9:42,CYCLE3_DAY1,0 H,356.1180602,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 29,12RSYC,2-Nov-21
C1071022,10681002,2,PF-06863135,T,6515784462,6.51578E+11,20210601,10:06,CYCLE4_DAY1,0 H,622.2324506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 30,141RSYC,17-May-23
C1071022,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,11:53,CYCLE1_DAY1,0 H,293.0558051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 31,119RSYC,27-Jul-22
C1071022,10031001,3,PF-06863135,T,6514857230,6.51486E+11,20210322,19:01,CYCLE1_DAY1,6 H,866.2047559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 32,122RSYC,29-Jul-22
C1071022,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,12:50,CYCLE1_DAY8,0 H,174.6884766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 33,11RSYC,2-Nov-21
C1071022,10031001,3,PF-06863135,T,6515792892,6.51579E+11,20210401,19:20,CYCLE1_DAY8,6 H,482.658697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 34,12RSYC,2-Nov-21
C1071022,10031001,3,PF-06863135,T,6514020347,6.51402E+11,20210407,10:46,CYCLE1_DAY15,0 H,912.6095381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 35,2RSYC,27-Oct-21
C1071022,10031001,3,PF-06863135,T,6515792899,6.51579E+11,20210414,11:49,CYCLE1_DAY22,0 H,518.7789454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 36,2RSYC,27-Oct-21
C1071022,10031001,3,PF-06863135,T,6514020351,6.51402E+11,20210421,13:10,CYCLE2_DAY1,0 H,414.1683529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 37,2RSYC,27-Oct-21
C1071022,10031001,3,PF-06863135,T,6515792911,6.51579E+11,20210616,17:56,CYCLE4_DAY1,0 H,599.3168531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 38,2RSYC,27-Oct-21
C1071022,10031001,3,PF-06863135,T,6517889683,6.51789E+11,20210908,9:45,CYCLE7_DAY1,0 H,784.3786145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 174,6RSYC,29-Oct-21
C1071022,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,10:50,CYCLE1_DAY1,0 H,95.70120971,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 39,2RSYC,27-Oct-21
C1071022,10071001,4,PF-06863135,T,6514020370,6.51402E+11,20210325,17:30,CYCLE1_DAY1,6 H,450.5695848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 40,11RSYC,2-Nov-21
C1071022,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,11:00,CYCLE1_DAY8,0 H,11.44639656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 41,11RSYC,2-Nov-21
C1071022,10071001,4,PF-06863135,T,6514020372,6.51402E+11,20210401,17:25,CYCLE1_DAY8,6 H,754.0252172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 42,12RSYC,2-Nov-21
C1071022,10071001,4,PF-06863135,T,6514020373,6.51402E+11,20210408,10:50,CYCLE1_DAY15,0 H,529.0611371,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 43,2RSYC,27-Oct-21
C1071022,10071001,4,PF-06863135,T,6514020376,6.51402E+11,20210415,14:00,CYCLE1_DAY22,0 H,451.1707584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 44,2RSYC,27-Oct-21
C1071022,10071001,4,PF-06863135,T,6514020378,6.51402E+11,20210422,14:15,CYCLE2_DAY1,0 H,839.8533535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 45,2RSYC,27-Oct-21
C1071022,10071001,4,PF-06863135,T,6515768699,6.51577E+11,20210519,13:45,CYCLE3_DAY1,0 H,507.2492209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 46,12RSYC,2-Nov-21
C1071022,10071001,4,PF-06863135,T,6515808065,6.51581E+11,20210617,14:00,CYCLE4_DAY1,0 H,688.970531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 47,2RSYC,27-Oct-21
C1071022,10071001,4,PF-06863135,T,6516303733,6.5163E+11,20210909,9:20,CYCLE7_DAY1,0 H,972.4645535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 161,6RSYC,29-Oct-21
C1071022,10071001,4,PF-06863135,T,6518265669,6.51827E+11,20211202,11:30,CYCLE10_DAY1,0 H,84.75690279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1092,107RSYC,24-May-22
C1071022,10071001,4,PF-06863135,T,6518265671,6.51827E+11,20220224,11:30,CYCLE13_DAY1,0 H,154.977028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1885,109RSYC,25-May-22
C1071022,10071001,4,PF-06863135,T,6520930827,6.52093E+11,20220811,11:08,CYCLE19_DAY1,0 H,905.5778072,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2074,129RSYC,21-Oct-22
C1071022,10071001,4,PF-06863135,T,6520930824,6.52093E+11,20221103,8:52,CYCLE22_DAY1,0 H,291.104201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2137,139RSYC,22-Mar-23
C1071022,10071001,4,PF-06863135,T,6520930826,6.52093E+11,20230126,11:18,CYCLE25_DAY1,0 H,96.55802106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2214,142RSYC,18-May-23
C1071022,10071001,4,PF-06863135,T,6521740467,6.52174E+11,20230420,11:18,CYCLE28_DAY1,0 H,833.9330477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2243,143RSYC,27-Nov-23
C1071022,10071001,4,PF-06863135,T,6521740464,6.52174E+11,20230713,11:32,CYCLE31_DAY1,0 H,394.1272993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2289,145RSYC,4-Jan-24
C1071022,10071001,4,PF-06863135,T,6524291345,6.52429E+11,20231228,11:34,CYCLE37_DAY1,0 H,900.9988459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2320,148RSYC,27-Mar-24
C1071022,10071001,4,PF-06863135,T,6518265672,6.51827E+11,20220608,10:25,UNPL,9001 H,254.0946359,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2005,115RSYC,25-Jul-22
C1071022,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,11:20,CYCLE1_DAY1,0 H,639.9929586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 48,2RSYC,27-Oct-21
C1071022,10191002,5,PF-06863135,T,6517246477,6.51725E+11,20210712,18:35,CYCLE1_DAY1,6 H,654.8725749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 49,11RSYC,2-Nov-21
C1071022,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,10:54,CYCLE1_DAY8,0 H,131.9970835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 50,11RSYC,2-Nov-21
C1071022,10191002,5,PF-06863135,T,6514020417,6.51402E+11,20210719,17:10,CYCLE1_DAY8,6 H,357.8401303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 51,12RSYC,2-Nov-21
C1071022,10191002,5,PF-06863135,T,6517418458,6.51742E+11,20210727,11:03,CYCLE1_DAY15,0 H,483.5815921,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 52,2RSYC,27-Oct-21
C1071022,10191002,5,PF-06863135,T,6517418463,6.51742E+11,20210803,11:01,CYCLE1_DAY22,0 H,516.9114565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 53,2RSYC,27-Oct-21
C1071022,10191002,5,PF-06863135,T,6517418466,6.51742E+11,20210810,14:50,CYCLE2_DAY1,0 H,520.2031131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 54,2RSYC,27-Oct-21
C1071022,10191002,5,PF-06863135,T,6517418472,6.51742E+11,20210907,13:01,CYCLE3_DAY1,0 H,337.1844513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 171,6RSYC,29-Oct-21
C1071022,10191002,5,PF-06863135,T,6517246394,6.51725E+11,20211005,11:57,CYCLE4_DAY1,0 H,353.7890556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 279,14RSYC,15-Nov-21
C1071022,10191002,5,PF-06863135,T,6517418479,6.51742E+11,20211228,9:17,CYCLE7_DAY1,0 H,540.9102254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 965,65RSYC,3-May-22
C1071022,10191002,5,PF-06863135,T,6518807116,6.51881E+11,20220322,10:45,CYCLE10_DAY1,0 H,116.2824381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1890,87RSYC,13-May-22
C1071022,10191002,5,PF-06863135,T,6518807118,6.51881E+11,20220614,10:34,CYCLE13_DAY1,0 H,254.5629062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2007,115RSYC,25-Jul-22
C1071022,10191002,5,PF-06863135,T,6520491233,6.52049E+11,20220906,11:18,CYCLE16_DAY1,0 H,227.6491177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2077,131RSYC,9-Nov-22
C1071022,10191002,5,PF-06863135,T,6520491234,6.52049E+11,20221130,10:23,CYCLE19_DAY1,0 H,780.1738505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2128,139RSYC,22-Mar-23
C1071022,10191002,5,PF-06863135,T,6521907800,6.52191E+11,20230221,10:32,CYCLE22_DAY1,0 H,66.23756284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2203,141RSYC,17-May-23
C1071022,10191002,5,PF-06863135,T,6521907798,6.52191E+11,20230518,13:22,CYCLE25_DAY1,0 H,943.3999879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2244,145RSYC,4-Jan-24
C1071022,10191002,5,PF-06863135,T,6521907801,6.52191E+11,20230718,11:56,END_OF_TRT,,672.2325107,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2280,145RSYC,4-Jan-24
C1071022,10191002,5,PF-06863135,T,6517246397,6.51725E+11,20210713,12:35,CYCLE1_DAY1,24 H,706.3911355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 55,11RSYC,2-Nov-21
C1071022,10191002,5,PF-06863135,T,6517418482,6.51742E+11,20210715,10:12,CYCLE1_DAY4,0 H,366.0218188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 56,13RSYC,15-Nov-21
C1071022,10191002,5,PF-06863135,T,6517246497,6.51725E+11,20210716,12:20,CYCLE1_DAY4,24 H,973.9842259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 57,12RSYC,2-Nov-21
C1071022,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,10:30,CYCLE1_DAY1,0 H,976.667349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 58,2RSYC,27-Oct-21
C1071022,10981001,6,PF-06863135,T,6517246478,6.51725E+11,20210719,20:30,CYCLE1_DAY1,6 H,233.3110403,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 59,2RSYC,27-Oct-21
C1071022,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,9:30,CYCLE1_DAY8,0 H,847.204917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 60,12RSYC,2-Nov-21
C1071022,10981001,6,PF-06863135,T,6516326701,6.51633E+11,20210727,16:30,CYCLE1_DAY8,6 H,637.5314466,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 61,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517246482,6.51725E+11,20210802,11:10,CYCLE1_DAY15,0 H,479.6469186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 62,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517769668,6.51777E+11,20210809,11:05,CYCLE1_DAY22,0 H,578.9697534,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 63,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517769674,6.51777E+11,20210816,11:45,CYCLE2_DAY1,0 H,398.4303797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 64,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517769676,6.51777E+11,20210913,11:00,CYCLE3_DAY1,0 H,314.082506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 194,7RSYC,29-Oct-21
C1071022,10981001,6,PF-06863135,T,6517768789,6.51777E+11,20211011,11:04,CYCLE4_DAY1,0 H,675.0453249,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 341,16RSYC,16-Nov-21
C1071022,10981001,6,PF-06863135,T,6517246506,6.51725E+11,20210721,14:44,UNPL,9003 H,426.1916047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 65,11RSYC,2-Nov-21
C1071022,10981001,6,PF-06863135,T,6517246494,6.51725E+11,20210720,14:30,CYCLE1_DAY1,24 H,183.3375416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 66,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517246496,6.51725E+11,20210722,6:25,CYCLE1_DAY4,0 H,550.6274891,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 67,3RSYC,28-Oct-21
C1071022,10981001,6,PF-06863135,T,6517246498,6.51725E+11,20210724,11:00,CYCLE1_DAY4,24 H,813.264064,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 68,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,10:56,CYCLE1_DAY1,0 H,196.8255348,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 69,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6516326700,6.51633E+11,20210723,19:48,CYCLE1_DAY1,6 H,736.6836632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 70,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210730,8:25,CYCLE1_DAY8,0 H,493.8353708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 71,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517769660,6.51777E+11,20210802,18:30,CYCLE1_DAY8,6 H,806.4772736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 72,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517769666,6.51777E+11,20210812,9:36,CYCLE1_DAY15,0 H,126.5132227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 73,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517246507,6.51725E+11,20210817,17:12,END_OF_TRT,,805.2795209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 74,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517560594,6.51756E+11,20210724,11:40,CYCLE1_DAY1,24 H,80.02265008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 75,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517560596,6.51756E+11,20210726,11:57,CYCLE1_DAY4,0 H,37.63257227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 76,3RSYC,28-Oct-21
C1071022,10981002,7,PF-06863135,T,6517560598,6.51756E+11,20210727,13:43,CYCLE1_DAY4,24 H,371.8584546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 77,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,12:32,CYCLE1_DAY1,0 H,123.1860171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 78,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6516580385,6.51658E+11,20210802,18:59,CYCLE1_DAY1,6 H,645.6390769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 79,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,10:50,CYCLE1_DAY8,0 H,891.5100533,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 80,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6517889669,6.51789E+11,20210812,17:00,CYCLE1_DAY8,6 H,628.6573671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 81,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6517473942,6.51747E+11,20210803,14:10,CYCLE1_DAY1,24 H,776.950719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 82,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6517473943,6.51747E+11,20210806,9:30,CYCLE1_DAY4,0 H,435.3722675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 83,3RSYC,28-Oct-21
C1071022,10031005,8,PF-06863135,T,6517473952,6.51747E+11,20210807,9:35,CYCLE1_DAY4,24 H,661.1860146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 84,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,9:36,CYCLE1_DAY1,0 H,204.3499787,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 85,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418450,6.51742E+11,20210802,17:10,CYCLE1_DAY1,6 H,567.4986881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 86,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,9:28,CYCLE1_DAY8,0 H,608.6505779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 87,12RSYC,2-Nov-21
C1071022,10191004,9,PF-06863135,T,6517418457,6.51742E+11,20210809,17:15,CYCLE1_DAY8,6 H,904.9105793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 88,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418459,6.51742E+11,20210816,8:40,CYCLE1_DAY15,0 H,623.226297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 89,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517246387,6.51725E+11,20210823,9:10,CYCLE1_DAY22,0 H,367.0989273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 172,6RSYC,29-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418467,6.51742E+11,20210830,8:50,CYCLE2_DAY1,0 H,949.9466056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 173,6RSYC,29-Oct-21
C1071022,10191004,9,PF-06863135,T,6517246393,6.51725E+11,20211025,10:19,CYCLE4_DAY1,0 H,523.322248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 517,25RSYC,22-Apr-22
C1071022,10191004,9,PF-06863135,T,6517418481,6.51742E+11,20220117,9:30,CYCLE7_DAY1,0 H,81.0568983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1610,97RSYC,12-May-22
C1071022,10191004,9,PF-06863135,T,6518807117,6.51881E+11,20220411,9:39,CYCLE10_DAY1,0 H,452.9514754,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1922,123RSYC,29-Jul-22
C1071022,10191004,9,PF-06863135,T,6520491237,6.52049E+11,20220705,10:31,CYCLE13_DAY1,0 H,930.8454279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2027,128RSYC,21-Oct-22
C1071022,10191004,9,PF-06863135,T,6520491231,6.52049E+11,20220926,10:05,CYCLE16_DAY1,0 H,195.1880589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2107,131RSYC,9-Nov-22
C1071022,10191004,9,PF-06863135,T,6521907799,6.52191E+11,20221219,9:32,CYCLE19_DAY1,0 H,139.4424324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2171,140RSYC,22-Mar-23
C1071022,10191004,9,PF-06863135,T,6521907796,6.52191E+11,20230313,10:19,CYCLE22_DAY1,0 H,951.9758636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2204,141RSYC,17-May-23
C1071022,10191004,9,PF-06863135,T,6522691980,6.52269E+11,20230605,10:30,CYCLE25_DAY1,0 H,336.1574113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2261,144RSYC,27-Nov-23
C1071022,10191004,9,PF-06863135,T,6522691972,6.52269E+11,20230828,10:29,CYCLE28_DAY1,0 H,902.970902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2300,147RSYC,29-Feb-24
C1071022,10191004,9,PF-06863135,T,6517246398,6.51725E+11,20210803,11:15,CYCLE1_DAY1,24 H,206.4938284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 90,3RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418484,6.51742E+11,20210805,8:24,CYCLE1_DAY4,0 H,845.4375983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 91,4RSYC,28-Oct-21
C1071022,10191004,9,PF-06863135,T,6517418487,6.51742E+11,20210806,11:05,CYCLE1_DAY4,24 H,369.4468705,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 92,12RSYC,2-Nov-21
C1071022,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,14:55,CYCLE1_DAY1,0 H,431.7734728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 93,4RSYC,28-Oct-21
C1071022,10681004,10,PF-06863135,T,6517472543,6.51747E+11,20210802,20:40,CYCLE1_DAY1,6 H,4.21942365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 94,4RSYC,28-Oct-21
C1071022,10681004,10,PF-06863135,T,6517763953,6.51776E+11,20210812,17:25,END_OF_TRT,,81.43922538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 95,4RSYC,28-Oct-21
C1071022,10681004,10,PF-06863135,T,6517260791,6.51726E+11,20210803,14:56,CYCLE1_DAY1,24 H,23.24918941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 96,4RSYC,28-Oct-21
C1071022,10681004,10,PF-06863135,T,6517472561,6.51747E+11,20210805,8:30,CYCLE1_DAY4,0 H,755.2258146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 97,4RSYC,28-Oct-21
C1071022,10681004,10,PF-06863135,T,6517763951,6.51776E+11,20210806,11:30,CYCLE1_DAY4,24 H,414.1609952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 98,4RSYC,28-Oct-21
C1071022,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,15:45,CYCLE1_DAY1,0 H,769.4950448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1,1RSYC,26-Oct-21
C1071022,10821001,11,PF-06863135,T,6603295436,6.6033E+11,20210809,22:10,CYCLE1_DAY1,6 H,643.2396092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2,11RSYC,2-Nov-21
C1071022,10821001,11,PF-06863135,T,6603295460,6.6033E+11,20210816,19:25,UNPL,9001 H,934.1259052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 3,1RSYC,26-Oct-21
C1071022,10821001,11,PF-06863135,T,6603295452,6.6033E+11,20210810,14:30,CYCLE1_DAY1,24 H,23.84406139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 4,11RSYC,2-Nov-21
C1071022,10821001,11,PF-06863135,T,6603295454,6.6033E+11,20210812,18:20,CYCLE1_DAY4,0 H,549.9997875,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 5,11RSYC,2-Nov-21
C1071022,10821001,11,PF-06863135,T,6603295456,6.6033E+11,20210813,19:02,CYCLE1_DAY4,24 H,184.6339672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 6,11RSYC,2-Nov-21
C1071022,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,13:05,CYCLE1_DAY1,0 H,140.594223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 185,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246446,6.51725E+11,20210806,20:10,CYCLE1_DAY1,6 H,660.684442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 184,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,10:00,CYCLE1_DAY8,0 H,256.4933143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 187,12RSYC,2-Nov-21
C1071022,10771001,12,PF-06863135,T,6517246448,6.51725E+11,20210813,17:20,CYCLE1_DAY8,6 H,769.1914042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 186,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517643718,6.51764E+11,20210819,10:20,CYCLE1_DAY15,0 H,423.5304453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 192,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246452,6.51725E+11,20210825,10:38,CYCLE1_DAY22,0 H,537.6606387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 188,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246453,6.51725E+11,20210908,10:52,CYCLE2_DAY1,0 H,221.8743932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 189,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246455,6.51725E+11,20211006,11:34,CYCLE3_DAY1,0 H,404.9853521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 280,14RSYC,15-Nov-21
C1071022,10771001,12,PF-06863135,T,6517775846,6.51778E+11,20211103,11:50,UNPL,9001 H,575.6403422,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 910,20RSYC,19-Apr-22
C1071022,10771001,12,PF-06863135,T,6517246461,6.51725E+11,20210807,14:10,CYCLE1_DAY1,24 H,21.50707067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 190,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517246464,6.51725E+11,20210809,12:20,CYCLE1_DAY4,0 H,552.5733312,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 191,7RSYC,29-Oct-21
C1071022,10771001,12,PF-06863135,T,6517775855,6.51778E+11,20210810,14:55,CYCLE1_DAY4,24 H,457.7890775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 193,7RSYC,29-Oct-21
C1071022,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,10:50,CYCLE1_DAY1,0 H,360.9355422,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 99,4RSYC,28-Oct-21
C1071022,10031004,13,PF-06863135,T,6516580382,6.51658E+11,20210809,18:15,CYCLE1_DAY1,6 H,819.9087405,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 100,4RSYC,28-Oct-21
C1071022,10031004,13,PF-06863135,T,6517751580,6.51775E+11,20211004,10:58,CYCLE3_DAY1,0 H,101.1752045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 332,16RSYC,16-Nov-21
C1071022,10031004,13,PF-06863135,T,6517751588,6.51775E+11,20211101,13:40,CYCLE4_DAY1,0 H,306.2812754,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 590,27RSYC,21-Apr-22
C1071022,10031004,13,PF-06863135,T,6517889684,6.51789E+11,20210810,12:27,CYCLE1_DAY1,24 H,511.6142894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 102,4RSYC,28-Oct-21
C1071022,10031004,13,PF-06863135,T,6517889686,6.51789E+11,20210811,16:15,CYCLE1_DAY4,0 H,365.87677,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 103,4RSYC,28-Oct-21
C1071022,10031004,13,PF-06863135,T,6517889689,6.51789E+11,20210812,16:57,CYCLE1_DAY4,24 H,76.59902708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 101,4RSYC,28-Oct-21
C1071022,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,10:23,CYCLE1_DAY1,0 H,204.0705628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 104,4RSYC,28-Oct-21
C1071022,11171001,14,PF-06863135,T,6517764044,6.51776E+11,20210809,17:23,CYCLE1_DAY1,6 H,559.461145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 105,9RSYC,1-Nov-21
C1071022,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,9:25,CYCLE1_DAY8,0 H,288.1699713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 106,12RSYC,2-Nov-21
C1071022,11171001,14,PF-06863135,T,6517764048,6.51776E+11,20210818,17:50,CYCLE1_DAY8,6 H,514.9096027,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 107,4RSYC,28-Oct-21
C1071022,11171001,14,PF-06863135,T,6517433559,6.51743E+11,20210826,9:41,CYCLE1_DAY15,0 H,503.0906497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 196,7RSYC,29-Oct-21
C1071022,11171001,14,PF-06863135,T,6517433562,6.51743E+11,20210902,9:30,CYCLE1_DAY22,0 H,477.3160097,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 195,7RSYC,29-Oct-21
C1071022,11171001,14,PF-06863135,T,6517433563,6.51743E+11,20210909,13:33,CYCLE2_DAY1,0 H,839.2462093,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 197,7RSYC,29-Oct-21
C1071022,11171001,14,PF-06863135,T,6518158468,6.51816E+11,20211007,9:00,CYCLE3_DAY1,0 H,53.00453714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 352,17RSYC,17-Nov-21
C1071022,11171001,14,PF-06863135,T,6518158472,6.51816E+11,20211104,10:41,CYCLE4_DAY1,0 H,871.5508197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 604,27RSYC,21-Apr-22
C1071022,11171001,14,PF-06863135,T,6517764069,6.51776E+11,20220127,9:20,CYCLE7_DAY1,0 H,139.0193189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1724,72RSYC,7-May-22
C1071022,11171001,14,PF-06863135,T,6518390144,6.51839E+11,20220421,8:04,CYCLE10_DAY1,0 H,713.1684874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1983,114RSYC,25-Jul-22
C1071022,11171001,14,PF-06863135,T,6518390143,6.51839E+11,20220714,8:45,CYCLE13_DAY1,0 H,103.9802134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2093,127RSYC,19-Oct-22
C1071022,11171001,14,PF-06863135,T,6517764086,6.51776E+11,20220912,7:30,END_OF_TRT,,155.6198265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2100,132RSYC,10-Nov-22
C1071022,11171001,14,PF-06863135,T,6517433571,6.51743E+11,20210810,11:15,CYCLE1_DAY1,24 H,537.2034865,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 108,4RSYC,28-Oct-21
C1071022,11171001,14,PF-06863135,T,6517433573,6.51743E+11,20210812,6:28,CYCLE1_DAY4,0 H,458.1694242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 109,4RSYC,28-Oct-21
C1071022,11171001,14,PF-06863135,T,6517433575,6.51743E+11,20210813,11:45,CYCLE1_DAY4,24 H,697.4828992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 110,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,10:30,CYCLE1_DAY1,0 H,406.2109227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 111,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517764040,6.51776E+11,20210809,17:30,CYCLE1_DAY1,6 H,333.3865939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 112,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,8:40,CYCLE1_DAY8,0 H,732.4335088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 113,12RSYC,2-Nov-21
C1071022,11171002,15,PF-06863135,T,6517764047,6.51776E+11,20210816,17:36,CYCLE1_DAY8,6 H,479.8823174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 114,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517433560,6.51743E+11,20210825,9:40,CYCLE1_DAY15,0 H,475.5172759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 199,7RSYC,29-Oct-21
C1071022,11171002,15,PF-06863135,T,6517433561,6.51743E+11,20210901,10:12,CYCLE1_DAY22,0 H,546.444651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 198,7RSYC,29-Oct-21
C1071022,11171002,15,PF-06863135,T,6517764062,6.51776E+11,20210908,12:20,CYCLE2_DAY1,0 H,393.1480457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 200,7RSYC,29-Oct-21
C1071022,11171002,15,PF-06863135,T,6518158467,6.51816E+11,20211006,9:25,CYCLE3_DAY1,0 H,681.7675538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 351,17RSYC,17-Nov-21
C1071022,11171002,15,PF-06863135,T,6518158471,6.51816E+11,20211102,10:37,CYCLE4_DAY1,0 H,637.5945943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 603,27RSYC,21-Apr-22
C1071022,11171002,15,PF-06863135,T,6517764089,6.51776E+11,20211123,9:24,END_OF_TRT,,565.5943555,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 906,86RSYC,13-May-22
C1071022,11171002,15,PF-06863135,T,6517764071,6.51776E+11,20210810,11:20,CYCLE1_DAY1,24 H,924.0202622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 115,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517764076,6.51776E+11,20210812,6:34,CYCLE1_DAY4,0 H,753.9761755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 116,4RSYC,28-Oct-21
C1071022,11171002,15,PF-06863135,T,6517433576,6.51743E+11,20210813,11:30,CYCLE1_DAY4,24 H,588.4954889,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 117,12RSYC,2-Nov-21
C1071022,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,10:35,CYCLE1_DAY1,0 H,862.4314978,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 118,4RSYC,28-Oct-21
C1071022,10031006,16,PF-06863135,T,6517751563,6.51775E+11,20210816,17:36,CYCLE1_DAY1,6 H,194.4711867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 119,4RSYC,28-Oct-21
C1071022,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,11:20,CYCLE1_DAY8,0 H,569.5320715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 179,12RSYC,2-Nov-21
C1071022,10031006,16,PF-06863135,T,6517889668,6.51789E+11,20210825,17:02,CYCLE1_DAY8,6 H,719.3617734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 178,6RSYC,29-Oct-21
C1071022,10031006,16,PF-06863135,T,6517751571,6.51775E+11,20210901,16:35,CYCLE1_DAY15,0 H,796.5143182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 175,6RSYC,29-Oct-21
C1071022,10031006,16,PF-06863135,T,6517751572,6.51775E+11,20210908,13:16,CYCLE1_DAY22,0 H,570.7840879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 176,6RSYC,29-Oct-21
C1071022,10031006,16,PF-06863135,T,6517751576,6.51775E+11,20210915,10:10,CYCLE2_DAY1,0 H,490.8543508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 177,6RSYC,29-Oct-21
C1071022,10031006,16,PF-06863135,T,6517751585,6.51775E+11,20211110,14:44,CYCLE4_DAY1,0 H,513.5023546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 901,20RSYC,19-Apr-22
C1071022,10031006,16,PF-06863135,T,6517260610,6.51726E+11,20210817,11:30,CYCLE1_DAY1,24 H,482.2298871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 120,5RSYC,28-Oct-21
C1071022,10031006,16,PF-06863135,T,6517889687,6.51789E+11,20210820,14:00,CYCLE1_DAY4,0 H,510.3781744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1086,67RSYC,8-May-22
C1071022,10031006,16,PF-06863135,T,6517889688,6.51789E+11,20210821,12:45,CYCLE1_DAY4,24 H,927.2320101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1087,87RSYC,13-May-22
C1071022,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,9:25,CYCLE1_DAY1,0 H,346.5389353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 7,1RSYC,26-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324910,6.60332E+11,20210816,16:26,CYCLE1_DAY1,6 H,978.5275253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 8,11RSYC,2-Nov-21
C1071022,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,13:15,CYCLE1_DAY8,0 H,512.4415402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 132,12RSYC,2-Nov-21
C1071022,10021001,17,PF-06863135,T,6603324913,6.60332E+11,20210823,20:00,CYCLE1_DAY8,6 H,36.60156749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 133,5RSYC,28-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324915,6.60332E+11,20210830,12:52,CYCLE1_DAY15,0 H,696.8990699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 134,5RSYC,28-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324917,6.60332E+11,20210906,10:00,CYCLE1_DAY22,0 H,455.2343267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 135,5RSYC,28-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324919,6.60332E+11,20210913,12:50,CYCLE2_DAY1,0 H,34.08854647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 136,5RSYC,28-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324921,6.60332E+11,20211013,13:40,CYCLE3_DAY1,0 H,891.5801179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 236,13RSYC,15-Nov-21
C1071022,10021001,17,PF-06863135,T,6603324923,6.60332E+11,20211110,14:40,CYCLE4_DAY1,0 H,626.9212517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 813,34RSYC,24-Apr-22
C1071022,10021001,17,PF-06863135,T,6603324924,6.60332E+11,20220202,11:35,CYCLE7_DAY1,0 H,460.2300618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1582,59RSYC,1-May-22
C1071022,10021001,17,PF-06863135,T,6603839288,6.60384E+11,20220427,12:25,CYCLE10_DAY1,0 H,647.9752235,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2002,115RSYC,25-Jul-22
C1071022,10021001,17,PF-06863135,T,6603324933,6.60332E+11,20220720,12:30,CYCLE13_DAY1,0 H,25.53649873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2066,132RSYC,10-Nov-22
C1071022,10021001,17,PF-06863135,T,6604204206,6.6042E+11,20221012,12:45,CYCLE16_DAY1,0 H,818.3701797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2114,131RSYC,9-Nov-22
C1071022,10021001,17,PF-06863135,T,6604204199,6.6042E+11,20230105,11:45,CYCLE19_DAY1,0 H,107.329022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2185,141RSYC,17-May-23
C1071022,10021001,17,PF-06863135,T,6604204200,6.6042E+11,20230329,11:10,CYCLE22_DAY1,0 H,282.158971,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2234,143RSYC,27-Nov-23
C1071022,10021001,17,PF-06863135,T,6604608949,6.60461E+11,20230913,12:38,CYCLE28_DAY1,0 H,906.9827528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2335,148RSYC,27-Mar-24
C1071022,10021001,17,PF-06863135,T,6604777912,6.60478E+11,20231206,14:30,CYCLE31_DAY1,0 H,971.3314302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2336,148RSYC,27-Mar-24
C1071022,10021001,17,PF-06863135,T,6604777916,6.60478E+11,20240228,13:40,CYCLE34_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,10021001,17,PF-06863135,T,6603324937,6.60332E+11,20210820,20:18,UNPL,9002 H,394.9627751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 137,5RSYC,28-Oct-21
C1071022,10021001,17,PF-06863135,T,6603324926,6.60332E+11,20210817,9:27,CYCLE1_DAY1,24 H,683.4159257,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 9,11RSYC,2-Nov-21
C1071022,10021001,17,PF-06863135,T,6603324929,6.60332E+11,20210819,9:35,CYCLE1_DAY4,0 H,245.6958628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 10,11RSYC,2-Nov-21
C1071022,10021001,17,PF-06863135,T,6603324931,6.60332E+11,20210820,9:20,CYCLE1_DAY4,24 H,555.5375732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 11,11RSYC,2-Nov-21
C1071022,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,10:11,CYCLE1_DAY1,0 H,738.2722128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 121,5RSYC,28-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764042,6.51776E+11,20210816,17:28,CYCLE1_DAY1,6 H,355.7610607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 122,9RSYC,1-Nov-21
C1071022,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,8:26,CYCLE1_DAY8,0 H,37.17544633,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 123,12RSYC,2-Nov-21
C1071022,11171003,18,PF-06863135,T,6517764046,6.51776E+11,20210823,17:10,CYCLE1_DAY8,6 H,140.3891155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 124,5RSYC,28-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764050,6.51776E+11,20210830,10:40,CYCLE1_DAY15,0 H,577.8797432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 201,7RSYC,29-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764058,6.51776E+11,20210907,10:40,CYCLE1_DAY22,0 H,558.3529709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 202,7RSYC,29-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764063,6.51776E+11,20210915,12:22,CYCLE2_DAY1,0 H,635.3775173,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 203,7RSYC,29-Oct-21
C1071022,11171003,18,PF-06863135,T,6517433565,6.51743E+11,20211015,9:10,CYCLE3_DAY1,0 H,237.9870764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 545,26RSYC,22-Apr-22
C1071022,11171003,18,PF-06863135,T,6517764068,6.51776E+11,20211110,11:57,CYCLE4_DAY1,0 H,953.6412871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 596,27RSYC,21-Apr-22
C1071022,11171003,18,PF-06863135,T,6517433570,6.51743E+11,20220202,8:24,CYCLE7_DAY1,0 H,628.5755789,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1725,72RSYC,7-May-22
C1071022,11171003,18,PF-06863135,T,6517764088,6.51776E+11,20220331,13:54,END_OF_TRT,,862.2095351,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1923,123RSYC,29-Jul-22
C1071022,11171003,18,PF-06863135,T,6517433572,6.51743E+11,20210817,11:02,CYCLE1_DAY1,24 H,196.0482958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 125,5RSYC,28-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764077,6.51776E+11,20210819,11:19,CYCLE1_DAY4,0 H,650.0226315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 126,5RSYC,28-Oct-21
C1071022,11171003,18,PF-06863135,T,6517764082,6.51776E+11,20210820,11:02,CYCLE1_DAY4,24 H,21.20192476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 204,7RSYC,29-Oct-21
C1071022,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,10:31,CYCLE1_DAY1,0 H,419.012197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 127,5RSYC,28-Oct-21
C1071022,11171005,19,PF-06863135,T,6517433556,6.51743E+11,20210816,17:32,CYCLE1_DAY1,6 H,115.775996,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 128,9RSYC,1-Nov-21
C1071022,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,7:50,CYCLE1_DAY8,0 H,469.6325439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 205,12RSYC,2-Nov-21
C1071022,11171005,19,PF-06863135,T,6517764045,6.51776E+11,20210823,18:15,CYCLE1_DAY8,6 H,444.8972718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 129,5RSYC,28-Oct-21
C1071022,11171005,19,PF-06863135,T,6517764053,6.51776E+11,20210901,10:12,CYCLE1_DAY15,0 H,186.4774573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 206,7RSYC,29-Oct-21
C1071022,11171005,19,PF-06863135,T,6517764057,6.51776E+11,20210907,10:15,CYCLE1_DAY22,0 H,835.7276977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 207,7RSYC,29-Oct-21
C1071022,11171005,19,PF-06863135,T,6518158469,6.51816E+11,20211011,8:50,CYCLE3_DAY1,0 H,367.3809986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 353,17RSYC,17-Nov-21
C1071022,11171005,19,PF-06863135,T,6517433586,6.51743E+11,20211108,11:25,END_OF_TRT,,807.7538042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 546,86RSYC,13-May-22
C1071022,11171005,19,PF-06863135,T,6517764073,6.51776E+11,20210817,10:50,CYCLE1_DAY1,24 H,599.5753842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 130,5RSYC,28-Oct-21
C1071022,11171005,19,PF-06863135,T,6517764078,6.51776E+11,20210819,11:18,CYCLE1_DAY4,0 H,997.5585386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 131,5RSYC,28-Oct-21
C1071022,11171005,19,PF-06863135,T,6517764081,6.51776E+11,20210820,11:22,CYCLE1_DAY4,24 H,420.9711149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 208,7RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,12:45,CYCLE1_DAY1,0 H,173.6349682,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 163,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472394,6.51747E+11,20210824,18:50,CYCLE1_DAY1,6 H,98.40613902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 162,9RSYC,1-Nov-21
C1071022,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,9:50,CYCLE1_DAY8,0 H,875.3914645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 164,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472396,6.51747E+11,20210903,16:31,CYCLE1_DAY8,6 H,560.1017718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 165,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472399,6.51747E+11,20210913,7:50,CYCLE1_DAY15,0 H,850.0469902,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 166,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472401,6.51747E+11,20210923,8:10,CYCLE1_DAY22,0 H,923.4816096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 167,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472403,6.51747E+11,20210930,8:30,CYCLE2_DAY1,0 H,876.3591165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 292,15RSYC,16-Nov-21
C1071022,10071002,20,PF-06863135,T,6517472405,6.51747E+11,20211104,8:10,CYCLE3_DAY1,0 H,378.2757256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 551,26RSYC,22-Apr-22
C1071022,10071002,20,PF-06863135,T,6517472408,6.51747E+11,20220217,8:40,CYCLE7_DAY1,0 H,726.9980354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1598,96RSYC,12-May-22
C1071022,10071002,20,PF-06863135,T,6517472417,6.51747E+11,20220520,9:43,CYCLE10_DAY1,0 H,344.7887022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1967,114RSYC,25-Jul-22
C1071022,10071002,20,PF-06863135,T,6518265670,6.51827E+11,20220812,8:40,CYCLE13_DAY1,0 H,604.5053518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2075,129RSYC,21-Oct-22
C1071022,10071002,20,PF-06863135,T,6520930829,6.52093E+11,20221104,8:01,CYCLE16_DAY1,0 H,869.8174728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2138,139RSYC,22-Mar-23
C1071022,10071002,20,PF-06863135,T,6521740462,6.52174E+11,20230127,7:52,CYCLE19_DAY1,0 H,692.7397544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2215,142RSYC,18-May-23
C1071022,10071002,20,PF-06863135,T,6521740465,6.52174E+11,20230421,7:55,CYCLE22_DAY1,0 H,268.8225512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2245,143RSYC,27-Nov-23
C1071022,10071002,20,PF-06863135,T,6521740463,6.52174E+11,20230714,8:51,CYCLE25_DAY1,0 H,18.04082416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2290,145RSYC,4-Jan-24
C1071022,10071002,20,PF-06863135,T,6523543385,6.52354E+11,20231229,9:17,CYCLE31_DAY1,0 H,660.3882483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2322,148RSYC,27-Mar-24
C1071022,10071002,20,PF-06863135,T,6520344352,6.52034E+11,20211203,8:10,UNPL,9001 H,121.0374149,NG/ML,,Received as 6517472406-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 992,66RSYC,3-May-22
C1071022,10071002,20,PF-06863135,T,6517472411,6.51747E+11,20210825,11:45,CYCLE1_DAY1,24 H,763.927868,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 168,11RSYC,2-Nov-21
C1071022,10071002,20,PF-06863135,T,6517472412,6.51747E+11,20210830,14:00,CYCLE1_DAY4,0 H,226.9844518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 169,6RSYC,29-Oct-21
C1071022,10071002,20,PF-06863135,T,6517472415,6.51747E+11,20210831,12:25,CYCLE1_DAY4,24 H,824.8461449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 170,6RSYC,29-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,9:13,CYCLE1_DAY1,0 H,85.9563956,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 138,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349515,6.60335E+11,20210830,17:40,CYCLE1_DAY1,6 H,899.4310473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 139,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,13:34,CYCLE1_DAY8,0 H,316.7851486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 140,12RSYC,2-Nov-21
C1071022,10381001,21,PF-06863135,T,6603349517,6.60335E+11,20210906,20:05,CYCLE1_DAY8,6 H,751.8521544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 141,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349519,6.60335E+11,20210914,13:32,CYCLE1_DAY15,0 H,481.4299757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 142,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349520,6.60335E+11,20210921,13:54,CYCLE1_DAY22,0 H,137.0221497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 143,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349525,6.60335E+11,20211026,13:10,CYCLE3_DAY1,0 H,334.2864156,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 617,90RSYC,11-May-22
C1071022,10381001,21,PF-06863135,T,6603349527,6.60335E+11,20211123,13:07,CYCLE4_DAY1,0 H,632.4577279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 814,34RSYC,24-Apr-22
C1071022,10381001,21,PF-06863135,T,6603349528,6.60335E+11,20220216,8:45,CYCLE7_DAY1,0 H,787.4930388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1589,59RSYC,1-May-22
C1071022,10381001,21,PF-06863135,T,6603682808,6.60368E+11,20220518,10:50,CYCLE10_DAY1,0 H,424.7360331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2004,115RSYC,25-Jul-22
C1071022,10381001,21,PF-06863135,T,6604047970,6.60405E+11,20220810,11:45,CYCLE13_DAY1,0 H,135.7938727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2068,129RSYC,21-Oct-22
C1071022,10381001,21,PF-06863135,T,6603682806,6.60368E+11,20221102,12:20,CYCLE16_DAY1,0 H,667.1398932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2150,139RSYC,22-Mar-23
C1071022,10381001,21,PF-06863135,T,6604047975,6.60405E+11,20230125,10:30,CYCLE19_DAY1,0 H,382.4535687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2187,141RSYC,17-May-23
C1071022,10381001,21,PF-06863135,T,6604254033,6.60425E+11,20230712,8:30,CYCLE25_DAY1,0 H,633.9869483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2270,144RSYC,27-Nov-23
C1071022,10381001,21,PF-06863135,T,6604594756,6.60459E+11,20231004,8:58,CYCLE28_DAY1,0 H,269.1386225,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2313,147RSYC,29-Feb-24
C1071022,10381001,21,PF-06863135,T,6605017953,6.60502E+11,20240110,11:40,END_OF_TRT,,651.460907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2337,152RSYC,9-Apr-24
C1071022,10381001,21,PF-06863135,T,6603349531,6.60335E+11,20210831,12:10,CYCLE1_DAY1,24 H,672.7585755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 144,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349532,6.60335E+11,20210902,12:20,CYCLE1_DAY4,0 H,537.7764855,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 145,5RSYC,28-Oct-21
C1071022,10381001,21,PF-06863135,T,6603349534,6.60335E+11,20210903,13:30,CYCLE1_DAY4,24 H,431.5479739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 146,5RSYC,28-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,13:40,CYCLE1_DAY1,0 H,578.3876623,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 147,5RSYC,28-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295435,6.6033E+11,20210906,20:15,CYCLE1_DAY1,6 H,157.2525363,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 148,5RSYC,28-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,12:21,CYCLE1_DAY8,0 H,50.17605055,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 149,5RSYC,28-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295437,6.6033E+11,20210913,19:50,CYCLE1_DAY8,6 H,910.2488465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 150,6RSYC,29-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295439,6.6033E+11,20210920,13:45,CYCLE1_DAY15,0 H,316.2782515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 232,21RSYC,20-Apr-22
C1071022,10821003,22,PF-06863135,T,6603295441,6.6033E+11,20210930,13:05,CYCLE1_DAY22,0 H,740.0582758,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 233,13RSYC,15-Nov-21
C1071022,10821003,22,PF-06863135,T,6603295459,6.6033E+11,20210908,18:45,UNPL,9001 H,692.1139349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 151,11RSYC,2-Nov-21
C1071022,10821003,22,PF-06863135,T,6603295451,6.6033E+11,20210907,14:15,CYCLE1_DAY1,24 H,301.9868709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 152,6RSYC,29-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295453,6.6033E+11,20210910,12:20,CYCLE1_DAY4,0 H,270.391095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 153,6RSYC,29-Oct-21
C1071022,10821003,22,PF-06863135,T,6603295455,6.6033E+11,20210911,12:50,CYCLE1_DAY4,24 H,353.0555222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 154,6RSYC,29-Oct-21
C1071022,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,12:10,CYCLE1_DAY1,0 H,417.6398521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 291,15RSYC,16-Nov-21
C1071022,10071003,23,PF-06863135,T,6517472395,6.51747E+11,20210930,18:20,CYCLE1_DAY1,6 H,643.641014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 290,15RSYC,16-Nov-21
C1071022,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,9:15,CYCLE1_DAY8,0 H,603.0088133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 548,26RSYC,22-Apr-22
C1071022,10071003,23,PF-06863135,T,6517472397,6.51747E+11,20211019,15:55,CYCLE1_DAY8,6 H,174.1549069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 547,26RSYC,22-Apr-22
C1071022,10071003,23,PF-06863135,T,6517472398,6.51747E+11,20211025,11:05,CYCLE1_DAY15,0 H,762.7474269,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 549,26RSYC,22-Apr-22
C1071022,10071003,23,PF-06863135,T,6517472402,6.51747E+11,20211101,8:40,CYCLE2_DAY1,0 H,417.7509104,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 550,26RSYC,22-Apr-22
C1071022,10071003,23,PF-06863135,T,6517472404,6.51747E+11,20211129,8:25,CYCLE3_DAY1,0 H,701.6029735,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 991,66RSYC,3-May-22
C1071022,10071003,23,PF-06863135,T,6517472407,6.51747E+11,20211227,9:00,CYCLE4_DAY1,0 H,427.3121052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 993,66RSYC,3-May-22
C1071022,10071003,23,PF-06863135,T,6517472425,6.51747E+11,20220124,8:25,END_OF_TRT,,647.8670551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1599,110RSYC,25-May-22
C1071022,10071003,23,PF-06863135,T,6517472410,6.51747E+11,20211001,12:15,CYCLE1_DAY1,24 H,203.0488437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 293,15RSYC,16-Nov-21
C1071022,10071003,23,PF-06863135,T,6517472413,6.51747E+11,20211015,11:00,CYCLE1_DAY4,0 H,275.4775755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 294,15RSYC,16-Nov-21
C1071022,10071003,23,PF-06863135,T,6517472414,6.51747E+11,20211016,10:30,CYCLE1_DAY4,24 H,336.9622346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 295,15RSYC,16-Nov-21
C1071022,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,9:04,CYCLE1_DAY1,0 H,770.1113707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 209,7RSYC,29-Oct-21
C1071022,11211001,24,PF-06863135,T,6801650268,6.80165E+11,20210913,18:40,CYCLE1_DAY1,6 H,574.0730296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 210,8RSYC,29-Oct-21
C1071022,11211001,24,PF-06863135,T,6801650270,6.80165E+11,20210921,8:55,CYCLE1_DAY8,0 H,849.8743929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 211,12RSYC,2-Nov-21
C1071022,11211001,24,PF-06863135,T,6801650271,6.80165E+11,20211013,9:00,CYCLE2_DAY1,0 H,11.94448697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 650,110RSYC,25-May-22
C1071022,11211001,24,PF-06863135,T,6801703038,6.8017E+11,20211111,9:25,CYCLE3_DAY1,0 H,804.7125773,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 670,30RSYC,22-Apr-22
C1071022,11211001,24,PF-06863135,T,6801703039,6.8017E+11,20211209,9:15,CYCLE4_DAY1,0 H,177.3083507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 959,65RSYC,3-May-22
C1071022,11211001,24,PF-06863135,T,6801793351,6.80179E+11,20220303,11:30,CYCLE7_DAY1,0 H,876.9080721,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1874,80RSYC,4-May-22
C1071022,11211001,24,PF-06863135,T,6801697216,6.8017E+11,20220525,10:20,CYCLE10_DAY1,0 H,568.6493624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1963,114RSYC,25-Jul-22
C1071022,11211001,24,PF-06863135,T,6802000328,6.802E+11,20220818,9:50,CYCLE13_DAY1,0 H,348.1601562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2073,129RSYC,21-Oct-22
C1071022,11211001,24,PF-06863135,T,6802000329,6.802E+11,20221110,8:45,CYCLE16_DAY1,0 H,176.4528365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2159,140RSYC,22-Mar-23
C1071022,11211001,24,PF-06863135,T,6802110620,6.80211E+11,20230202,9:10,CYCLE19_DAY1,0 H,,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,11211001,24,PF-06863135,T,6802110621,6.80211E+11,20230427,10:45,CYCLE22_DAY1,0 H,863.3969057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2254,145RSYC,4-Jan-24
C1071022,11211001,24,PF-06863135,T,6802330963,6.80233E+11,20230720,10:10,CYCLE25_DAY1,0 H,115.008498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2271,145RSYC,4-Jan-24
C1071022,11211001,24,PF-06863135,T,6802351832,6.80235E+11,20231012,9:00,CYCLE28_DAY1,0 H,24.70303738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2314,147RSYC,29-Feb-24
C1071022,11211001,24,PF-06863135,T,6801650286,6.80165E+11,20210915,10:40,UNPL,9001 H,824.1209124,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 212,8RSYC,29-Oct-21
C1071022,11211001,24,PF-06863135,T,6802024260,6.80202E+11,20211013,17:40,UNPL,9002 H,651.601991,NG/ML,9,Received as 6801650271-05,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,11211001,24,PF-06863135,T,6801650280,6.80165E+11,20210914,11:25,CYCLE1_DAY1,24 H,610.5094003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 213,8RSYC,29-Oct-21
C1071022,11211001,24,PF-06863135,T,6801650282,6.80165E+11,20210916,8:35,CYCLE1_DAY4,0 H,934.6055401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 214,8RSYC,29-Oct-21
C1071022,11211001,24,PF-06863135,T,6801650284,6.80165E+11,20210917,12:00,CYCLE1_DAY4,24 H,711.4860264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 215,8RSYC,29-Oct-21
C1071022,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,11:27,CYCLE1_DAY1,0 H,670.321255,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1084,41RSYC,26-Apr-22
C1071022,10031007,25,PF-06863135,T,6517889667,6.51789E+11,20210914,18:00,CYCLE1_DAY1,6 H,860.9904712,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1083,41RSYC,26-Apr-22
C1071022,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,10:55,CYCLE1_DAY8,0 H,140.2008882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 182,12RSYC,2-Nov-21
C1071022,10031007,25,PF-06863135,T,6517751566,6.51775E+11,20210921,16:27,CYCLE1_DAY8,6 H,874.9303109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 181,7RSYC,29-Oct-21
C1071022,10031007,25,PF-06863135,T,6517751569,6.51775E+11,20210928,12:43,CYCLE1_DAY15,0 H,457.1387934,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 331,16RSYC,16-Nov-21
C1071022,10031007,25,PF-06863135,T,6517751583,6.51775E+11,20211109,11:43,CYCLE3_DAY1,0 H,46.36778982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 589,27RSYC,21-Apr-22
C1071022,10031007,25,PF-06863135,T,6515337624,6.51534E+11,20211207,10:45,CYCLE4_DAY1,0 H,864.1041489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1924,123RSYC,29-Jul-22
C1071022,10031007,25,PF-06863135,T,6519134606,6.51913E+11,20221108,12:55,END_OF_TRT,,350.8377277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2139,139RSYC,22-Mar-23
C1071022,10031007,25,PF-06863135,T,6517260611,6.51726E+11,20210916,12:15,CYCLE1_DAY4,0 H,187.1536544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 962,65RSYC,3-May-22
C1071022,10031007,25,PF-06863135,T,6517473951,6.51747E+11,20210917,13:40,CYCLE1_DAY4,24 H,899.2408191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 180,7RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,10:10,CYCLE1_DAY1,0 H,10.90009274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 216,8RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650151,6.80165E+11,20210914,19:12,CYCLE1_DAY1,6 H,967.9337756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 217,9RSYC,1-Nov-21
C1071022,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,10:50,CYCLE1_DAY8,0 H,521.1711573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 218,12RSYC,2-Nov-21
C1071022,11081002,26,PF-06863135,T,6801650153,6.80165E+11,20210921,19:55,CYCLE1_DAY8,6 H,746.6711199,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 219,8RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650155,6.80165E+11,20210928,9:05,CYCLE1_DAY15,0 H,902.5751602,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 220,8RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650157,6.80165E+11,20211005,10:15,CYCLE1_DAY22,0 H,84.46169433,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 247,13RSYC,15-Nov-21
C1071022,11081002,26,PF-06863135,T,6801650159,6.80165E+11,20211012,11:56,CYCLE2_DAY1,0 H,699.380139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 248,13RSYC,15-Nov-21
C1071022,11081002,26,PF-06863135,T,6801701817,6.8017E+11,20211109,11:25,CYCLE3_DAY1,0 H,875.5802458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 669,30RSYC,22-Apr-22
C1071022,11081002,26,PF-06863135,T,6801701819,6.8017E+11,20211207,10:40,CYCLE4_DAY1,0 H,976.4361964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 950,65RSYC,3-May-22
C1071022,11081002,26,PF-06863135,T,6801790622,6.80179E+11,20220301,11:00,CYCLE7_DAY1,0 H,493.0166215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1590,110RSYC,25-May-22
C1071022,11081002,26,PF-06863135,T,6801701821,6.8017E+11,20220524,11:08,CYCLE10_DAY1,0 H,244.6206914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1960,114RSYC,25-Jul-22
C1071022,11081002,26,PF-06863135,T,6801893000,6.80189E+11,20220816,10:42,CYCLE13_DAY1,0 H,952.2881831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2069,129RSYC,21-Oct-22
C1071022,11081002,26,PF-06863135,T,6801958743,6.80196E+11,20221108,10:56,CYCLE16_DAY1,0 H,694.3969678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2151,139RSYC,22-Mar-23
C1071022,11081002,26,PF-06863135,T,6802068779,6.80207E+11,20230131,10:49,CYCLE19_DAY1,0 H,577.7852784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2201,141RSYC,17-May-23
C1071022,11081002,26,PF-06863135,T,6802135340,6.80214E+11,20230425,10:40,CYCLE22_DAY1,0 H,14.86823701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2253,143RSYC,27-Nov-23
C1071022,11081002,26,PF-06863135,T,6802256363,6.80226E+11,20230718,10:52,CYCLE25_DAY1,0 H,932.9640141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2272,144RSYC,27-Nov-23
C1071022,11081002,26,PF-06863135,T,6802256365,6.80226E+11,20231010,10:47,CYCLE28_DAY1,0 H,411.7760305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2315,147RSYC,29-Feb-24
C1071022,11081002,26,PF-06863135,T,6802408401,6.80241E+11,20240109,11:00,CYCLE31_DAY1,0 H,421.5608241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2338,148RSYC,27-Mar-24
C1071022,11081002,26,PF-06863135,T,6801650169,6.80165E+11,20210916,9:50,UNPL,9001 H,375.1586391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 221,11RSYC,2-Nov-21
C1071022,11081002,26,PF-06863135,T,6801650163,6.80165E+11,20210915,13:07,CYCLE1_DAY1,24 H,104.559352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 222,8RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650165,6.80165E+11,20210917,10:39,CYCLE1_DAY4,0 H,993.5243944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 223,8RSYC,29-Oct-21
C1071022,11081002,26,PF-06863135,T,6801650167,6.80165E+11,20210918,13:20,CYCLE1_DAY4,24 H,734.1395474,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 224,13RSYC,15-Nov-21
C1071022,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,16:40,CYCLE1_DAY1,0 H,723.0833209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 155,6RSYC,29-Oct-21
C1071022,10821005,27,PF-06863135,T,6603459530,6.60346E+11,20210920,22:40,CYCLE1_DAY1,6 H,585.2272766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 156,6RSYC,29-Oct-21
C1071022,10821005,27,PF-06863135,T,6603459541,6.60346E+11,20210921,16:45,CYCLE1_DAY1,24 H,460.5315467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 240,13RSYC,15-Nov-21
C1071022,10821005,27,PF-06863135,T,6603459544,6.60346E+11,20210923,15:40,CYCLE1_DAY4,0 H,178.5451439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 241,13RSYC,15-Nov-21
C1071022,10821005,27,PF-06863135,T,6603459547,6.60346E+11,20210924,16:57,CYCLE1_DAY4,24 H,238.5218984,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 242,13RSYC,15-Nov-21
C1071022,10031008,28,PF-06863135,T,6517889666,6.51789E+11,20210920,11:20,CYCLE1_DAY1,0 H,372.5614364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 183,7RSYC,29-Oct-21
C1071022,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,11:40,CYCLE1_DAY8,0 H,322.0253718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 330,16RSYC,16-Nov-21
C1071022,10031008,28,PF-06863135,T,6517751567,6.51775E+11,20210929,17:30,CYCLE1_DAY8,6 H,569.7203163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 329,16RSYC,16-Nov-21
C1071022,10031008,28,PF-06863135,T,6517889671,6.51789E+11,20211006,12:55,CYCLE1_DAY15,0 H,670.0692388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 346,16RSYC,16-Nov-21
C1071022,10031008,28,PF-06863135,T,6516580398,6.51658E+11,20211013,13:00,CYCLE1_DAY22,0 H,623.8879678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 278,14RSYC,15-Nov-21
C1071022,10031008,28,PF-06863135,T,6517889674,6.51789E+11,20211020,15:50,CYCLE2_DAY1,0 H,972.2281998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 347,16RSYC,16-Nov-21
C1071022,10031008,28,PF-06863135,T,6517889678,6.51789E+11,20211117,10:45,CYCLE3_DAY1,0 H,422.6219832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 911,20RSYC,19-Apr-22
C1071022,10031008,28,PF-06863135,T,6518620858,6.51862E+11,20211215,17:30,CYCLE4_DAY1,0 H,612.0136156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1925,123RSYC,29-Jul-22
C1071022,10031008,28,PF-06863135,T,6516580425,6.51658E+11,20220309,15:20,CYCLE7_DAY1,0 H,781.9544968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2009,115RSYC,25-Jul-22
C1071022,10031008,28,PF-06863135,T,6519134616,6.51913E+11,20220601,18:00,CYCLE10_DAY1,0 H,326.0847203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2010,115RSYC,25-Jul-22
C1071022,10031008,28,PF-06863135,T,6519134614,6.51913E+11,20221116,16:17,CYCLE16_DAY1,0 H,249.3884056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2140,139RSYC,22-Mar-23
C1071022,10031008,28,PF-06863135,T,6521762368,6.52176E+11,20230206,15:10,CYCLE19_DAY1,0 H,710.304002,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2217,142RSYC,18-May-23
C1071022,10031008,28,PF-06863135,T,6522244541,6.52224E+11,20230503,15:36,CYCLE22_DAY1,0 H,30.30418898,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2281,144RSYC,27-Nov-23
C1071022,10031008,28,PF-06863135,T,6524705277,6.52471E+11,,,,,991.4490958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2323,148RSYC,27-Mar-24
C1071022,10031008,28,PF-06863135,T,6517473947,6.51747E+11,20210923,10:56,CYCLE1_DAY4,0 H,79.85638295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 296,15RSYC,16-Nov-21
C1071022,10031008,28,PF-06863135,T,6517260614,6.51726E+11,20210924,10:37,CYCLE1_DAY4,24 H,321.5070218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 964,65RSYC,3-May-22
C1071022,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,10:44,CYCLE1_DAY1,0 H,310.1738572,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 303,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559654,6.51756E+11,20210928,17:37,CYCLE1_DAY1,6 H,487.8431469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 302,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,8:16,CYCLE1_DAY8,0 H,161.6924589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 305,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559655,6.51756E+11,20211006,15:02,CYCLE1_DAY8,6 H,701.8104013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 304,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559658,6.51756E+11,20211013,8:22,CYCLE1_DAY15,0 H,709.0424877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 309,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6518459660,6.51846E+11,20211124,10:50,CYCLE3_DAY1,0 H,516.538849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 679,30RSYC,22-Apr-22
C1071022,10101002,29,PF-06863135,T,6518877338,6.51888E+11,20211220,11:45,CYCLE4_DAY1,0 H,0.289581715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1167,104RSYC,22-May-22
C1071022,10101002,29,PF-06863135,T,6519690726,6.51969E+11,20220316,9:20,CYCLE7_DAY1,0 H,101.8095558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1891,87RSYC,13-May-22
C1071022,10101002,29,PF-06863135,T,6517559676,6.51756E+11,20220608,10:51,CYCLE10_DAY1,0 H,473.9833948,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2008,115RSYC,25-Jul-22
C1071022,10101002,29,PF-06863135,T,6520726026,6.52073E+11,20220831,0:00,CYCLE13_DAY1,0 H,878.8815791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2078,129RSYC,21-Oct-22
C1071022,10101002,29,PF-06863135,T,6520726028,6.52073E+11,20221123,0:00,CYCLE16_DAY1,0 H,908.0028638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2129,139RSYC,22-Mar-23
C1071022,10101002,29,PF-06863135,T,6521315623,6.52132E+11,20230215,9:51,CYCLE19_DAY1,0 H,639.334823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2190,141RSYC,17-May-23
C1071022,10101002,29,PF-06863135,T,6521315621,6.52132E+11,20230508,12:20,CYCLE22_DAY1,0 H,770.0084846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2246,143RSYC,27-Nov-23
C1071022,10101002,29,PF-06863135,T,6524471823,6.52447E+11,20240117,10:16,CYCLE31_DAY1,0 H,997.6571787,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2354,148RSYC,27-Mar-24
C1071022,10101002,29,PF-06863135,T,6521205060,6.52121E+11,20211110,11:16,UNPL,9001 H,857.943048,NG/ML,,Received as 6517559662-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 563,26RSYC,22-Apr-22
C1071022,10101002,29,PF-06863135,T,6517559670,6.51756E+11,20210929,11:30,CYCLE1_DAY1,24 H,1.232759692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 312,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559672,6.51756E+11,20211001,10:50,CYCLE1_DAY4,0 H,338.4344369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 314,15RSYC,16-Nov-21
C1071022,10101002,29,PF-06863135,T,6517559673,6.51756E+11,20211002,10:50,CYCLE1_DAY4,24 H,977.5922431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 315,15RSYC,16-Nov-21
C1071022,10541001,30,PF-06863135,T,6216170878,6.21617E+11,20210921,10:10,CYCLE1_DAY1,0 H,474.5929272,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 157,6RSYC,29-Oct-21
C1071022,10541001,30,PF-06863135,T,6216170880,6.21617E+11,20210927,10:19,CYCLE1_DAY8,0 H,791.9656681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 158,6RSYC,29-Oct-21
C1071022,10541001,30,PF-06863135,T,6216170882,6.21617E+11,20211004,9:20,CYCLE1_DAY15,0 H,126.0056461,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 365,17RSYC,17-Nov-21
C1071022,10541001,30,PF-06863135,T,6216170885,6.21617E+11,20211011,7:50,CYCLE1_DAY22,0 H,537.3221421,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 366,17RSYC,17-Nov-21
C1071022,10541001,30,PF-06863135,T,6216170886,6.21617E+11,20211018,8:30,CYCLE2_DAY1,0 H,394.3130324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 367,17RSYC,17-Nov-21
C1071022,10541001,30,PF-06863135,T,6216170888,6.21617E+11,20211115,8:30,CYCLE3_DAY1,0 H,52.19954365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 698,31RSYC,23-Apr-22
C1071022,10541001,30,PF-06863135,T,6216170890,6.21617E+11,20211213,8:40,CYCLE4_DAY1,0 H,904.0245943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1275,89RSYC,11-May-22
C1071022,10541001,30,PF-06863135,T,6216170909,6.21617E+11,20220217,10:50,END_OF_TRT,,65.78177967,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1771,87RSYC,13-May-22
C1071022,10541001,30,PF-06863135,T,6216170895,6.21617E+11,20210922,11:25,CYCLE1_DAY1,24 H,903.9657845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 159,6RSYC,29-Oct-21
C1071022,10541001,30,PF-06863135,T,6216170896,6.21617E+11,20210923,12:05,CYCLE1_DAY4,0 H,72.88660457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 160,6RSYC,29-Oct-21
C1071022,10541001,30,PF-06863135,T,6216170898,6.21617E+11,20210924,12:30,CYCLE1_DAY4,24 H,965.9095216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1770,71RSYC,7-May-22
C1071022,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,10:32,CYCLE1_DAY1,0 H,199.7535002,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 361,17RSYC,17-Nov-21
C1071022,10101001,31,PF-06863135,T,6518332217,6.51833E+11,20210927,16:00,CYCLE1_DAY1,6 H,520.237377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 360,17RSYC,17-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,8:32,CYCLE1_DAY8,0 H,866.4745264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 307,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559656,6.51756E+11,20211005,17:47,CYCLE1_DAY8,6 H,878.3625607,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 306,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559657,6.51756E+11,20211012,8:26,CYCLE1_DAY15,0 H,307.4216849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 308,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559660,6.51756E+11,20211019,7:54,CYCLE1_DAY22,0 H,269.0404006,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 310,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559661,6.51756E+11,20211025,8:26,CYCLE2_DAY1,0 H,458.3472467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 562,26RSYC,22-Apr-22
C1071022,10101001,31,PF-06863135,T,6517559664,6.51756E+11,20211122,8:53,CYCLE3_DAY1,0 H,24.6796365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 879,19RSYC,19-Apr-22
C1071022,10101001,31,PF-06863135,T,6518877339,6.51888E+11,20211220,8:30,CYCLE4_DAY1,0 H,843.5416042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1168,104RSYC,22-May-22
C1071022,10101001,31,PF-06863135,T,6519690725,6.51969E+11,20220314,8:48,CYCLE7_DAY1,0 H,348.2156649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1892,81RSYC,4-May-22
C1071022,10101001,31,PF-06863135,T,6517559675,6.51756E+11,20220829,0:00,CYCLE13_DAY1,0 H,691.3595019,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2079,129RSYC,21-Oct-22
C1071022,10101001,31,PF-06863135,T,6518806985,6.51881E+11,20221121,8:42,CYCLE16_DAY1,0 H,801.7246943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2169,140RSYC,22-Mar-23
C1071022,10101001,31,PF-06863135,T,6520726024,6.52073E+11,20230215,9:25,CYCLE19_DAY1,0 H,143.2889067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2191,141RSYC,17-May-23
C1071022,10101001,31,PF-06863135,T,6522542260,6.52254E+11,20230508,8:45,CYCLE22_DAY1,0 H,435.6840409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2247,143RSYC,27-Nov-23
C1071022,10101001,31,PF-06863135,T,6522542261,6.52254E+11,20230731,8:26,CYCLE25_DAY1,0 H,443.7030185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2291,145RSYC,4-Jan-24
C1071022,10101001,31,PF-06863135,T,6524145854,6.52415E+11,20240115,7:57,CYCLE31_DAY1,0 H,124.2577692,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2355,148RSYC,27-Mar-24
C1071022,10101001,31,PF-06863135,T,6522365006,6.52237E+11,20221219,8:51,UNPL,9001 H,320.5659806,NG/ML,,Received as 6520726027-02,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2192,141RSYC,17-May-23
C1071022,10101001,31,PF-06863135,T,6517559669,6.51756E+11,20210928,10:17,CYCLE1_DAY1,24 H,99.52124756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 311,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559671,6.51756E+11,20211001,9:55,CYCLE1_DAY4,0 H,245.5062302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 313,15RSYC,16-Nov-21
C1071022,10101001,31,PF-06863135,T,6517559674,6.51756E+11,20211002,10:16,CYCLE1_DAY4,24 H,424.2913091,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 316,15RSYC,16-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,9:50,CYCLE1_DAY1,0 H,639.5339931,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 270,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650368,6.80165E+11,20210927,19:01,CYCLE1_DAY1,6 H,136.2933423,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 271,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,9:00,CYCLE1_DAY8,0 H,954.7355414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 273,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650369,6.80165E+11,20211005,18:00,CYCLE1_DAY8,6 H,453.4133993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 272,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650371,6.80165E+11,20211012,9:15,CYCLE1_DAY15,0 H,676.7878237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 274,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650373,6.80165E+11,20211018,10:37,CYCLE1_DAY22,0 H,369.9964542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 275,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650388,6.80165E+11,20211027,9:45,END_OF_TRT,,859.6055117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 668,64RSYC,3-May-22
C1071022,11111002,32,PF-06863135,T,6801650379,6.80165E+11,20210928,13:05,CYCLE1_DAY1,24 H,818.6986149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 225,8RSYC,29-Oct-21
C1071022,11111002,32,PF-06863135,T,6801650399,6.80165E+11,20211001,8:35,CYCLE1_DAY4,0 H,528.6149888,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 277,14RSYC,15-Nov-21
C1071022,11111002,32,PF-06863135,T,6801650383,6.80165E+11,20211002,11:40,CYCLE1_DAY4,24 H,417.0810473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 276,14RSYC,15-Nov-21
C1071022,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,9:45,CYCLE1_DAY1,0 H,506.5672458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 226,21RSYC,20-Apr-22
C1071022,11091001,33,PF-06863135,T,6801650191,6.80165E+11,20210927,20:58,CYCLE1_DAY1,6 H,686.23492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 227,8RSYC,29-Oct-21
C1071022,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211004,10:05,CYCLE1_DAY8,0 H,269.2826712,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 253,13RSYC,15-Nov-21
C1071022,11091001,33,PF-06863135,T,6801650192,6.80165E+11,20211005,21:30,CYCLE1_DAY8,6 H,98.14475802,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 252,13RSYC,15-Nov-21
C1071022,11091001,33,PF-06863135,T,6801650194,6.80165E+11,20211012,8:50,CYCLE1_DAY15,0 H,575.6141954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 256,13RSYC,15-Nov-21
C1071022,11091001,33,PF-06863135,T,6801650196,6.80165E+11,20211019,13:10,CYCLE1_DAY22,0 H,718.2232101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 258,13RSYC,15-Nov-21
C1071022,11091001,33,PF-06863135,T,6801650198,6.80165E+11,20211026,12:50,CYCLE2_DAY1,0 H,289.5957058,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 637,29RSYC,22-Apr-22
C1071022,11091001,33,PF-06863135,T,6801709454,6.80171E+11,20211124,11:22,CYCLE3_DAY1,0 H,561.7440427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 838,35RSYC,25-Apr-22
C1071022,11091001,33,PF-06863135,T,6801709455,6.80171E+11,20211221,11:25,CYCLE4_DAY1,0 H,18.27382052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 954,65RSYC,3-May-22
C1071022,11091001,33,PF-06863135,T,6801812297,6.80181E+11,20220315,11:00,CYCLE7_DAY1,0 H,409.9966122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1873,80RSYC,4-May-22
C1071022,11091001,33,PF-06863135,T,6801893157,6.80189E+11,20220607,10:55,CYCLE10_DAY1,0 H,564.2975777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2016,115RSYC,25-Jul-22
C1071022,11091001,33,PF-06863135,T,6801962917,6.80196E+11,20220830,10:54,CYCLE13_DAY1,0 H,628.0434571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2071,129RSYC,21-Oct-22
C1071022,11091001,33,PF-06863135,T,6802045271,6.80205E+11,20221122,10:55,CYCLE16_DAY1,0 H,363.4037797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2152,139RSYC,22-Mar-23
C1071022,11091001,33,PF-06863135,T,6801962918,6.80196E+11,20221208,11:20,END_OF_TRT,,161.4713348,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2160,140RSYC,22-Mar-23
C1071022,11091001,33,PF-06863135,T,6801650208,6.80165E+11,20210929,8:40,UNPL,9001 H,913.1768496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 228,8RSYC,29-Oct-21
C1071022,11091001,33,PF-06863135,T,6801650202,6.80165E+11,20210928,15:15,CYCLE1_DAY1,24 H,573.7924172,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 229,8RSYC,29-Oct-21
C1071022,11091001,33,PF-06863135,T,6801650204,6.80165E+11,20210930,9:53,CYCLE1_DAY4,0 H,945.9626845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 230,8RSYC,29-Oct-21
C1071022,11091001,33,PF-06863135,T,6801650206,6.80165E+11,20211001,15:15,CYCLE1_DAY4,24 H,176.5579844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 261,14RSYC,15-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,14:15,CYCLE1_DAY1,0 H,55.56392466,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 371,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170981,6.21617E+11,20210927,20:55,CYCLE1_DAY1,6 H,146.9708043,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 370,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170982,6.21617E+11,20211004,14:24,CYCLE1_DAY8,0 H,989.714462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 372,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170985,6.21617E+11,20211011,15:07,CYCLE1_DAY15,0 H,57.8834317,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 375,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216843014,6.21684E+11,20211018,14:27,CYCLE1_DAY22,0 H,941.4283958,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 396,18RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170988,6.21617E+11,20211025,17:30,CYCLE2_DAY1,0 H,435.4498763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 416,21RSYC,20-Apr-22
C1071022,10791001,34,PF-06863135,T,6217031634,6.21703E+11,20211124,17:24,CYCLE3_DAY1,0 H,413.282748,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 767,33RSYC,24-Apr-22
C1071022,10791001,34,PF-06863135,T,6217184137,6.21718E+11,20211223,14:18,CYCLE4_DAY1,0 H,791.0361654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1521,97RSYC,12-May-22
C1071022,10791001,34,PF-06863135,T,6216170994,6.21617E+11,20220315,12:48,CYCLE7_DAY1,0 H,225.6352222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1879,80RSYC,4-May-22
C1071022,10791001,34,PF-06863135,T,6216171003,6.21617E+11,20220615,14:57,CYCLE10_DAY1,0 H,272.1399121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2041,128RSYC,21-Oct-22
C1071022,10791001,34,PF-06863135,T,6217178487,6.21718E+11,20220914,13:21,CYCLE13_DAY1,0 H,240.289955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2102,132RSYC,10-Nov-22
C1071022,10791001,34,PF-06863135,T,6219244642,6.21924E+11,20221209,17:50,CYCLE16_DAY1,0 H,951.8249542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2182,141RSYC,17-May-23
C1071022,10791001,34,PF-06863135,T,6219947540,6.21995E+11,20230302,14:20,CYCLE19_DAY1,0 H,38.69748841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2212,143RSYC,27-Nov-23
C1071022,10791001,34,PF-06863135,T,6219947539,6.21995E+11,20230525,13:20,CYCLE22_DAY1,0 H,445.143924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2256,144RSYC,27-Nov-23
C1071022,10791001,34,PF-06863135,T,6219947542,6.21995E+11,20230824,13:15,CYCLE25_DAY1,0 H,240.100001,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2294,145RSYC,4-Jan-24
C1071022,10791001,34,PF-06863135,T,6219244645,6.21924E+11,20240229,14:49,CYCLE31_DAY1,0 H,645.9521045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2366,152RSYC,9-Apr-24
C1071022,10791001,34,PF-06863135,T,6216170997,6.21617E+11,20210928,13:57,CYCLE1_DAY1,24 H,768.5017895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 377,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216170999,6.21617E+11,20210930,14:33,CYCLE1_DAY4,0 H,606.1397556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 379,17RSYC,17-Nov-21
C1071022,10791001,34,PF-06863135,T,6216171001,6.21617E+11,20211001,14:44,CYCLE1_DAY4,24 H,945.4798128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 381,18RSYC,17-Nov-21
C1071022,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,12:10,CYCLE1_DAY1,0 H,219.2634535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 349,16RSYC,16-Nov-21
C1071022,10071005,35,PF-06863135,T,6518157745,6.51816E+11,20211005,18:15,CYCLE1_DAY1,6 H,157.3876057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 348,16RSYC,16-Nov-21
C1071022,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,10:45,CYCLE1_DAY8,0 H,718.7219558,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 355,17RSYC,17-Nov-21
C1071022,10071005,35,PF-06863135,T,6518265654,6.51827E+11,20211015,17:30,CYCLE1_DAY8,6 H,273.0441215,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 354,17RSYC,17-Nov-21
C1071022,10071005,35,PF-06863135,T,6518418506,6.51842E+11,20211021,9:00,CYCLE1_DAY15,0 H,607.8260361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 609,90RSYC,11-May-22
C1071022,10071005,35,PF-06863135,T,6518418507,6.51842E+11,20211027,11:10,CYCLE1_DAY22,0 H,498.5435437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 610,90RSYC,11-May-22
C1071022,10071005,35,PF-06863135,T,6518157746,6.51816E+11,20211105,9:50,CYCLE2_DAY1,0 H,799.5164671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 602,27RSYC,21-Apr-22
C1071022,10071005,35,PF-06863135,T,6518265659,6.51827E+11,20211203,11:45,CYCLE3_DAY1,0 H,800.6881775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1091,67RSYC,8-May-22
C1071022,10071005,35,PF-06863135,T,6518265662,6.51827E+11,20211230,10:22,CYCLE4_DAY1,0 H,430.8704444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1600,96RSYC,12-May-22
C1071022,10071005,35,PF-06863135,T,6518265664,6.51827E+11,20220324,10:12,CYCLE7_DAY1,0 H,352.0316093,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1926,123RSYC,29-Jul-22
C1071022,10071005,35,PF-06863135,T,6517472416,6.51747E+11,20220616,10:00,CYCLE10_DAY1,0 H,924.956384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2006,115RSYC,25-Jul-22
C1071022,10071005,35,PF-06863135,T,6520930825,6.52093E+11,20220908,9:50,CYCLE13_DAY1,0 H,301.7003003,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2076,129RSYC,21-Oct-22
C1071022,10071005,35,PF-06863135,T,6520930828,6.52093E+11,20221201,10:00,CYCLE16_DAY1,0 H,815.7523569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2130,139RSYC,22-Mar-23
C1071022,10071005,35,PF-06863135,T,6521240600,6.52124E+11,20230106,10:02,END_OF_TRT,,405.1468145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2168,140RSYC,22-Mar-23
C1071022,10071005,35,PF-06863135,T,6518157753,6.51816E+11,20211006,13:03,CYCLE1_DAY1,24 H,46.76389486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 350,17RSYC,17-Nov-21
C1071022,10071005,35,PF-06863135,T,6518265665,6.51827E+11,20211011,12:00,CYCLE1_DAY4,0 H,937.5102547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 356,17RSYC,17-Nov-21
C1071022,10071005,35,PF-06863135,T,6518265668,6.51827E+11,20211012,11:45,CYCLE1_DAY4,24 H,766.1612738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 357,17RSYC,17-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,9:50,CYCLE1_DAY1,0 H,713.7302133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 231,8RSYC,29-Oct-21
C1071022,11091002,36,PF-06863135,T,6801650190,6.80165E+11,20210930,17:40,CYCLE1_DAY1,6 H,222.2216842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 251,18RSYC,17-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,10:25,CYCLE1_DAY8,0 H,525.8409644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 255,13RSYC,15-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650193,6.80165E+11,20211007,17:35,CYCLE1_DAY8,6 H,172.3779099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 254,13RSYC,15-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650195,6.80165E+11,20211014,10:10,END_OF_TRT,,53.48671861,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 257,13RSYC,15-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650203,6.80165E+11,20211001,11:23,CYCLE1_DAY1,24 H,188.8316701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 259,13RSYC,15-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650205,6.80165E+11,20211004,6:55,CYCLE1_DAY4,0 H,560.9895961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 260,14RSYC,15-Nov-21
C1071022,11091002,36,PF-06863135,T,6801650207,6.80165E+11,20211005,11:34,CYCLE1_DAY4,24 H,160.2301392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 262,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,10:08,CYCLE1_DAY1,0 H,701.5643395,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 263,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650307,6.80165E+11,20211004,16:39,CYCLE1_DAY1,6 H,409.285791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 264,18RSYC,17-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,11:12,CYCLE1_DAY8,0 H,797.6314415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 266,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650309,6.80165E+11,20211011,17:55,CYCLE1_DAY8,6 H,162.7611057,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 265,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650313,6.80165E+11,20211025,10:10,CYCLE1_DAY22,0 H,736.0093197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 656,29RSYC,22-Apr-22
C1071022,11241001,37,PF-06863135,T,6801650328,6.80165E+11,20211101,11:05,END_OF_TRT,,318.857656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 661,86RSYC,13-May-22
C1071022,11241001,37,PF-06863135,T,6801650319,6.80165E+11,20211005,10:10,CYCLE1_DAY1,24 H,650.5976809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 267,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650321,6.80165E+11,20211007,10:39,CYCLE1_DAY4,0 H,87.57480074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 268,14RSYC,15-Nov-21
C1071022,11241001,37,PF-06863135,T,6801650323,6.80165E+11,20211008,11:32,CYCLE1_DAY4,24 H,709.0088201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 269,18RSYC,17-Nov-21
C1071022,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,10:20,CYCLE1_DAY1,0 H,226.4277518,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 343,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517769657,6.51777E+11,20211004,21:15,CYCLE1_DAY1,6 H,401.2596702,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 342,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,8:50,CYCLE1_DAY8,0 H,75.0648223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 345,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517769662,6.51777E+11,20211011,13:56,CYCLE1_DAY8,6 H,463.3100805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 344,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517768773,6.51777E+11,20211020,9:20,CYCLE1_DAY15,0 H,668.4975112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 340,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517768774,6.51777E+11,20211027,8:33,CYCLE1_DAY22,0 H,115.9522689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 597,27RSYC,21-Apr-22
C1071022,10981003,38,PF-06863135,T,6517769672,6.51777E+11,20211103,8:50,CYCLE2_DAY1,0 H,393.8199494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 600,27RSYC,21-Apr-22
C1071022,10981003,38,PF-06863135,T,6517769678,6.51777E+11,20211130,8:50,CYCLE3_DAY1,0 H,183.6781364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1082,41RSYC,26-Apr-22
C1071022,10981003,38,PF-06863135,T,6517769686,6.51777E+11,20211229,9:35,CYCLE4_DAY1,0 H,320.8748885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1717,72RSYC,7-May-22
C1071022,10981003,38,PF-06863135,T,6517769690,6.51777E+11,20220324,9:00,CYCLE7_DAY1,0 H,603.6860222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1927,123RSYC,29-Jul-22
C1071022,10981003,38,PF-06863135,T,6518807318,6.51881E+11,20220615,9:28,CYCLE10_DAY1,0 H,719.5855386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2034,128RSYC,21-Oct-22
C1071022,10981003,38,PF-06863135,T,6520972522,6.52097E+11,20220923,9:20,CYCLE13_DAY1,0 H,692.7546449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2111,131RSYC,9-Nov-22
C1071022,10981003,38,PF-06863135,T,6521653169,6.52165E+11,20221228,8:20,CYCLE16_DAY1,0 H,625.8604893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2173,140RSYC,22-Mar-23
C1071022,10981003,38,PF-06863135,T,6520972524,6.52097E+11,20230324,9:10,CYCLE19_DAY1,0 H,896.3793968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2222,142RSYC,18-May-23
C1071022,10981003,38,PF-06863135,T,6522845154,6.52285E+11,20230613,8:41,CYCLE22_DAY1,0 H,350.231783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2262,144RSYC,27-Nov-23
C1071022,10981003,38,PF-06863135,T,6524724652,6.52472E+11,20240103,9:25,CYCLE28_DAY1,0 H,66.55169632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2324,148RSYC,27-Mar-24
C1071022,10981003,38,PF-06863135,T,6517755820,6.51776E+11,20211005,15:25,CYCLE1_DAY1,24 H,587.3511969,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 333,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517755822,6.51776E+11,20211007,12:05,CYCLE1_DAY4,0 H,446.371491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 334,16RSYC,16-Nov-21
C1071022,10981003,38,PF-06863135,T,6517755828,6.51776E+11,20211008,11:00,CYCLE1_DAY4,24 H,498.008152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 335,16RSYC,16-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,11:45,CYCLE1_DAY1,0 H,199.6273845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 283,14RSYC,15-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433455,6.51743E+11,20211004,18:35,CYCLE1_DAY1,6 H,800.5713204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 282,18RSYC,17-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,9:25,CYCLE1_DAY8,0 H,850.0165585,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 284,14RSYC,15-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433457,6.51743E+11,20211011,17:07,CYCLE1_DAY8,6 H,992.2856444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 531,25RSYC,22-Apr-22
C1071022,10671003,39,PF-06863135,T,6517433460,6.51743E+11,20211018,11:00,CYCLE1_DAY15,0 H,135.8274999,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 285,14RSYC,15-Nov-21
C1071022,10671003,39,PF-06863135,T,6518354391,6.51835E+11,20211025,9:11,CYCLE1_DAY22,0 H,276.1516007,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 607,90RSYC,11-May-22
C1071022,10671003,39,PF-06863135,T,6518354392,6.51835E+11,20211101,10:21,CYCLE2_DAY1,0 H,163.4850954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 608,90RSYC,11-May-22
C1071022,10671003,39,PF-06863135,T,6517433465,6.51743E+11,20211129,10:33,CYCLE3_DAY1,0 H,288.9459681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 967,65RSYC,3-May-22
C1071022,10671003,39,PF-06863135,T,6517433472,6.51743E+11,20211005,12:35,CYCLE1_DAY1,24 H,590.914654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 286,14RSYC,15-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433474,6.51743E+11,20211007,11:43,CYCLE1_DAY4,0 H,261.7782911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 287,14RSYC,15-Nov-21
C1071022,10671003,39,PF-06863135,T,6517433476,6.51743E+11,20211008,13:05,CYCLE1_DAY4,24 H,127.246925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 288,14RSYC,15-Nov-21
C1071022,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,9:15,CYCLE1_DAY1,0 H,249.1110464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 383,18RSYC,17-Nov-21
C1071022,10351001,40,PF-06863135,T,6216407870,6.21641E+11,20211015,16:15,CYCLE1_DAY1,6 H,260.3710668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 382,18RSYC,17-Nov-21
C1071022,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,10:30,CYCLE1_DAY8,0 H,277.2396953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 402,21RSYC,20-Apr-22
C1071022,10351001,40,PF-06863135,T,6215033391,6.21503E+11,20211025,16:30,CYCLE1_DAY8,6 H,225.6592304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 401,21RSYC,20-Apr-22
C1071022,10351001,40,PF-06863135,T,6216407874,6.21641E+11,20211101,8:15,CYCLE1_DAY15,0 H,912.2988369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 428,88RSYC,11-May-22
C1071022,10351001,40,PF-06863135,T,6217091593,6.21709E+11,20211108,10:24,CYCLE1_DAY22,0 H,388.2847327,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 507,24RSYC,20-Apr-22
C1071022,10351001,40,PF-06863135,T,6216407878,6.21641E+11,20211115,10:06,CYCLE2_DAY1,0 H,743.934585,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 429,88RSYC,11-May-22
C1071022,10351001,40,PF-06863135,T,6216407885,6.21641E+11,20211016,10:15,CYCLE1_DAY1,24 H,899.1091227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 384,18RSYC,17-Nov-21
C1071022,10351001,40,PF-06863135,T,6216407888,6.21641E+11,20211018,9:28,CYCLE1_DAY4,0 H,139.2932721,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 385,18RSYC,17-Nov-21
C1071022,10351001,40,PF-06863135,T,6216407890,6.21641E+11,20211019,10:37,CYCLE1_DAY4,24 H,107.9740658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 386,18RSYC,17-Nov-21
C1071022,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,13:00,CYCLE1_DAY1,0 H,261.0560612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 326,16RSYC,16-Nov-21
C1071022,10771002,41,PF-06863135,T,6517643711,6.51764E+11,20211005,20:30,CYCLE1_DAY1,6 H,659.2860957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 325,16RSYC,16-Nov-21
C1071022,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,2:53,CYCLE1_DAY8,0 H,528.4635709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 892,19RSYC,19-Apr-22
C1071022,10771002,41,PF-06863135,T,6517643714,6.51764E+11,20211015,19:45,CYCLE1_DAY8,6 H,536.5830221,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 891,19RSYC,19-Apr-22
C1071022,10771002,41,PF-06863135,T,6517246450,6.51725E+11,20211021,7:55,CYCLE1_DAY15,0 H,5.961118528,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 842,35RSYC,25-Apr-22
C1071022,10771002,41,PF-06863135,T,6517529121,6.51753E+11,20211027,8:40,CYCLE1_DAY22,0 H,260.1290042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 872,19RSYC,19-Apr-22
C1071022,10771002,41,PF-06863135,T,6517775835,6.51778E+11,20211101,11:34,CYCLE2_DAY1,0 H,966.2130525,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 909,20RSYC,19-Apr-22
C1071022,10771002,41,PF-06863135,T,6517246469,6.51725E+11,20211012,13:40,UNPL,9001 H,242.3341836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 281,14RSYC,15-Nov-21
C1071022,10771002,41,PF-06863135,T,6517643721,6.51764E+11,20211006,14:35,CYCLE1_DAY1,24 H,952.8340574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 327,16RSYC,16-Nov-21
C1071022,10771002,41,PF-06863135,T,6517643725,6.51764E+11,20211009,8:15,CYCLE1_DAY4,0 H,870.4283143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2126,137RSYC,18-Nov-22
C1071022,10771002,41,PF-06863135,T,6517756053,6.51776E+11,20211010,9:30,CYCLE1_DAY4,24 H,71.24659286,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 336,16RSYC,16-Nov-21
C1071022,10151001,42,PF-06863135,T,6517560122,6.51756E+11,20211013,8:25,CYCLE1_DAY1,0 H,971.6736115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 317,15RSYC,16-Nov-21
C1071022,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,9:45,CYCLE1_DAY8,0 H,199.1690756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 320,16RSYC,16-Nov-21
C1071022,10151001,42,PF-06863135,T,6517560124,6.51756E+11,20211020,16:35,CYCLE1_DAY8,6 H,561.2013053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 319,15RSYC,16-Nov-21
C1071022,10151001,42,PF-06863135,T,6517560126,6.51756E+11,20211027,10:20,CYCLE1_DAY15,0 H,875.953235,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 578,27RSYC,21-Apr-22
C1071022,10151001,42,PF-06863135,T,6517560128,6.51756E+11,20211103,10:20,CYCLE1_DAY22,0 H,586.3189675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 580,27RSYC,21-Apr-22
C1071022,10151001,42,PF-06863135,T,6517560130,6.51756E+11,20211110,10:30,CYCLE2_DAY1,0 H,210.7317703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 582,27RSYC,21-Apr-22
C1071022,10151001,42,PF-06863135,T,6517560133,6.51756E+11,20211208,13:02,CYCLE3_DAY1,0 H,943.3747872,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1050,40RSYC,26-Apr-22
C1071022,10151001,42,PF-06863135,T,6517560135,6.51756E+11,20220105,11:01,CYCLE4_DAY1,0 H,246.6874883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1660,100RSYC,23-May-22
C1071022,10151001,42,PF-06863135,T,6517560137,6.51756E+11,20220330,11:00,CYCLE7_DAY1,0 H,105.4526732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1928,123RSYC,29-Jul-22
C1071022,10151001,42,PF-06863135,T,6523756324,6.52376E+11,20230828,11:50,UNPL,9001 H,782.2470554,NG/ML,,Visit revised from C25D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2303,147RSYC,29-Feb-24
C1071022,10151001,42,PF-06863135,T,6517560139,6.51756E+11,20211014,17:00,CYCLE1_DAY1,24 H,126.7989913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 321,16RSYC,16-Nov-21
C1071022,10151001,42,PF-06863135,T,6517560141,6.51756E+11,20211015,16:30,CYCLE1_DAY4,0 H,180.995324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 323,16RSYC,16-Nov-21
C1071022,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,11:50,CYCLE1_DAY1,0 H,852.8694788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 568,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559759,6.51756E+11,20211014,19:57,CYCLE1_DAY1,6 H,48.19138988,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 567,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,8:50,CYCLE1_DAY8,0 H,792.1366614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 570,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559760,6.51756E+11,20211022,18:15,CYCLE1_DAY8,6 H,915.0040299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 569,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559762,6.51756E+11,20211028,9:20,CYCLE1_DAY15,0 H,613.7782387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 571,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559764,6.51756E+11,20211103,8:30,CYCLE1_DAY22,0 H,846.4811853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 572,86RSYC,13-May-22
C1071022,10111001,43,PF-06863135,T,6514526586,6.51453E+11,20211109,8:33,CYCLE2_DAY1,0 H,402.7906061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 839,64RSYC,3-May-22
C1071022,10111001,43,PF-06863135,T,6517559769,6.51756E+11,20211206,11:00,CYCLE3_DAY1,0 H,821.7228481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1031,40RSYC,26-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559774,6.51756E+11,20211015,12:50,CYCLE1_DAY1,24 H,38.22563074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 573,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559776,6.51756E+11,20211018,9:45,CYCLE1_DAY4,0 H,134.9999442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 574,26RSYC,22-Apr-22
C1071022,10111001,43,PF-06863135,T,6517559779,6.51756E+11,20211019,12:55,CYCLE1_DAY4,24 H,688.8266654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 575,86RSYC,13-May-22
C1071022,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,11:30,CYCLE1_DAY1,0 H,718.2169314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 359,17RSYC,17-Nov-21
C1071022,10101003,44,PF-06863135,T,6518332216,6.51833E+11,20211012,18:00,CYCLE1_DAY1,6 H,442.4356767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 358,17RSYC,17-Nov-21
C1071022,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,8:00,CYCLE1_DAY8,0 H,381.4878701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 564,26RSYC,22-Apr-22
C1071022,10101003,44,PF-06863135,T,6517559677,6.51756E+11,20211022,16:15,CYCLE1_DAY8,6 H,715.8389107,NG/ML,,Received as 6517559679-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 565,86RSYC,13-May-22
C1071022,10101003,44,PF-06863135,T,6518558183,6.51856E+11,20211105,9:04,CYCLE1_DAY22,0 H,314.8339919,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 611,90RSYC,11-May-22
C1071022,10101003,44,PF-06863135,T,6518706283,6.51871E+11,20211112,12:50,CYCLE2_DAY1,0 H,343.6251739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 935,36RSYC,25-Apr-22
C1071022,10101003,44,PF-06863135,T,6518877335,6.51888E+11,20211210,8:33,CYCLE3_DAY1,0 H,226.9502768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1166,104RSYC,22-May-22
C1071022,10101003,44,PF-06863135,T,6518877340,6.51888E+11,20220107,8:19,CYCLE4_DAY1,0 H,160.5243036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1612,97RSYC,12-May-22
C1071022,10101003,44,PF-06863135,T,6519690724,6.51969E+11,20220401,8:13,CYCLE7_DAY1,0 H,828.0943065,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1929,122RSYC,29-Jul-22
C1071022,10101003,44,PF-06863135,T,6518806983,6.51881E+11,20220624,8:20,CYCLE10_DAY1,0 H,243.8805784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2028,131RSYC,9-Nov-22
C1071022,10101003,44,PF-06863135,T,6520726025,6.52073E+11,20220916,0:00,CYCLE13_DAY1,0 H,962.9770994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2098,132RSYC,10-Nov-22
C1071022,10101003,44,PF-06863135,T,6520726030,6.52073E+11,20221216,10:14,UNPL,9001 H,242.2740316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2131,139RSYC,22-Mar-23
C1071022,10101003,44,PF-06863135,T,6518459661,6.51846E+11,20211013,12:00,CYCLE1_DAY1,24 H,255.0907045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 362,17RSYC,17-Nov-21
C1071022,10101003,44,PF-06863135,T,6518499635,6.5185E+11,20211015,10:35,CYCLE1_DAY4,0 H,626.8471231,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 363,17RSYC,17-Nov-21
C1071022,10101003,44,PF-06863135,T,6518499636,6.5185E+11,20211016,12:22,CYCLE1_DAY4,24 H,95.78419233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 364,17RSYC,17-Nov-21
C1071022,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,9:09,CYCLE1_DAY1,0 H,423.6029417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 234,18RSYC,17-Nov-21
C1071022,10021002,45,PF-06863135,T,6603324911,6.60332E+11,20211011,16:09,CYCLE1_DAY1,6 H,211.5011026,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 235,13RSYC,15-Nov-21
C1071022,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,9:25,CYCLE1_DAY8,0 H,361.0465084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 244,13RSYC,15-Nov-21
C1071022,10021002,45,PF-06863135,T,6603529935,6.60353E+11,20211018,15:09,CYCLE1_DAY8,6 H,753.7833873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 243,13RSYC,15-Nov-21
C1071022,10021002,45,PF-06863135,T,6603529938,6.60353E+11,20211025,9:10,CYCLE1_DAY15,0 H,399.0814356,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 629,64RSYC,3-May-22
C1071022,10021002,45,PF-06863135,T,6603529940,6.60353E+11,20211101,9:10,CYCLE1_DAY22,0 H,689.7774449,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 630,64RSYC,3-May-22
C1071022,10021002,45,PF-06863135,T,6603563110,6.60356E+11,20211108,11:00,CYCLE2_DAY1,0 H,949.972124,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 820,35RSYC,25-Apr-22
C1071022,10021002,45,PF-06863135,T,6603529946,6.60353E+11,20211206,10:10,CYCLE3_DAY1,0 H,521.2098,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 942,65RSYC,3-May-22
C1071022,10021002,45,PF-06863135,T,6603529947,6.60353E+11,20220105,9:49,CYCLE4_DAY1,0 H,159.0153928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1583,59RSYC,1-May-22
C1071022,10021002,45,PF-06863135,T,6603529950,6.60353E+11,20220330,9:45,CYCLE7_DAY1,0 H,864.5167158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1917,122RSYC,29-Jul-22
C1071022,10021002,45,PF-06863135,T,6603578688,6.60358E+11,20220620,8:55,CYCLE10_DAY1,0 H,542.8320737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2024,132RSYC,10-Nov-22
C1071022,10021002,45,PF-06863135,T,6603839290,6.60384E+11,20220912,10:25,CYCLE13_DAY1,0 H,14.63005812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2115,131RSYC,9-Nov-22
C1071022,10021002,45,PF-06863135,T,6604204202,6.6042E+11,20221205,9:00,CYCLE16_DAY1,0 H,910.2268562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2161,140RSYC,22-Mar-23
C1071022,10021002,45,PF-06863135,T,6604204197,6.6042E+11,20230227,10:45,CYCLE19_DAY1,0 H,971.8112725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2208,142RSYC,18-May-23
C1071022,10021002,45,PF-06863135,T,6604608948,6.60461E+11,20230522,10:50,CYCLE22_DAY1,0 H,113.5704239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2252,143RSYC,27-Nov-23
C1071022,10021002,45,PF-06863135,T,6604608946,6.60461E+11,20230828,10:35,CYCLE25_DAY1,0 H,35.69128993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2339,149RSYC,27-Mar-24
C1071022,10021002,45,PF-06863135,T,6604608947,6.60461E+11,20231120,12:00,CYCLE28_DAY1,0 H,698.9754251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2340,148RSYC,27-Mar-24
C1071022,10021002,45,PF-06863135,T,6604777913,6.60478E+11,20240212,10:25,CYCLE31_DAY1,0 H,774.8941187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2359,152RSYC,9-Apr-24
C1071022,10021002,45,PF-06863135,T,6603324927,6.60332E+11,20211012,9:25,CYCLE1_DAY1,24 H,857.3110887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 237,13RSYC,15-Nov-21
C1071022,10021002,45,PF-06863135,T,6603324928,6.60332E+11,20211014,9:55,CYCLE1_DAY4,0 H,259.5007347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 238,13RSYC,15-Nov-21
C1071022,10021002,45,PF-06863135,T,6603324930,6.60332E+11,20211015,9:35,CYCLE1_DAY4,24 H,33.39355531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 239,13RSYC,15-Nov-21
C1071022,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,17:10,CYCLE1_DAY1,0 H,397.9561512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 434,76RSYC,4-May-22
C1071022,10481001,46,PF-06863135,T,6216407971,6.21641E+11,20211012,23:10,CYCLE1_DAY1,6 H,987.7369851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 433,88RSYC,11-May-22
C1071022,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,10:05,CYCLE1_DAY8,0 H,380.9238369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 438,88RSYC,11-May-22
C1071022,10481001,46,PF-06863135,T,6216407973,6.21641E+11,20211019,16:00,CYCLE1_DAY8,6 H,584.4854346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 437,88RSYC,11-May-22
C1071022,10481001,46,PF-06863135,T,6216407976,6.21641E+11,20211026,9:30,CYCLE1_DAY15,0 H,271.7897168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 439,88RSYC,11-May-22
C1071022,10481001,46,PF-06863135,T,6216856431,6.21686E+11,20211102,9:00,CYCLE1_DAY22,0 H,42.85600392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 477,23RSYC,20-Apr-22
C1071022,10481001,46,PF-06863135,T,6216408001,6.21641E+11,20211111,10:55,END_OF_TRT,,531.9497588,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 710,64RSYC,3-May-22
C1071022,10481001,46,PF-06863135,T,6216407987,6.21641E+11,20211013,17:10,CYCLE1_DAY1,24 H,958.6982039,NG/ML,9; Tube received empty,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 440,,
C1071022,10481001,46,PF-06863135,T,6216407989,6.21641E+11,20211015,11:55,CYCLE1_DAY4,0 H,156.2878687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 442,88RSYC,11-May-22
C1071022,10481001,46,PF-06863135,T,6216407991,6.21641E+11,20211016,12:00,CYCLE1_DAY4,24 H,582.9874217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 443,88RSYC,11-May-22
C1071022,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,11:27,CYCLE1_DAY1,0 H,56.18719922,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1068,41RSYC,26-Apr-22
C1071022,10031009,47,PF-06863135,T,6517751561,6.51775E+11,20211012,18:00,CYCLE1_DAY1,6 H,183.6863361,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1067,41RSYC,26-Apr-22
C1071022,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,10:35,CYCLE1_DAY8,0 H,477.6432069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 588,27RSYC,21-Apr-22
C1071022,10031009,47,PF-06863135,T,6517751564,6.51775E+11,20211020,17:30,CYCLE1_DAY8,6 H,254.9241383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 587,27RSYC,21-Apr-22
C1071022,10031009,47,PF-06863135,T,6517472379,6.51747E+11,20211013,10:35,CYCLE1_DAY1,24 H,38.90020185,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 988,66RSYC,3-May-22
C1071022,10031009,47,PF-06863135,T,6517260612,6.51726E+11,20211014,12:35,CYCLE1_DAY4,0 H,275.504792,NG/ML,,Visit revised from C1D8 and Time Point updated; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2011,126RSYC,1-Aug-22
C1071022,10031009,47,PF-06863135,T,6517260613,6.51726E+11,20211015,12:30,CYCLE1_DAY4,24 H,553.6479455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 963,65RSYC,3-May-22
C1071022,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,12:00,CYCLE1_DAY1,0 H,498.1557352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 451,76RSYC,4-May-22
C1071022,11041001,48,PF-06863135,T,6216725274,6.21673E+11,20211013,22:00,CYCLE1_DAY1,6 H,631.1514294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 450,88RSYC,11-May-22
C1071022,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211021,15:10,CYCLE1_DAY8,0 H,499.725769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 484,23RSYC,20-Apr-22
C1071022,11041001,48,PF-06863135,T,6216923991,6.21692E+11,20211022,1:20,CYCLE1_DAY8,6 H,185.0267009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 483,23RSYC,20-Apr-22
C1071022,11041001,48,PF-06863135,T,6216923998,6.21692E+11,20211029,13:00,CYCLE1_DAY15,0 H,942.5386817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1418,57RSYC,30-Apr-22
C1071022,11041001,48,PF-06863135,T,6216924001,6.21692E+11,20211108,12:00,CYCLE1_DAY22,0 H,155.7733075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 746,32RSYC,23-Apr-22
C1071022,11041001,48,PF-06863135,T,6216924046,6.21692E+11,20211116,15:40,END_OF_TRT,,991.2025059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1425,108RSYC,24-May-22
C1071022,11041001,48,PF-06863135,T,6216725290,6.21673E+11,20211014,16:00,CYCLE1_DAY1,24 H,711.9093833,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 452,89RSYC,11-May-22
C1071022,11041001,48,PF-06863135,T,6216725293,6.21673E+11,20211018,14:00,CYCLE1_DAY4,0 H,761.8024515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 454,89RSYC,11-May-22
C1071022,11041001,48,PF-06863135,T,6216725294,6.21673E+11,20211019,16:20,CYCLE1_DAY4,24 H,572.1422924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 387,18RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,12:18,CYCLE1_DAY1,0 H,392.178308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 369,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216170980,6.21617E+11,20211013,19:21,CYCLE1_DAY1,6 H,459.1814203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 368,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,14:48,CYCLE1_DAY8,0 H,636.3260407,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 374,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216170983,6.21617E+11,20211019,21:07,CYCLE1_DAY8,6 H,111.0440812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 373,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216843012,6.21684E+11,20211028,16:18,CYCLE1_DAY15,0 H,627.527728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 473,23RSYC,20-Apr-22
C1071022,10791002,49,PF-06863135,T,6216170996,6.21617E+11,20211014,14:12,CYCLE1_DAY1,24 H,534.4928314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 376,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216170998,6.21617E+11,20211015,14:15,CYCLE1_DAY4,0 H,907.8621127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 378,17RSYC,17-Nov-21
C1071022,10791002,49,PF-06863135,T,6216171000,6.21617E+11,20211016,14:34,CYCLE1_DAY4,24 H,884.7716538,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 380,18RSYC,17-Nov-21
C1071022,10151002,50,PF-06863135,T,6517560123,6.51756E+11,20211015,16:30,CYCLE1_DAY1,0 H,905.2599004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 318,15RSYC,16-Nov-21
C1071022,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,9:30,CYCLE1_DAY8,0 H,974.0453327,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 577,27RSYC,21-Apr-22
C1071022,10151002,50,PF-06863135,T,6517560125,6.51756E+11,20211022,15:24,CYCLE1_DAY8,6 H,736.4958798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 576,27RSYC,21-Apr-22
C1071022,10151002,50,PF-06863135,T,6517560127,6.51756E+11,20211029,10:50,CYCLE1_DAY15,0 H,217.8704367,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 579,27RSYC,21-Apr-22
C1071022,10151002,50,PF-06863135,T,6517560129,6.51756E+11,20211105,10:25,CYCLE1_DAY22,0 H,674.6524476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 581,27RSYC,21-Apr-22
C1071022,10151002,50,PF-06863135,T,6517560131,6.51756E+11,20211112,10:09,CYCLE2_DAY1,0 H,309.1434671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 886,19RSYC,19-Apr-22
C1071022,10151002,50,PF-06863135,T,6517560132,6.51756E+11,20211210,10:38,CYCLE3_DAY1,0 H,63.4132111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1049,40RSYC,26-Apr-22
C1071022,10151002,50,PF-06863135,T,6519170849,6.51917E+11,20220107,10:30,CYCLE4_DAY1,0 H,733.8361166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1661,100RSYC,23-May-22
C1071022,10151002,50,PF-06863135,T,6520320365,6.52032E+11,20220623,10:34,CYCLE10_DAY1,0 H,695.6597142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2033,128RSYC,21-Oct-22
C1071022,10151002,50,PF-06863135,T,6517560152,6.51756E+11,20220707,11:00,END_OF_TRT,,519.3851453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2032,128RSYC,21-Oct-22
C1071022,10151002,50,PF-06863135,T,6517560140,6.51756E+11,20211018,13:15,CYCLE1_DAY4,0 H,58.25402463,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 322,16RSYC,16-Nov-21
C1071022,10151002,50,PF-06863135,T,6517560142,6.51756E+11,20211019,14:05,CYCLE1_DAY4,24 H,592.0452548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 324,16RSYC,16-Nov-21
C1071022,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,13:28,CYCLE1_DAY1,0 H,952.0824938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 467,23RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216840408,6.21684E+11,20211014,20:08,CYCLE1_DAY1,6 H,100.8353296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 466,23RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,13:33,CYCLE1_DAY8,0 H,724.3999065,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 472,23RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216843010,6.21684E+11,20211021,19:23,CYCLE1_DAY8,6 H,889.0695701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 471,23RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216170984,6.21617E+11,20211028,14:30,CYCLE1_DAY15,0 H,556.7439202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 415,21RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216843015,6.21684E+11,20211104,13:22,CYCLE1_DAY22,0 H,106.5754127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 474,23RSYC,20-Apr-22
C1071022,10791004,51,PF-06863135,T,6216170989,6.21617E+11,20211111,14:00,CYCLE2_DAY1,0 H,451.3149127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 702,64RSYC,3-May-22
C1071022,10791004,51,PF-06863135,T,6217142537,6.21714E+11,20211216,13:20,CYCLE3_DAY1,0 H,60.49125451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1467,54RSYC,30-Apr-22
C1071022,10791004,51,PF-06863135,T,6217031636,6.21703E+11,20220113,13:35,CYCLE4_DAY1,0 H,269.0148732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1811,92RSYC,12-May-22
C1071022,10791004,51,PF-06863135,T,6217031638,6.21703E+11,20220407,13:19,CYCLE7_DAY1,0 H,325.1116741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1912,123RSYC,29-Jul-22
C1071022,10791004,51,PF-06863135,T,6219244643,6.21924E+11,20221222,14:21,CYCLE16_DAY1,0 H,84.39306201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2183,141RSYC,17-May-23
C1071022,10791004,51,PF-06863135,T,6219244641,6.21924E+11,20230316,15:45,CYCLE19_DAY1,0 H,953.0035968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2213,142RSYC,18-May-23
C1071022,10791004,51,PF-06863135,T,6219244644,6.21924E+11,20230608,9:53,CYCLE22_DAY1,0 H,790.4164227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2257,144RSYC,27-Nov-23
C1071022,10791004,51,PF-06863135,T,6219947541,6.21995E+11,20230829,14:00,CYCLE25_DAY1,0 H,734.973457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2311,147RSYC,29-Feb-24
C1071022,10791004,51,PF-06863135,T,6219947543,6.21995E+11,20240222,13:38,CYCLE31_DAY1,0 H,728.0959782,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2367,153RSYC,10-Apr-24
C1071022,10791004,51,PF-06863135,T,6216840412,6.21684E+11,20211015,14:07,CYCLE1_DAY1,24 H,918.5249895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 394,18RSYC,17-Nov-21
C1071022,10791004,51,PF-06863135,T,6216840413,6.21684E+11,20211018,14:00,CYCLE1_DAY4,0 H,593.6418701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 395,18RSYC,17-Nov-21
C1071022,10791004,51,PF-06863135,T,6216840410,6.21684E+11,20211019,14:00,CYCLE1_DAY4,24 H,353.2867685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 393,18RSYC,17-Nov-21
C1071022,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,11:25,CYCLE1_DAY1,0 H,520.4294335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 338,16RSYC,16-Nov-21
C1071022,11171006,52,PF-06863135,T,6517764043,6.51776E+11,20211018,17:32,CYCLE1_DAY1,6 H,399.6686195,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 337,16RSYC,16-Nov-21
C1071022,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,10:50,CYCLE1_DAY8,0 H,578.2632237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 544,25RSYC,22-Apr-22
C1071022,11171006,52,PF-06863135,T,6517433558,6.51743E+11,20211025,16:47,CYCLE1_DAY8,6 H,772.0783105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 543,25RSYC,22-Apr-22
C1071022,11171006,52,PF-06863135,T,6517764054,6.51776E+11,20211102,9:42,CYCLE1_DAY15,0 H,796.6029497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 594,27RSYC,21-Apr-22
C1071022,11171006,52,PF-06863135,T,6517764059,6.51776E+11,20211108,9:03,CYCLE1_DAY22,0 H,836.2897018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 595,27RSYC,21-Apr-22
C1071022,11171006,52,PF-06863135,T,6517764064,6.51776E+11,20211115,12:05,CYCLE2_DAY1,0 H,585.8088862,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 903,20RSYC,19-Apr-22
C1071022,11171006,52,PF-06863135,T,6517433585,6.51743E+11,20211122,8:32,END_OF_TRT,,238.9385743,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 848,107RSYC,24-May-22
C1071022,11171006,52,PF-06863135,T,6517764070,6.51776E+11,20211019,10:30,CYCLE1_DAY1,24 H,868.1018565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 339,16RSYC,16-Nov-21
C1071022,11171006,52,PF-06863135,T,6517433574,6.51743E+11,20211021,9:42,CYCLE1_DAY4,0 H,395.9892189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 289,14RSYC,15-Nov-21
C1071022,11171006,52,PF-06863135,T,6518011622,6.51801E+11,20211022,9:20,CYCLE1_DAY4,24 H,87.10366139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 601,27RSYC,21-Apr-22
C1071022,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,11:52,CYCLE1_DAY1,0 H,325.0877358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 298,15RSYC,16-Nov-21
C1071022,10321001,53,PF-06863135,T,6517509070,6.51751E+11,20211015,19:24,CYCLE1_DAY1,6 H,604.204976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 297,15RSYC,16-Nov-21
C1071022,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,11:41,CYCLE1_DAY8,0 H,298.9229597,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 557,26RSYC,22-Apr-22
C1071022,10321001,53,PF-06863135,T,6517509073,6.51751E+11,20211022,17:46,CYCLE1_DAY8,6 H,823.0580021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 556,26RSYC,22-Apr-22
C1071022,10321001,53,PF-06863135,T,6517509074,6.51751E+11,20211028,14:41,CYCLE1_DAY15,0 H,739.186675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 558,26RSYC,22-Apr-22
C1071022,10321001,53,PF-06863135,T,6517509077,6.51751E+11,20211104,8:33,CYCLE1_DAY22,0 H,781.6373845,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 559,26RSYC,22-Apr-22
C1071022,10321001,53,PF-06863135,T,6517509078,6.51751E+11,20211110,11:25,CYCLE2_DAY1,0 H,47.48285491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 869,19RSYC,19-Apr-22
C1071022,10321001,53,PF-06863135,T,6518150043,6.51815E+11,20211209,11:55,CYCLE3_DAY1,0 H,170.7159566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1090,67RSYC,8-May-22
C1071022,10321001,53,PF-06863135,T,6518150044,6.51815E+11,20220106,11:56,CYCLE4_DAY1,0 H,366.2599578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1630,85RSYC,10-May-22
C1071022,10321001,53,PF-06863135,T,6517559966,6.51756E+11,20220331,14:24,CYCLE7_DAY1,0 H,654.5055145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1930,123RSYC,29-Jul-22
C1071022,10321001,53,PF-06863135,T,6517559974,6.51756E+11,20220627,12:55,CYCLE10_DAY1,0 H,62.24669733,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2030,128RSYC,21-Oct-22
C1071022,10321001,53,PF-06863135,T,6518807506,6.51881E+11,20220919,9:21,CYCLE13_DAY1,0 H,481.83792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2099,132RSYC,10-Nov-22
C1071022,10321001,53,PF-06863135,T,6519136799,6.51914E+11,20221128,11:33,END_OF_TRT,,914.4408814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2132,139RSYC,22-Mar-23
C1071022,10321001,53,PF-06863135,T,6517509082,6.51751E+11,20211016,13:35,CYCLE1_DAY1,24 H,803.3145055,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 299,15RSYC,16-Nov-21
C1071022,10321001,53,PF-06863135,T,6517509084,6.51751E+11,20211018,12:51,CYCLE1_DAY4,0 H,467.2993082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 300,15RSYC,16-Nov-21
C1071022,10321001,53,PF-06863135,T,6517509086,6.51751E+11,20211019,13:41,CYCLE1_DAY4,24 H,842.6960261,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 301,15RSYC,16-Nov-21
C1071022,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,14:05,CYCLE1_DAY1,0 H,987.2910202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 390,18RSYC,17-Nov-21
C1071022,11021001,54,PF-06863135,T,6216756800,6.21676E+11,20211018,20:00,CYCLE1_DAY1,6 H,9.149799305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1384,100RSYC,23-May-22
C1071022,11021001,54,PF-06863135,T,6217023832,6.21702E+11,20211102,19:10,CYCLE1_DAY15,0 H,734.5510429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 505,24RSYC,20-Apr-22
C1071022,11021001,54,PF-06863135,T,6217136144,6.21714E+11,20211108,15:50,CYCLE1_DAY22,0 H,571.0865408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 509,24RSYC,20-Apr-22
C1071022,11021001,54,PF-06863135,T,6217023837,6.21702E+11,20211115,17:00,CYCLE2_DAY1,0 H,626.4762379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 757,33RSYC,24-Apr-22
C1071022,11021001,54,PF-06863135,T,6217142695,6.21714E+11,20211216,15:00,END_OF_TRT,,179.1752762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1469,109RSYC,25-May-22
C1071022,11021001,54,PF-06863135,T,6216756811,6.21676E+11,20211019,14:27,CYCLE1_DAY1,24 H,559.6583068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 391,18RSYC,17-Nov-21
C1071022,11021001,54,PF-06863135,T,6216756814,6.21676E+11,20211021,14:45,CYCLE1_DAY4,0 H,880.7624565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 461,23RSYC,20-Apr-22
C1071022,11021001,54,PF-06863135,T,6216756816,6.21676E+11,20211022,16:05,CYCLE1_DAY4,24 H,101.6063052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 463,23RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211018,11:00,CYCLE1_DAY1,0 H,687.7498792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 482,23RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216923990,6.21692E+11,20211019,0:30,CYCLE1_DAY1,6 H,105.7797321,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 481,23RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,10:30,CYCLE1_DAY8,0 H,136.2970708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 486,24RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216923994,6.21692E+11,20211025,17:45,CYCLE1_DAY8,6 H,889.466506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 485,24RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216923995,6.21692E+11,20211102,11:45,CYCLE1_DAY15,0 H,318.3638139,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 487,24RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216924002,6.21692E+11,20211108,12:40,CYCLE1_DAY22,0 H,443.2547708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 488,24RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216725284,6.21673E+11,20211214,10:42,CYCLE3_DAY1,0 H,515.3390398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1377,84RSYC,10-May-22
C1071022,11041002,55,PF-06863135,T,6216725304,6.21673E+11,20220113,12:45,END_OF_TRT,,4.571862388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1756,109RSYC,25-May-22
C1071022,11041002,55,PF-06863135,T,6216725291,6.21673E+11,20211019,18:30,CYCLE1_DAY1,24 H,786.5947024,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 453,89RSYC,11-May-22
C1071022,11041002,55,PF-06863135,T,6216924029,6.21692E+11,20211021,6:00,CYCLE1_DAY4,0 H,969.9701513,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 490,24RSYC,20-Apr-22
C1071022,11041002,55,PF-06863135,T,6216924033,6.21692E+11,20211022,13:45,CYCLE1_DAY4,24 H,991.6522504,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 493,24RSYC,20-Apr-22
C1071022,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,8:58,CYCLE1_DAY1,0 H,385.209798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 522,25RSYC,22-Apr-22
C1071022,10121001,56,PF-06863135,T,6517433306,6.51743E+11,20211019,16:12,CYCLE1_DAY1,6 H,346.3619924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 521,25RSYC,22-Apr-22
C1071022,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,9:55,CYCLE1_DAY8,0 H,29.61614881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 524,25RSYC,22-Apr-22
C1071022,10121001,56,PF-06863135,T,6517433308,6.51743E+11,20211026,15:55,CYCLE1_DAY8,6 H,759.6784447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 523,25RSYC,22-Apr-22
C1071022,10121001,56,PF-06863135,T,6518019676,6.51802E+11,20220426,11:32,END_OF_TRT,,984.4274256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1982,114RSYC,25-Jul-22
C1071022,10121001,56,PF-06863135,T,6517433322,6.51743E+11,20211020,11:35,CYCLE1_DAY1,24 H,518.7852298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 526,107RSYC,24-May-22
C1071022,10121001,56,PF-06863135,T,6517433323,6.51743E+11,20211021,12:10,CYCLE1_DAY4,0 H,491.7419945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 527,109RSYC,25-May-22
C1071022,10121001,56,PF-06863135,T,6517433326,6.51743E+11,20211022,11:25,CYCLE1_DAY4,24 H,769.0749811,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 530,25RSYC,22-Apr-22
C1071022,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,9:55,CYCLE1_DAY1,0 H,200.1569784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 245,13RSYC,15-Nov-21
C1071022,11081003,57,PF-06863135,T,6801650152,6.80165E+11,20211019,20:10,CYCLE1_DAY1,6 H,15.37994346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 246,13RSYC,15-Nov-21
C1071022,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,10:00,CYCLE1_DAY8,0 H,200.295224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 632,64RSYC,3-May-22
C1071022,11081003,57,PF-06863135,T,6801650154,6.80165E+11,20211026,19:35,CYCLE1_DAY8,6 H,436.7119532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 631,64RSYC,3-May-22
C1071022,11081003,57,PF-06863135,T,6801650156,6.80165E+11,20211102,8:40,CYCLE1_DAY15,0 H,422.1972638,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 633,64RSYC,3-May-22
C1071022,11081003,57,PF-06863135,T,6801650158,6.80165E+11,20211109,9:35,CYCLE1_DAY22,0 H,420.3464302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 634,64RSYC,3-May-22
C1071022,11081003,57,PF-06863135,T,6801650160,6.80165E+11,20211116,9:45,CYCLE2_DAY1,0 H,424.4230814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 635,29RSYC,22-Apr-22
C1071022,11081003,57,PF-06863135,T,6801650172,6.80165E+11,20211210,11:20,END_OF_TRT,,788.8245648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 951,86RSYC,13-May-22
C1071022,11081003,57,PF-06863135,T,6801650164,6.80165E+11,20211020,14:35,CYCLE1_DAY1,24 H,666.0119302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 249,13RSYC,15-Nov-21
C1071022,11081003,57,PF-06863135,T,6801650166,6.80165E+11,20211022,8:40,CYCLE1_DAY4,0 H,373.6252707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 250,13RSYC,15-Nov-21
C1071022,11081003,57,PF-06863135,T,6801650168,6.80165E+11,20211023,12:58,CYCLE1_DAY4,24 H,300.1605122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 636,29RSYC,22-Apr-22
C1071022,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,13:05,CYCLE1_DAY1,0 H,444.5592753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 389,18RSYC,17-Nov-21
C1071022,11021002,58,PF-06863135,T,6216756799,6.21676E+11,20211020,19:00,CYCLE1_DAY1,6 H,617.6314909,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 388,18RSYC,17-Nov-21
C1071022,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,17:20,CYCLE1_DAY8,0 H,187.9987716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 459,23RSYC,20-Apr-22
C1071022,11021002,58,PF-06863135,T,6216756801,6.21676E+11,20211027,23:20,CYCLE1_DAY8,6 H,166.0613168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 458,23RSYC,20-Apr-22
C1071022,11021002,58,PF-06863135,T,6217023831,6.21702E+11,20211103,16:30,CYCLE1_DAY15,0 H,737.1467412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 504,24RSYC,20-Apr-22
C1071022,11021002,58,PF-06863135,T,6217118740,6.21712E+11,20211110,12:10,CYCLE1_DAY22,0 H,790.7476591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1452,54RSYC,30-Apr-22
C1071022,11021002,58,PF-06863135,T,6217170460,6.21717E+11,20211117,15:10,CYCLE2_DAY1,0 H,787.6764084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 795,34RSYC,24-Apr-22
C1071022,11021002,58,PF-06863135,T,6217136148,6.21714E+11,20211215,15:35,CYCLE3_DAY1,0 H,971.8976945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1465,54RSYC,30-Apr-22
C1071022,11021002,58,PF-06863135,T,6217142692,6.21714E+11,20220105,13:50,END_OF_TRT,,889.1066046,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1834,86RSYC,13-May-22
C1071022,11021002,58,PF-06863135,T,6216756812,6.21676E+11,20211021,13:15,CYCLE1_DAY1,24 H,385.2607476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 392,18RSYC,17-Nov-21
C1071022,11021002,58,PF-06863135,T,6216756813,6.21676E+11,20211022,15:35,CYCLE1_DAY4,0 H,621.0565938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 460,23RSYC,20-Apr-22
C1071022,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,14:57,CYCLE1_DAY1,0 H,781.0713346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 398,21RSYC,20-Apr-22
C1071022,10171001,60,PF-06863135,T,6215033337,6.21503E+11,20211021,22:00,CYCLE1_DAY1,6 H,657.2985144,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 397,21RSYC,20-Apr-22
C1071022,10171001,60,PF-06863135,T,6216407831,6.21641E+11,20211109,11:30,END_OF_TRT,,705.919186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 705,64RSYC,3-May-22
C1071022,10171001,60,PF-06863135,T,6216407817,6.21641E+11,20211022,16:00,CYCLE1_DAY1,24 H,782.5945078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 419,21RSYC,20-Apr-22
C1071022,10171001,60,PF-06863135,T,6216407820,6.21641E+11,20211027,12:00,CYCLE1_DAY4,0 H,392.8154135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 422,21RSYC,20-Apr-22
C1071022,10171001,60,PF-06863135,T,6216407821,6.21641E+11,20211028,15:03,CYCLE1_DAY4,24 H,116.1984408,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 423,21RSYC,20-Apr-22
C1071022,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,17:45,CYCLE1_DAY1,0 H,551.3120315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 465,23RSYC,20-Apr-22
C1071022,10791005,61,PF-06863135,T,6216840407,6.21684E+11,20211021,23:48,CYCLE1_DAY1,6 H,784.8672047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 464,23RSYC,20-Apr-22
C1071022,10791005,61,PF-06863135,T,6216170987,6.21617E+11,20211111,13:49,CYCLE1_DAY22,0 H,817.3544105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 701,31RSYC,23-Apr-22
C1071022,10791005,61,PF-06863135,T,6216843016,6.21684E+11,20211118,14:14,CYCLE2_DAY1,0 H,478.641628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 737,32RSYC,23-Apr-22
C1071022,10791005,61,PF-06863135,T,6216171011,6.21617E+11,20211210,12:17,END_OF_TRT,,69.58744206,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1291,108RSYC,24-May-22
C1071022,10791005,61,PF-06863135,T,6216840409,6.21684E+11,20211022,16:00,CYCLE1_DAY1,24 H,126.1434694,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 468,23RSYC,20-Apr-22
C1071022,10791005,61,PF-06863135,T,6216840415,6.21684E+11,20211025,17:09,CYCLE1_DAY4,0 H,781.9140497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 469,23RSYC,20-Apr-22
C1071022,10791005,61,PF-06863135,T,6216840418,6.21684E+11,20211026,17:21,CYCLE1_DAY4,24 H,420.1017319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 470,23RSYC,20-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,14:35,CYCLE1_DAY1,0 H,695.3777951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 536,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433521,6.51743E+11,20211025,21:35,CYCLE1_DAY1,6 H,199.7931429,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 535,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,16:15,CYCLE1_DAY8,0 H,319.2695759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 538,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433523,6.51743E+11,20211101,22:32,CYCLE1_DAY8,6 H,868.4451759,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 537,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433526,6.51743E+11,20211108,14:58,CYCLE1_DAY15,0 H,285.0647867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 539,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433538,6.51743E+11,20211026,15:54,CYCLE1_DAY1,24 H,111.5294029,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 540,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433539,6.51743E+11,20211028,12:18,CYCLE1_DAY4,0 H,462.3184512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 541,25RSYC,22-Apr-22
C1071022,10901001,62,PF-06863135,T,6517433541,6.51743E+11,20211029,15:30,CYCLE1_DAY4,24 H,100.5167335,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 542,86RSYC,13-May-22
C1071022,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,10:35,CYCLE1_DAY1,0 H,794.8647098,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 512,24RSYC,20-Apr-22
C1071022,10031010,63,PF-06863135,T,6516580384,6.51658E+11,20211025,17:45,CYCLE1_DAY1,6 H,445.0399854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 511,24RSYC,20-Apr-22
C1071022,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,11:50,CYCLE1_DAY8,0 H,854.9044522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 514,24RSYC,20-Apr-22
C1071022,10031010,63,PF-06863135,T,6516580386,6.51658E+11,20211103,17:30,CYCLE1_DAY8,6 H,989.1858034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 513,24RSYC,20-Apr-22
C1071022,10031010,63,PF-06863135,T,6517751570,6.51775E+11,20211110,17:12,CYCLE1_DAY15,0 H,551.15834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1069,41RSYC,26-Apr-22
C1071022,10031010,63,PF-06863135,T,6518620863,6.51862E+11,20211026,10:40,CYCLE1_DAY1,24 H,224.3905457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 615,90RSYC,11-May-22
C1071022,10031010,63,PF-06863135,T,6518620865,6.51862E+11,20211027,10:43,CYCLE1_DAY4,0 H,81.10539801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1123,94RSYC,12-May-22
C1071022,10031010,63,PF-06863135,T,6517473948,6.51747E+11,20211028,10:51,CYCLE1_DAY4,24 H,366.7660604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1008,39RSYC,26-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,10:29,CYCLE1_DAY1,0 H,204.6661641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 651,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650308,6.80165E+11,20211025,16:53,CYCLE1_DAY1,6 H,843.3728318,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 652,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,10:13,CYCLE1_DAY8,0 H,832.1955886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 654,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650310,6.80165E+11,20211101,16:31,CYCLE1_DAY8,6 H,139.7219121,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 653,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650312,6.80165E+11,20211110,14:15,CYCLE1_DAY15,0 H,223.5080117,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 655,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801700252,6.8017E+11,20211116,14:32,CYCLE1_DAY22,0 H,436.0467219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 831,64RSYC,3-May-22
C1071022,11241002,64,PF-06863135,T,6801650316,6.80165E+11,20211124,14:39,CYCLE2_DAY1,0 H,259.2482817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 829,35RSYC,25-Apr-22
C1071022,11241002,64,PF-06863135,T,6801700259,6.8017E+11,20211221,12:49,CYCLE3_DAY1,0 H,722.5628402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 960,65RSYC,3-May-22
C1071022,11241002,64,PF-06863135,T,6801700262,6.8017E+11,20220118,14:47,CYCLE4_DAY1,0 H,165.3347482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1597,96RSYC,12-May-22
C1071022,11241002,64,PF-06863135,T,6801805147,6.80181E+11,20220412,14:50,CYCLE7_DAY1,0 H,167.3249404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1918,122RSYC,29-Jul-22
C1071022,11241002,64,PF-06863135,T,6801913233,6.80191E+11,20220705,14:24,CYCLE10_DAY1,0 H,887.9412205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2026,131RSYC,9-Nov-22
C1071022,11241002,64,PF-06863135,T,6801913234,6.80191E+11,20220927,14:08,CYCLE13_DAY1,0 H,960.7926217,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2120,134RSYC,11-Nov-22
C1071022,11241002,64,PF-06863135,T,6802054682,6.80205E+11,20221220,15:07,CYCLE16_DAY1,0 H,35.41704762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2162,143RSYC,27-Nov-23
C1071022,11241002,64,PF-06863135,T,6802054683,6.80205E+11,20230315,14:18,CYCLE19_DAY1,0 H,209.1347601,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2209,142RSYC,18-May-23
C1071022,11241002,64,PF-06863135,T,6802232421,6.80223E+11,20230606,14:45,CYCLE22_DAY1,0 H,932.5226333,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2273,144RSYC,27-Nov-23
C1071022,11241002,64,PF-06863135,T,6802232422,6.80223E+11,20230829,13:55,CYCLE25_DAY1,0 H,574.4706818,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2299,147RSYC,29-Feb-24
C1071022,11241002,64,PF-06863135,T,6802432310,6.80243E+11,20231121,13:25,CYCLE28_DAY1,0 H,846.2880018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2341,148RSYC,27-Mar-24
C1071022,11241002,64,PF-06863135,T,6802432311,6.80243E+11,20240213,14:40,CYCLE31_DAY1,0 H,774.7704311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2360,153RSYC,10-Apr-24
C1071022,11241002,64,PF-06863135,T,6801650325,6.80165E+11,20211027,11:35,UNPL,9001 H,270.820595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 660,64RSYC,3-May-22
C1071022,11241002,64,PF-06863135,T,6801650320,6.80165E+11,20211026,11:22,CYCLE1_DAY1,24 H,944.4751689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 657,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650322,6.80165E+11,20211029,10:22,CYCLE1_DAY4,0 H,68.73642407,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 658,29RSYC,22-Apr-22
C1071022,11241002,64,PF-06863135,T,6801650324,6.80165E+11,20211030,11:20,CYCLE1_DAY4,24 H,149.8196308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 659,29RSYC,22-Apr-22
C1071022,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,11:00,CYCLE1_DAY1,0 H,77.27195145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 404,21RSYC,20-Apr-22
C1071022,10961001,65,PF-06863135,T,6215349420,6.21535E+11,20211025,20:15,CYCLE1_DAY1,6 H,13.57589644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 403,21RSYC,20-Apr-22
C1071022,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,16:00,CYCLE1_DAY8,0 H,588.0728248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 700,31RSYC,23-Apr-22
C1071022,10961001,65,PF-06863135,T,6216170914,6.21617E+11,20211104,22:15,CYCLE1_DAY8,6 H,684.6257828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 699,31RSYC,23-Apr-22
C1071022,10961001,65,PF-06863135,T,6215349424,6.21535E+11,20211112,15:25,CYCLE1_DAY15,0 H,880.1510573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 694,30RSYC,22-Apr-22
C1071022,10961001,65,PF-06863135,T,6215349426,6.21535E+11,20211122,14:00,CYCLE1_DAY22,0 H,474.0091512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 695,30RSYC,22-Apr-22
C1071022,10961001,65,PF-06863135,T,6216170920,6.21617E+11,20211201,13:58,CYCLE2_DAY1,0 H,926.3747039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1276,89RSYC,11-May-22
C1071022,10961001,65,PF-06863135,T,6216170922,6.21617E+11,20211227,10:20,CYCLE3_DAY1,0 H,447.7431974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1783,71RSYC,7-May-22
C1071022,10961001,65,PF-06863135,T,6216170924,6.21617E+11,20220124,9:40,CYCLE4_DAY1,0 H,275.3943599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1784,71RSYC,7-May-22
C1071022,10961001,65,PF-06863135,T,6218290587,6.21829E+11,20220419,12:00,CYCLE7_DAY1,0 H,350.0761808,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1913,123RSYC,29-Jul-22
C1071022,10961001,65,PF-06863135,T,6217142393,6.21714E+11,20220711,11:00,CYCLE10_DAY1,0 H,998.2539152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2040,128RSYC,21-Oct-22
C1071022,10961001,65,PF-06863135,T,6216170943,6.21617E+11,20220725,9:00,END_OF_TRT,,255.1013155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2053,132RSYC,10-Nov-22
C1071022,10961001,65,PF-06863135,T,6216170928,6.21617E+11,20211026,14:15,CYCLE1_DAY1,24 H,838.0726873,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 412,107RSYC,24-May-22
C1071022,10961001,65,PF-06863135,T,6216170930,6.21617E+11,20211028,14:00,CYCLE1_DAY4,0 H,711.8408951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 413,21RSYC,20-Apr-22
C1071022,10961001,65,PF-06863135,T,6216170933,6.21617E+11,20211029,14:15,CYCLE1_DAY4,24 H,144.3556913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 414,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,12:38,CYCLE1_DAY1,0 H,438.1691279,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 400,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6215033338,6.21503E+11,20211025,19:44,CYCLE1_DAY1,6 H,613.3051693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 399,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,13:05,CYCLE1_DAY8,0 H,497.6043908,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 418,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407803,6.21641E+11,20211108,19:20,CYCLE1_DAY8,6 H,15.64933282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 417,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407806,6.21641E+11,20211115,12:00,CYCLE1_DAY15,0 H,69.38804308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 703,31RSYC,23-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407807,6.21641E+11,20211122,11:17,CYCLE1_DAY22,0 H,279.7890994,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 704,31RSYC,23-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407816,6.21641E+11,20220420,11:01,CYCLE7_DAY1,0 H,614.7536157,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1990,114RSYC,25-Jul-22
C1071022,10171002,66,PF-06863135,T,6217142268,6.21714E+11,20220711,10:10,CYCLE10_DAY1,0 H,492.8431629,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2038,128RSYC,21-Oct-22
C1071022,10171002,66,PF-06863135,T,6219335461,6.21934E+11,20221004,16:11,CYCLE13_DAY1,0 H,25.89953933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2122,131RSYC,9-Nov-22
C1071022,10171002,66,PF-06863135,T,6221257540,6.22126E+11,20231128,8:25,CYCLE28_DAY1,0 H,422.8581775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2346,151RSYC,8-Apr-24
C1071022,10171002,66,PF-06863135,T,6222063119,6.22206E+11,20240219,8:24,CYCLE31_DAY1,0 H,920.8718499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2363,152RSYC,9-Apr-24
C1071022,10171002,66,PF-06863135,T,6216407809,6.21641E+11,20211221,14:50,UNPL,9001 H,115.2953081,NG/ML,,Visit revised from C2D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1292,84RSYC,10-May-22
C1071022,10171002,66,PF-06863135,T,6219335460,6.21934E+11,20230327,11:30,UNPL,9002 H,92.74034567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2227,145RSYC,4-Jan-24
C1071022,10171002,66,PF-06863135,T,6216407818,6.21641E+11,20211026,14:10,CYCLE1_DAY1,24 H,939.3325762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 420,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407819,6.21641E+11,20211103,15:08,CYCLE1_DAY4,0 H,996.6575428,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 421,21RSYC,20-Apr-22
C1071022,10171002,66,PF-06863135,T,6216407822,6.21641E+11,20211104,14:00,CYCLE1_DAY4,24 H,686.2027298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 424,21RSYC,20-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,9:45,CYCLE1_DAY1,0 H,264.5966104,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 456,23RSYC,20-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756763,6.21676E+11,20211109,18:00,CYCLE1_DAY1,6 H,64.67675706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 455,23RSYC,20-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,10:40,CYCLE1_DAY8,0 H,763.7973752,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 731,32RSYC,23-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756764,6.21676E+11,20211118,19:00,CYCLE1_DAY8,6 H,440.9638734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 730,32RSYC,23-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756767,6.21676E+11,20211124,10:50,CYCLE1_DAY15,0 H,369.6434194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1380,84RSYC,10-May-22
C1071022,10461001,67,PF-06863135,T,6216756769,6.21676E+11,20211201,10:50,CYCLE1_DAY22,0 H,744.6947192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1382,84RSYC,10-May-22
C1071022,10461001,67,PF-06863135,T,6217283546,6.21728E+11,20211208,9:30,CYCLE2_DAY1,0 H,712.814945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1565,58RSYC,1-May-22
C1071022,10461001,67,PF-06863135,T,6217233434,6.21723E+11,20220105,6:00,CYCLE3_DAY1,0 H,132.452478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1812,92RSYC,12-May-22
C1071022,10461001,67,PF-06863135,T,6217233437,6.21723E+11,20220202,10:47,CYCLE4_DAY1,0 H,808.2989271,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1813,92RSYC,12-May-22
C1071022,10461001,67,PF-06863135,T,6217647292,6.21765E+11,20220504,10:20,CYCLE7_DAY1,0 H,231.4085771,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2001,115RSYC,25-Jul-22
C1071022,10461001,67,PF-06863135,T,6217647302,6.21765E+11,20220727,9:50,CYCLE10_DAY1,0 H,246.5074635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2058,132RSYC,10-Nov-22
C1071022,10461001,67,PF-06863135,T,6219611638,6.21961E+11,20230118,10:45,CYCLE16_DAY1,0 H,362.3004352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2200,141RSYC,17-May-23
C1071022,10461001,67,PF-06863135,T,6219611636,6.21961E+11,20230712,9:45,CYCLE22_DAY1,0 H,215.7079177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2276,144RSYC,27-Nov-23
C1071022,10461001,67,PF-06863135,T,6220331901,6.22033E+11,20231004,11:35,CYCLE25_DAY1,0 H,845.1369095,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2316,147RSYC,29-Feb-24
C1071022,10461001,67,PF-06863135,T,6220331903,6.22033E+11,20231227,9:55,CYCLE28_DAY1,0 H,104.8752128,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2368,152RSYC,9-Apr-24
C1071022,10461001,67,PF-06863135,T,6216756774,6.21676E+11,20211110,11:10,CYCLE1_DAY1,24 H,307.9940366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 457,23RSYC,20-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756776,6.21676E+11,20211115,13:00,CYCLE1_DAY4,0 H,260.9068156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 733,32RSYC,23-Apr-22
C1071022,10461001,67,PF-06863135,T,6216756779,6.21676E+11,20211116,15:10,CYCLE1_DAY4,24 H,290.4590145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 736,32RSYC,23-Apr-22
C1071022,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,13:00,CYCLE1_DAY1,0 H,26.04354983,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 446,76RSYC,4-May-22
C1071022,10561001,68,PF-06863135,T,6216408039,6.21641E+11,20211025,20:15,CYCLE1_DAY1,6 H,95.10816492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 445,88RSYC,11-May-22
C1071022,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,9:40,CYCLE1_DAY8,0 H,621.4005028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 480,23RSYC,20-Apr-22
C1071022,10561001,68,PF-06863135,T,6216898572,6.2169E+11,20211103,20:50,CYCLE1_DAY8,6 H,469.3965407,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 479,23RSYC,20-Apr-22
C1071022,10561001,68,PF-06863135,T,6217026143,6.21703E+11,20211116,10:00,CYCLE1_DAY22,0 H,71.99382542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 766,33RSYC,24-Apr-22
C1071022,10561001,68,PF-06863135,T,6216408048,6.21641E+11,20211125,9:15,CYCLE2_DAY1,0 H,583.940516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 713,31RSYC,23-Apr-22
C1071022,10561001,68,PF-06863135,T,6217026165,6.21703E+11,20211223,14:05,CYCLE3_DAY1,0 H,349.4666668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1432,57RSYC,30-Apr-22
C1071022,10561001,68,PF-06863135,T,6216898587,6.2169E+11,20220119,13:00,CYCLE4_DAY1,0 H,362.7671089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1773,71RSYC,7-May-22
C1071022,10561001,68,PF-06863135,T,6216408053,6.21641E+11,20220414,10:40,CYCLE7_DAY1,0 H,687.3680051,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1914,123RSYC,29-Jul-22
C1071022,10561001,68,PF-06863135,T,6218590825,6.21859E+11,20220706,10:50,CYCLE10_DAY1,0 H,522.1282452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2039,128RSYC,21-Oct-22
C1071022,10561001,68,PF-06863135,T,6219498866,6.2195E+11,20230316,10:50,CYCLE19_DAY1,0 H,175.8841671,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2210,142RSYC,18-May-23
C1071022,10561001,68,PF-06863135,T,6220036098,6.22004E+11,20230608,9:40,CYCLE22_DAY1,0 H,450.0221042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2258,147RSYC,29-Feb-24
C1071022,10561001,68,PF-06863135,T,6220036108,6.22004E+11,20230831,12:30,CYCLE25_DAY1,0 H,864.4367475,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2308,148RSYC,27-Mar-24
C1071022,10561001,68,PF-06863135,T,6222181789,6.22218E+11,20240215,9:15,CYCLE31_DAY1,0 H,939.0169011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2361,152RSYC,9-Apr-24
C1071022,10561001,68,PF-06863135,T,6219498868,6.2195E+11,20230105,9:40,UNPL,9001 H,447.1275341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2178,140RSYC,22-Mar-23
C1071022,10561001,68,PF-06863135,T,6216408056,6.21641E+11,20211026,14:15,CYCLE1_DAY1,24 H,407.9162964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 447,88RSYC,11-May-22
C1071022,10561001,68,PF-06863135,T,6216408058,6.21641E+11,20211028,13:30,CYCLE1_DAY4,0 H,186.7577359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 448,88RSYC,11-May-22
C1071022,10561001,68,PF-06863135,T,6216408060,6.21641E+11,20211029,14:30,CYCLE1_DAY4,24 H,562.7776505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 449,88RSYC,11-May-22
C1071022,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,9:17,CYCLE1_DAY1,0 H,863.6071662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 841,35RSYC,25-Apr-22
C1071022,10981004,69,PF-06863135,T,6516326699,6.51633E+11,20211025,18:07,CYCLE1_DAY1,6 H,483.5157214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 840,35RSYC,25-Apr-22
C1071022,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,9:25,CYCLE1_DAY8,0 H,777.6180062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 599,27RSYC,21-Apr-22
C1071022,10981004,69,PF-06863135,T,6517769661,6.51777E+11,20211102,17:35,CYCLE1_DAY8,6 H,181.0599237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 598,27RSYC,21-Apr-22
C1071022,10981004,69,PF-06863135,T,6517769663,6.51777E+11,20211109,9:42,CYCLE1_DAY15,0 H,569.6561701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 907,20RSYC,19-Apr-22
C1071022,10981004,69,PF-06863135,T,6517769670,6.51777E+11,20211118,8:45,CYCLE1_DAY22,0 H,219.5688353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 908,20RSYC,19-Apr-22
C1071022,10981004,69,PF-06863135,T,6517768779,6.51777E+11,20211124,9:37,CYCLE2_DAY1,0 H,258.2235134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1075,41RSYC,26-Apr-22
C1071022,10981004,69,PF-06863135,T,6517768782,6.51777E+11,20211223,9:50,CYCLE3_DAY1,0 H,987.6418648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1076,41RSYC,26-Apr-22
C1071022,10981004,69,PF-06863135,T,6517768786,6.51777E+11,20220120,9:09,CYCLE4_DAY1,0 H,350.9573583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1718,72RSYC,7-May-22
C1071022,10981004,69,PF-06863135,T,6517769688,6.51777E+11,20220412,9:14,CYCLE7_DAY1,0 H,923.2691252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1931,122RSYC,29-Jul-22
C1071022,10981004,69,PF-06863135,T,6518807319,6.51881E+11,20220706,9:25,CYCLE10_DAY1,0 H,223.9399575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2035,128RSYC,21-Oct-22
C1071022,10981004,69,PF-06863135,T,6520972525,6.52097E+11,20220928,10:54,CYCLE13_DAY1,0 H,21.98406909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2112,131RSYC,9-Nov-22
C1071022,10981004,69,PF-06863135,T,6521653170,6.52165E+11,20221227,11:10,CYCLE16_DAY1,0 H,348.1303879,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2174,140RSYC,22-Mar-23
C1071022,10981004,69,PF-06863135,T,6521653171,6.52165E+11,20230322,10:44,CYCLE19_DAY1,0 H,781.7415029,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2223,142RSYC,18-May-23
C1071022,10981004,69,PF-06863135,T,6522845153,6.52285E+11,20230614,12:00,CYCLE22_DAY1,0 H,338.4310388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2263,144RSYC,27-Nov-23
C1071022,10981004,69,PF-06863135,T,6524724651,6.52472E+11,20231218,12:10,CYCLE28_DAY1,0 H,681.7626402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2325,148RSYC,27-Mar-24
C1071022,10981004,69,PF-06863135,T,6517755819,6.51776E+11,20211026,10:35,CYCLE1_DAY1,24 H,832.7264913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 591,27RSYC,21-Apr-22
C1071022,10981004,69,PF-06863135,T,6517755824,6.51776E+11,20211029,6:19,CYCLE1_DAY4,0 H,333.461304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 592,27RSYC,21-Apr-22
C1071022,10981004,69,PF-06863135,T,6517755826,6.51776E+11,20211030,13:00,CYCLE1_DAY4,24 H,216.578595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 593,27RSYC,21-Apr-22
C1071022,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,10:25,CYCLE1_DAY1,0 H,332.4488779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 606,63RSYC,2-May-22
C1071022,10401001,70,PF-06863135,T,6518161422,6.51816E+11,20211026,16:22,CYCLE1_DAY1,6 H,703.758108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 605,89RSYC,11-May-22
C1071022,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,8:46,CYCLE1_DAY8,0 H,122.006823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 888,19RSYC,19-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560297,6.51756E+11,20211105,15:16,CYCLE1_DAY8,6 H,731.1754252,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 887,19RSYC,19-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560298,6.51756E+11,20211112,10:57,CYCLE1_DAY15,0 H,908.8485723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 889,19RSYC,19-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560300,6.51756E+11,20211119,12:10,CYCLE1_DAY22,0 H,67.08172512,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 890,19RSYC,19-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560303,6.51756E+11,20211125,11:47,CYCLE2_DAY1,0 H,804.4685935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1051,40RSYC,26-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560305,6.51756E+11,20211223,11:10,CYCLE3_DAY1,0 H,868.5587677,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1052,40RSYC,26-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560307,6.51756E+11,20220121,9:08,CYCLE4_DAY1,0 H,942.9781951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1721,72RSYC,7-May-22
C1071022,10401001,70,PF-06863135,T,6517560308,6.51756E+11,20220414,11:00,CYCLE7_DAY1,0 H,573.1945569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1932,123RSYC,29-Jul-22
C1071022,10401001,70,PF-06863135,T,6517560317,6.51756E+11,20220706,10:05,CYCLE10_DAY1,0 H,544.806459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2036,131RSYC,9-Nov-22
C1071022,10401001,70,PF-06863135,T,6520956318,6.52096E+11,20221005,13:00,CYCLE13_DAY1,0 H,798.5829392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2113,134RSYC,11-Nov-22
C1071022,10401001,70,PF-06863135,T,6523034191,6.52303E+11,20230614,8:28,CYCLE22_DAY1,0 H,76.50678829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2264,144RSYC,27-Nov-23
C1071022,10401001,70,PF-06863135,T,6521647797,6.52165E+11,20230907,9:29,CYCLE25_DAY1,0 H,244.8134223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2305,147RSYC,29-Feb-24
C1071022,10401001,70,PF-06863135,T,6524124731,6.52412E+11,20231130,12:29,CYCLE28_DAY1,0 H,334.3756958,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2326,148RSYC,27-Mar-24
C1071022,10401001,70,PF-06863135,T,6524124733,6.52412E+11,20240306,12:14,CYCLE31_DAY1,0 H,213.7997914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2372,152RSYC,9-Apr-24
C1071022,10401001,70,PF-06863135,T,6517560319,6.51756E+11,20211029,10:48,UNPL,9001 H,648.9321176,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 586,27RSYC,21-Apr-22
C1071022,10401001,70,PF-06863135,T,6521647796,6.52165E+11,20230125,10:29,UNPL,9002 H,271.7096005,NG/ML,,Visit revised from C16D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2205,141RSYC,17-May-23
C1071022,10401001,70,PF-06863135,T,6517560311,6.51756E+11,20211027,10:20,CYCLE1_DAY1,24 H,43.76796473,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 583,27RSYC,21-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560312,6.51756E+11,20211101,10:40,CYCLE1_DAY4,0 H,711.7660542,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 584,27RSYC,21-Apr-22
C1071022,10401001,70,PF-06863135,T,6517560315,6.51756E+11,20211102,11:58,CYCLE1_DAY4,24 H,214.5010966,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 585,86RSYC,13-May-22
C1071022,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,8:59,CYCLE1_DAY1,0 H,635.3401703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 516,25RSYC,22-Apr-22
C1071022,10191007,71,PF-06863135,T,6517246381,6.51725E+11,20211026,19:30,CYCLE1_DAY1,6 H,173.9367817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 515,25RSYC,22-Apr-22
C1071022,10191007,71,PF-06863135,T,6517246493,6.51725E+11,20211027,13:30,CYCLE1_DAY1,24 H,225.094232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 518,63RSYC,2-May-22
C1071022,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,11:00,CYCLE1_DAY1,0 H,559.8136531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 436,76RSYC,4-May-22
C1071022,10481005,72,PF-06863135,T,6216407972,6.21641E+11,20211029,17:00,CYCLE1_DAY1,6 H,342.830554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 435,88RSYC,11-May-22
C1071022,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,9:00,CYCLE1_DAY8,0 H,37.13028793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 476,23RSYC,20-Apr-22
C1071022,10481005,72,PF-06863135,T,6216856419,6.21686E+11,20211105,15:20,CYCLE1_DAY8,6 H,940.3394648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 475,23RSYC,20-Apr-22
C1071022,10481005,72,PF-06863135,T,6216856423,6.21686E+11,20211112,8:55,CYCLE1_DAY15,0 H,481.8878018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 738,32RSYC,23-Apr-22
C1071022,10481005,72,PF-06863135,T,6216407977,6.21641E+11,20211119,9:25,CYCLE1_DAY22,0 H,971.0255864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1306,49RSYC,29-Apr-22
C1071022,10481005,72,PF-06863135,T,6216856440,6.21686E+11,20211126,11:15,CYCLE2_DAY1,0 H,814.0152197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1400,95RSYC,13-May-22
C1071022,10481005,72,PF-06863135,T,6216856453,6.21686E+11,20211223,10:00,CYCLE3_DAY1,0 H,962.7799641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1401,95RSYC,13-May-22
C1071022,10481005,72,PF-06863135,T,6217184393,6.21718E+11,20220120,8:30,CYCLE4_DAY1,0 H,212.5375282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1749,91RSYC,11-May-22
C1071022,10481005,72,PF-06863135,T,6217142723,6.21714E+11,20220707,9:00,CYCLE10_DAY1,0 H,795.20431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2037,128RSYC,21-Oct-22
C1071022,10481005,72,PF-06863135,T,6217142722,6.21714E+11,20220929,10:40,CYCLE13_DAY1,0 H,285.0218749,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2121,131RSYC,9-Nov-22
C1071022,10481005,72,PF-06863135,T,6219283083,6.21928E+11,20221222,9:30,CYCLE16_DAY1,0 H,978.5166856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2177,140RSYC,22-Mar-23
C1071022,10481005,72,PF-06863135,T,6219283082,6.21928E+11,20230316,9:30,CYCLE19_DAY1,0 H,570.9684864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2226,142RSYC,18-May-23
C1071022,10481005,72,PF-06863135,T,6219283081,6.21928E+11,20230608,9:00,CYCLE22_DAY1,0 H,244.9943795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2259,144RSYC,27-Nov-23
C1071022,10481005,72,PF-06863135,T,6220027062,6.22003E+11,20230831,8:57,CYCLE25_DAY1,0 H,459.2857576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2307,147RSYC,29-Feb-24
C1071022,10481005,72,PF-06863135,T,6220027063,6.22003E+11,20231123,12:21,CYCLE28_DAY1,0 H,967.0511936,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2347,148RSYC,27-Mar-24
C1071022,10481005,72,PF-06863135,T,6221581756,6.22158E+11,20240214,9:15,CYCLE31_DAY1,0 H,9.46985209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2364,152RSYC,9-Apr-24
C1071022,10481005,72,PF-06863135,T,6222579039,6.22258E+11,20240228,8:05,END_OF_TRT,,181.6656291,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2369,152RSYC,9-Apr-24
C1071022,10481005,72,PF-06863135,T,6218548367,6.21855E+11,20220428,9:30,UNPL,9001 H,904.6636069,NG/ML,,Received as 6216407986-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2163,141RSYC,17-May-23
C1071022,10481005,72,PF-06863135,T,6216407988,6.21641E+11,20211030,11:00,CYCLE1_DAY1,24 H,848.9643565,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 441,88RSYC,11-May-22
C1071022,10481005,72,PF-06863135,T,6216856467,6.21686E+11,20211101,12:20,CYCLE1_DAY4,0 H,801.0866507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 478,23RSYC,20-Apr-22
C1071022,10481005,72,PF-06863135,T,6216407992,6.21641E+11,20211102,12:20,CYCLE1_DAY4,24 H,161.6243245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 444,88RSYC,11-May-22
C1071022,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,10:57,CYCLE1_DAY1,0 H,469.9198177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 561,26RSYC,22-Apr-22
C1071022,10101004,73,PF-06863135,T,6517559653,6.51756E+11,20211029,18:17,CYCLE1_DAY1,6 H,626.4387899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 560,26RSYC,22-Apr-22
C1071022,10101004,73,PF-06863135,T,6518706277,6.51871E+11,20211106,13:59,CYCLE1_DAY8,0 H,479.6201078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 616,90RSYC,11-May-22
C1071022,10101004,73,PF-06863135,T,6518558181,6.51856E+11,20211112,10:43,CYCLE1_DAY15,0 H,451.525186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 915,20RSYC,19-Apr-22
C1071022,10101004,73,PF-06863135,T,6517559659,6.51756E+11,20211119,10:00,CYCLE1_DAY22,0 H,336.4389704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 878,19RSYC,19-Apr-22
C1071022,10101004,73,PF-06863135,T,6518922660,6.51892E+11,20211126,10:16,CYCLE2_DAY1,0 H,881.2281066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 680,30RSYC,22-Apr-22
C1071022,10101004,73,PF-06863135,T,6517559680,6.51756E+11,20211030,12:07,CYCLE1_DAY1,24 H,920.7161726,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 566,26RSYC,22-Apr-22
C1071022,10101004,73,PF-06863135,T,6518558186,6.51856E+11,20211101,10:45,CYCLE1_DAY4,0 H,872.0890735,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 612,90RSYC,11-May-22
C1071022,10101004,73,PF-06863135,T,6518558188,6.51856E+11,20211102,14:20,CYCLE1_DAY4,24 H,821.5395957,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 613,90RSYC,11-May-22
C1071022,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,8:20,CYCLE1_DAY1,0 H,175.7130458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 520,25RSYC,22-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433305,6.51743E+11,20211101,16:00,CYCLE1_DAY1,6 H,385.1711583,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 519,25RSYC,22-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,10:35,CYCLE1_DAY8,0 H,631.0816379,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 844,35RSYC,25-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433307,6.51743E+11,20211109,16:35,CYCLE1_DAY8,6 H,642.5337311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 843,35RSYC,25-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433310,6.51743E+11,20211116,8:10,CYCLE1_DAY15,0 H,399.7131063,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 845,35RSYC,25-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433311,6.51743E+11,20211123,10:03,CYCLE1_DAY22,0 H,285.3098412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 966,65RSYC,3-May-22
C1071022,10121002,74,PF-06863135,T,6518019666,6.51802E+11,20211130,10:15,CYCLE2_DAY1,0 H,606.8992881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1088,67RSYC,8-May-22
C1071022,10121002,74,PF-06863135,T,6517433316,6.51743E+11,20211229,9:00,CYCLE3_DAY1,0 H,668.8001728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1628,85RSYC,10-May-22
C1071022,10121002,74,PF-06863135,T,6517433318,6.51743E+11,20220127,9:25,CYCLE4_DAY1,0 H,15.38187946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1629,85RSYC,10-May-22
C1071022,10121002,74,PF-06863135,T,6518019671,6.51802E+11,20220420,11:20,CYCLE7_DAY1,0 H,661.8591287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1933,123RSYC,29-Jul-22
C1071022,10121002,74,PF-06863135,T,6517433328,6.51743E+11,20220714,10:30,CYCLE10_DAY1,0 H,70.87426704,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2029,131RSYC,9-Nov-22
C1071022,10121002,74,PF-06863135,T,6520915406,6.52092E+11,20221007,10:15,CYCLE13_DAY1,0 H,195.7130386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2108,134RSYC,11-Nov-22
C1071022,10121002,74,PF-06863135,T,6520915405,6.52092E+11,20221229,9:25,CYCLE16_DAY1,0 H,533.421582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2170,140RSYC,22-Mar-23
C1071022,10121002,74,PF-06863135,T,6520915407,6.52092E+11,20230321,10:00,CYCLE19_DAY1,0 H,956.1546951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2219,142RSYC,18-May-23
C1071022,10121002,74,PF-06863135,T,6523311141,6.52331E+11,20230615,9:45,CYCLE22_DAY1,0 H,757.061926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2265,144RSYC,27-Nov-23
C1071022,10121002,74,PF-06863135,T,6523311142,6.52331E+11,20230907,10:20,CYCLE25_DAY1,0 H,915.8465834,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2301,147RSYC,29-Feb-24
C1071022,10121002,74,PF-06863135,T,6523737982,6.52374E+11,20231130,10:15,CYCLE28_DAY1,0 H,604.6150506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2327,148RSYC,27-Mar-24
C1071022,10121002,74,PF-06863135,T,6523737988,6.52374E+11,20231212,8:20,END_OF_TRT,,452.5562458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2328,149RSYC,27-Mar-24
C1071022,10121002,74,PF-06863135,T,6517433321,6.51743E+11,20211102,10:30,CYCLE1_DAY1,24 H,594.6563306,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 525,107RSYC,24-May-22
C1071022,10121002,74,PF-06863135,T,6517433324,6.51743E+11,20211104,13:15,CYCLE1_DAY4,0 H,190.8816277,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 528,25RSYC,22-Apr-22
C1071022,10121002,74,PF-06863135,T,6517433325,6.51743E+11,20211105,11:50,CYCLE1_DAY4,24 H,123.5779364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 529,25RSYC,22-Apr-22
C1071022,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211028,19:15,CYCLE1_DAY1,0 H,703.082717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 499,24RSYC,20-Apr-22
C1071022,11021003,75,PF-06863135,T,6217023822,6.21702E+11,20211029,0:30,CYCLE1_DAY1,6 H,685.5478023,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 498,24RSYC,20-Apr-22
C1071022,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211109,20:30,CYCLE1_DAY8,0 H,447.8061341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 503,24RSYC,20-Apr-22
C1071022,11021003,75,PF-06863135,T,6217023825,6.21702E+11,20211110,2:50,CYCLE1_DAY8,6 H,720.5920435,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 502,24RSYC,20-Apr-22
C1071022,11021003,75,PF-06863135,T,6217170434,6.21717E+11,20211116,14:00,CYCLE1_DAY15,0 H,173.912067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 790,34RSYC,24-Apr-22
C1071022,11021003,75,PF-06863135,T,6217170449,6.21717E+11,20211123,12:30,CYCLE1_DAY22,0 H,429.2993395,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 794,34RSYC,24-Apr-22
C1071022,11021003,75,PF-06863135,T,6217170457,6.21717E+11,20211130,10:30,CYCLE2_DAY1,0 H,188.0965893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1507,56RSYC,30-Apr-22
C1071022,11021003,75,PF-06863135,T,6217023844,6.21702E+11,20211228,11:40,CYCLE3_DAY1,0 H,561.722434,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1835,93RSYC,12-May-22
C1071022,11021003,75,PF-06863135,T,6217417531,6.21742E+11,20220125,11:30,CYCLE4_DAY1,0 H,935.3354339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1836,93RSYC,12-May-22
C1071022,11021003,75,PF-06863135,T,6217170495,6.21717E+11,20220419,12:15,CYCLE7_DAY1,0 H,55.47981529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1915,123RSYC,29-Jul-22
C1071022,11021003,75,PF-06863135,T,6218223703,6.21822E+11,20220601,12:30,END_OF_TRT,,646.4563169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2019,115RSYC,25-Jul-22
C1071022,11021003,75,PF-06863135,T,6217023853,6.21702E+11,20211102,14:00,CYCLE1_DAY4,0 H,309.6591785,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 506,24RSYC,20-Apr-22
C1071022,11021003,75,PF-06863135,T,6216756815,6.21676E+11,20211103,14:10,CYCLE1_DAY4,24 H,962.2415955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 462,23RSYC,20-Apr-22
C1071022,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,17:00,CYCLE1_DAY1,0 H,584.3882817,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 497,24RSYC,20-Apr-22
C1071022,11021004,76,PF-06863135,T,6217023821,6.21702E+11,20211108,23:00,CYCLE1_DAY1,6 H,522.5293088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 496,24RSYC,20-Apr-22
C1071022,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,15:50,CYCLE1_DAY8,0 H,279.625651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 802,34RSYC,24-Apr-22
C1071022,11021004,76,PF-06863135,T,6217184362,6.21718E+11,20211115,22:00,CYCLE1_DAY8,6 H,445.4363661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 801,34RSYC,24-Apr-22
C1071022,11021004,76,PF-06863135,T,6217170435,6.21717E+11,20211122,15:00,CYCLE1_DAY15,0 H,863.018594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 791,34RSYC,24-Apr-22
C1071022,11021004,76,PF-06863135,T,6217170446,6.21717E+11,20211129,13:00,CYCLE1_DAY22,0 H,595.8294637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1501,55RSYC,30-Apr-22
C1071022,11021004,76,PF-06863135,T,6217170459,6.21717E+11,20211206,13:30,CYCLE2_DAY1,0 H,44.23425179,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1508,56RSYC,30-Apr-22
C1071022,11021004,76,PF-06863135,T,6217023846,6.21702E+11,20220103,14:30,CYCLE3_DAY1,0 H,153.0883942,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1837,93RSYC,12-May-22
C1071022,11021004,76,PF-06863135,T,6217170486,6.21717E+11,20220131,16:25,CYCLE4_DAY1,0 H,64.85083084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1838,93RSYC,12-May-22
C1071022,11021004,76,PF-06863135,T,6217170501,6.21717E+11,20220425,14:58,CYCLE7_DAY1,0 H,529.2992675,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1997,115RSYC,25-Jul-22
C1071022,11021004,76,PF-06863135,T,6218384029,6.21838E+11,20220719,14:50,CYCLE10_DAY1,0 H,976.2403998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2103,132RSYC,10-Nov-22
C1071022,11021004,76,PF-06863135,T,6218384031,6.21838E+11,20221010,14:40,CYCLE13_DAY1,0 H,969.4492777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2124,131RSYC,9-Nov-22
C1071022,11021004,76,PF-06863135,T,6217136150,6.21714E+11,20211109,17:00,CYCLE1_DAY1,24 H,290.9750078,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 510,24RSYC,20-Apr-22
C1071022,11021004,76,PF-06863135,T,6217023851,6.21702E+11,20211110,16:15,CYCLE1_DAY4,0 H,509.031792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 759,33RSYC,24-Apr-22
C1071022,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211108,18:10,CYCLE1_DAY1,0 H,206.3225301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 501,24RSYC,20-Apr-22
C1071022,11021005,77,PF-06863135,T,6217023823,6.21702E+11,20211109,0:30,CYCLE1_DAY1,6 H,737.6550807,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 500,24RSYC,20-Apr-22
C1071022,11021005,77,PF-06863135,T,6217023826,6.21702E+11,20211115,16:50,CYCLE1_DAY8,0 H,962.4314719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 752,32RSYC,23-Apr-22
C1071022,11021005,77,PF-06863135,T,6217170433,6.21717E+11,20211122,15:30,CYCLE1_DAY15,0 H,584.9264092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 789,34RSYC,24-Apr-22
C1071022,11021005,77,PF-06863135,T,6217170443,6.21717E+11,20211129,15:10,CYCLE1_DAY22,0 H,625.2201025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1500,55RSYC,30-Apr-22
C1071022,11021005,77,PF-06863135,T,6217170456,6.21717E+11,20211206,15:30,CYCLE2_DAY1,0 H,94.37173314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1506,56RSYC,30-Apr-22
C1071022,11021005,77,PF-06863135,T,6217142696,6.21714E+11,20220103,14:10,END_OF_TRT,,430.3420639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1839,86RSYC,13-May-22
C1071022,11021005,77,PF-06863135,T,6217118743,6.21712E+11,20211109,18:25,CYCLE1_DAY1,24 H,147.2385756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 508,24RSYC,20-Apr-22
C1071022,11021005,77,PF-06863135,T,6217023850,6.21702E+11,20211110,13:45,CYCLE1_DAY4,0 H,737.396467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 758,33RSYC,24-Apr-22
C1071022,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,17:10,CYCLE1_DAY1,0 H,332.918837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 495,24RSYC,20-Apr-22
C1071022,11021006,78,PF-06863135,T,6217023820,6.21702E+11,20211109,23:15,CYCLE1_DAY1,6 H,202.9296664,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 494,24RSYC,20-Apr-22
C1071022,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211116,17:50,CYCLE1_DAY8,0 H,724.7578899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 754,32RSYC,23-Apr-22
C1071022,11021006,78,PF-06863135,T,6217023827,6.21702E+11,20211117,0:00,CYCLE1_DAY8,6 H,506.3631191,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 753,32RSYC,23-Apr-22
C1071022,11021006,78,PF-06863135,T,6217170440,6.21717E+11,20211123,12:30,CYCLE1_DAY15,0 H,237.2745213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 793,34RSYC,24-Apr-22
C1071022,11021006,78,PF-06863135,T,6217170448,6.21717E+11,20211130,13:30,CYCLE1_DAY22,0 H,453.5236529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1502,55RSYC,30-Apr-22
C1071022,11021006,78,PF-06863135,T,6217170461,6.21717E+11,20211207,12:30,CYCLE2_DAY1,0 H,337.4413703,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1509,56RSYC,30-Apr-22
C1071022,11021006,78,PF-06863135,T,6217170478,6.21717E+11,20220104,9:50,CYCLE3_DAY1,0 H,43.69557134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1840,93RSYC,12-May-22
C1071022,11021006,78,PF-06863135,T,6217170492,6.21717E+11,20220201,10:55,CYCLE4_DAY1,0 H,556.0185604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1841,93RSYC,12-May-22
C1071022,11021006,78,PF-06863135,T,6217170502,6.21717E+11,20220426,10:50,CYCLE7_DAY1,0 H,460.5451267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1998,115RSYC,25-Jul-22
C1071022,11021006,78,PF-06863135,T,6217142672,6.21714E+11,20220719,14:55,CYCLE10_DAY1,0 H,714.8676756,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2064,132RSYC,10-Nov-22
C1071022,11021006,78,PF-06863135,T,6218384030,6.21838E+11,20221011,10:45,CYCLE13_DAY1,0 H,110.8906861,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2125,131RSYC,9-Nov-22
C1071022,11021006,78,PF-06863135,T,6217136153,6.21714E+11,20211110,17:15,CYCLE1_DAY1,24 H,903.2106486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 786,34RSYC,24-Apr-22
C1071022,11021006,78,PF-06863135,T,6217184363,6.21718E+11,20211112,17:50,CYCLE1_DAY4,0 H,956.8616896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 803,34RSYC,24-Apr-22
C1071022,11021006,78,PF-06863135,T,6217136154,6.21714E+11,20211113,18:15,CYCLE1_DAY4,24 H,21.32744013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 787,34RSYC,24-Apr-22
C1071022,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,13:30,CYCLE1_DAY1,0 H,951.7327738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 800,34RSYC,24-Apr-22
C1071022,11021007,79,PF-06863135,T,6217184361,6.21718E+11,20211115,20:10,CYCLE1_DAY1,6 H,497.6292061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 799,34RSYC,24-Apr-22
C1071022,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,16:30,CYCLE1_DAY8,0 H,865.9832643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 810,64RSYC,3-May-22
C1071022,11021007,79,PF-06863135,T,6217233479,6.21723E+11,20211122,23:00,CYCLE1_DAY8,6 H,375.7945893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 809,34RSYC,24-Apr-22
C1071022,11021007,79,PF-06863135,T,6217170436,6.21717E+11,20211129,15:30,CYCLE1_DAY15,0 H,82.70388807,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1496,55RSYC,30-Apr-22
C1071022,11021007,79,PF-06863135,T,6217170512,6.21717E+11,20211116,13:00,CYCLE1_DAY1,24 H,639.6053626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1515,56RSYC,30-Apr-22
C1071022,11021007,79,PF-06863135,T,6217233481,6.21723E+11,20211118,15:00,CYCLE1_DAY4,0 H,32.6244237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1545,58RSYC,1-May-22
C1071022,11021007,79,PF-06863135,T,6217184366,6.21718E+11,20211119,15:30,CYCLE1_DAY4,24 H,669.3428312,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1523,56RSYC,30-Apr-22
C1071022,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,12:55,CYCLE1_DAY1,0 H,800.8069767,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 619,63RSYC,2-May-22
C1071022,10821007,80,PF-06863135,T,6603459531,6.60346E+11,20211101,19:40,CYCLE1_DAY1,6 H,28.23008732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 620,90RSYC,11-May-22
C1071022,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,9:40,CYCLE1_DAY8,0 H,376.8469668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 625,64RSYC,3-May-22
C1071022,10821007,80,PF-06863135,T,6603491873,6.60349E+11,20211108,16:20,CYCLE1_DAY8,6 H,690.5868153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 624,64RSYC,3-May-22
C1071022,10821007,80,PF-06863135,T,6603459535,6.60346E+11,20211115,11:20,CYCLE1_DAY15,0 H,647.5517665,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 621,90RSYC,11-May-22
C1071022,10821007,80,PF-06863135,T,6603541506,6.60354E+11,20211122,12:10,END_OF_TRT,,224.6144645,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 818,107RSYC,24-May-22
C1071022,10821007,80,PF-06863135,T,6603505731,6.60351E+11,20211103,2:10,UNPL,9001 H,48.05160832,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 627,107RSYC,24-May-22
C1071022,10821007,80,PF-06863135,T,6603491879,6.60349E+11,20211103,17:30,UNPL,9002 H,678.7661789,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 626,107RSYC,24-May-22
C1071022,10821007,80,PF-06863135,T,6603505732,6.60351E+11,20211105,15:25,UNPL,9003 H,71.22300189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 628,107RSYC,24-May-22
C1071022,10821007,80,PF-06863135,T,6603459540,6.60346E+11,20211102,13:45,CYCLE1_DAY1,24 H,268.603035,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 622,64RSYC,3-May-22
C1071022,10821007,80,PF-06863135,T,6603451262,6.60345E+11,20211104,15:20,CYCLE1_DAY4,0 H,713.5234293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 618,90RSYC,11-May-22
C1071022,10821007,80,PF-06863135,T,6603459546,6.60346E+11,20211105,16:50,CYCLE1_DAY4,24 H,543.3819949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 623,64RSYC,3-May-22
C1071022,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,10:30,CYCLE1_DAY1,0 H,356.9732106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 672,30RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801708299,6.80171E+11,20211101,20:38,CYCLE1_DAY1,6 H,39.90434541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 673,30RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,9:15,CYCLE1_DAY8,0 H,49.24161357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 663,29RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650370,6.80165E+11,20211108,18:30,CYCLE1_DAY8,6 H,384.904544,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 662,29RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650372,6.80165E+11,20211115,10:00,CYCLE1_DAY15,0 H,557.5424624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 664,29RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650374,6.80165E+11,20211122,9:55,CYCLE1_DAY22,0 H,360.1635883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 830,35RSYC,25-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650376,6.80165E+11,20211129,10:25,CYCLE2_DAY1,0 H,403.4976062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 940,65RSYC,3-May-22
C1071022,11111003,81,PF-06863135,T,6801697214,6.8017E+11,20211227,11:30,CYCLE3_DAY1,0 H,888.207307,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 958,65RSYC,3-May-22
C1071022,11111003,81,PF-06863135,T,6801697215,6.8017E+11,20220124,10:55,CYCLE4_DAY1,0 H,545.7935392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1596,96RSYC,12-May-22
C1071022,11111003,81,PF-06863135,T,6801828108,6.80183E+11,20220418,9:50,CYCLE7_DAY1,0 H,343.7056791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1919,123RSYC,29-Jul-22
C1071022,11111003,81,PF-06863135,T,6801891347,6.80189E+11,20220711,9:25,CYCLE10_DAY1,0 H,889.6665906,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2025,132RSYC,10-Nov-22
C1071022,11111003,81,PF-06863135,T,6801944848,6.80194E+11,20221003,9:40,END_OF_TRT,,174.178643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2119,131RSYC,9-Nov-22
C1071022,11111003,81,PF-06863135,T,6801650380,6.80165E+11,20211102,14:38,CYCLE1_DAY1,24 H,420.1645903,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 665,29RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650382,6.80165E+11,20211104,9:05,CYCLE1_DAY4,0 H,879.9266647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 666,30RSYC,22-Apr-22
C1071022,11111003,81,PF-06863135,T,6801650384,6.80165E+11,20211105,12:40,CYCLE1_DAY4,24 H,800.7197626,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 667,30RSYC,22-Apr-22
C1071022,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,11:38,CYCLE1_DAY1,0 H,182.7653751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 426,76RSYC,4-May-22
C1071022,10351002,82,PF-06863135,T,6216407869,6.21641E+11,20211101,21:30,CYCLE1_DAY1,6 H,980.4542652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 425,88RSYC,11-May-22
C1071022,10351002,82,PF-06863135,T,6216407872,6.21641E+11,20211111,8:32,CYCLE1_DAY8,0 H,432.5015722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 427,88RSYC,11-May-22
C1071022,10351002,82,PF-06863135,T,6216407873,6.21641E+11,20211118,8:50,CYCLE1_DAY15,0 H,884.5509842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 706,31RSYC,23-Apr-22
C1071022,10351002,82,PF-06863135,T,6217091592,6.21709E+11,20211124,9:15,CYCLE1_DAY22,0 H,418.7735238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 783,33RSYC,24-Apr-22
C1071022,10351002,82,PF-06863135,T,6216407877,6.21641E+11,20211201,9:25,CYCLE2_DAY1,0 H,796.0708302,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1297,49RSYC,29-Apr-22
C1071022,10351002,82,PF-06863135,T,6216407899,6.21641E+11,20211208,12:10,END_OF_TRT,,328.1897287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1298,108RSYC,24-May-22
C1071022,10351002,82,PF-06863135,T,6216407886,6.21641E+11,20211102,13:35,CYCLE1_DAY1,24 H,786.3463823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 430,88RSYC,11-May-22
C1071022,10351002,82,PF-06863135,T,6216407887,6.21641E+11,20211104,8:15,CYCLE1_DAY4,0 H,661.7597455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 431,88RSYC,11-May-22
C1071022,10351002,82,PF-06863135,T,6216407889,6.21641E+11,20211105,9:45,CYCLE1_DAY4,24 H,930.9348961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 432,88RSYC,11-May-22
C1071022,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,15:37,CYCLE1_DAY1,0 H,315.3346323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 553,26RSYC,22-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472607,6.51747E+11,20211101,22:45,CYCLE1_DAY1,6 H,13.37203778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 552,26RSYC,22-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,14:35,CYCLE1_DAY8,0 H,681.629959,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 857,36RSYC,25-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472609,6.51747E+11,20211108,20:01,CYCLE1_DAY8,6 H,918.6487008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 856,36RSYC,25-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472610,6.51747E+11,20211115,9:23,CYCLE1_DAY15,0 H,719.6478517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 858,36RSYC,25-Apr-22
C1071022,10931001,83,PF-06863135,T,6518778274,6.51878E+11,20211201,14:30,CYCLE2_DAY1,0 H,863.7617917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1147,107RSYC,24-May-22
C1071022,10931001,83,PF-06863135,T,6518934245,6.51893E+11,20220126,13:35,CYCLE4_DAY1,0 H,784.195619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1708,72RSYC,7-May-22
C1071022,10931001,83,PF-06863135,T,6517472623,6.51747E+11,20211102,16:45,CYCLE1_DAY1,24 H,787.5620278,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 554,26RSYC,22-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472625,6.51747E+11,20211104,11:50,CYCLE1_DAY4,0 H,439.6414835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 555,26RSYC,22-Apr-22
C1071022,10931001,83,PF-06863135,T,6517472626,6.51747E+11,20211105,11:50,CYCLE1_DAY4,24 H,92.14234236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 861,36RSYC,25-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,10:00,CYCLE1_DAY1,0 H,976.5990993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 406,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170879,6.21617E+11,20211102,18:30,CYCLE1_DAY1,6 H,120.8715865,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 405,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,9:00,CYCLE1_DAY8,0 H,436.1065941,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 408,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170881,6.21617E+11,20211108,17:50,CYCLE1_DAY8,6 H,117.9499298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 407,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170883,6.21617E+11,20211115,9:21,CYCLE1_DAY15,0 H,222.9119598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 696,31RSYC,23-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170884,6.21617E+11,20211122,9:10,CYCLE1_DAY22,0 H,312.9860534,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 697,31RSYC,23-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170887,6.21617E+11,20211129,9:40,CYCLE2_DAY1,0 H,734.7695245,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1274,89RSYC,11-May-22
C1071022,10541002,84,PF-06863135,T,6216170889,6.21617E+11,20211227,9:20,END_OF_TRT,,390.2051964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1772,71RSYC,7-May-22
C1071022,10541002,84,PF-06863135,T,6216170894,6.21617E+11,20211103,12:30,CYCLE1_DAY1,24 H,997.4973194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 409,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170897,6.21617E+11,20211104,9:40,CYCLE1_DAY4,0 H,401.374793,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 410,21RSYC,20-Apr-22
C1071022,10541002,84,PF-06863135,T,6216170899,6.21617E+11,20211105,12:30,CYCLE1_DAY4,24 H,54.72989563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 411,21RSYC,20-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,10:25,CYCLE1_DAY1,0 H,733.9170143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 638,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650229,6.80165E+11,20211104,16:08,CYCLE1_DAY1,6 H,935.9166086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 639,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,10:12,CYCLE1_DAY8,0 H,181.4138203,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 643,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650231,6.80165E+11,20211111,15:50,CYCLE1_DAY8,6 H,977.5138034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 642,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650233,6.80165E+11,20211117,15:45,CYCLE1_DAY15,0 H,300.4293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 826,35RSYC,25-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650235,6.80165E+11,20211124,13:25,CYCLE1_DAY22,0 H,788.8317468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 828,35RSYC,25-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650237,6.80165E+11,20211201,13:15,CYCLE2_DAY1,0 H,625.9366742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 956,65RSYC,3-May-22
C1071022,11101003,85,PF-06863135,T,6801747726,6.80175E+11,20211228,11:00,CYCLE3_DAY1,0 H,144.1091392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 957,65RSYC,3-May-22
C1071022,11101003,85,PF-06863135,T,6801747727,6.80175E+11,20220126,11:36,CYCLE4_DAY1,0 H,415.7121951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1595,59RSYC,1-May-22
C1071022,11101003,85,PF-06863135,T,6801650250,6.80165E+11,20220401,11:35,END_OF_TRT,,797.600378,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1920,123RSYC,29-Jul-22
C1071022,11101003,85,PF-06863135,T,6801650241,6.80165E+11,20211105,10:05,CYCLE1_DAY1,24 H,788.107437,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 644,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650243,6.80165E+11,20211108,15:18,CYCLE1_DAY4,0 H,801.2593489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 646,29RSYC,22-Apr-22
C1071022,11101003,85,PF-06863135,T,6801650245,6.80165E+11,20211109,14:10,CYCLE1_DAY4,24 H,986.8006715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 648,29RSYC,22-Apr-22
C1071022,11041003,86,PF-06863135,T,6216923989,6.21692E+11,20211104,12:30,CYCLE1_DAY1,0 H,253.8419571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1758,91RSYC,11-May-22
C1071022,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,16:30,CYCLE1_DAY8,0 H,981.8493087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 744,32RSYC,23-Apr-22
C1071022,11041003,86,PF-06863135,T,6216923993,6.21692E+11,20211115,23:35,CYCLE1_DAY8,6 H,194.078619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 743,32RSYC,23-Apr-22
C1071022,11041003,86,PF-06863135,T,6216725279,6.21673E+11,20211123,8:50,CYCLE1_DAY15,0 H,771.124914,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 725,31RSYC,23-Apr-22
C1071022,11041003,86,PF-06863135,T,6216725280,6.21673E+11,20211129,15:00,CYCLE1_DAY22,0 H,491.4784662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1376,84RSYC,10-May-22
C1071022,11041003,86,PF-06863135,T,6216924003,6.21692E+11,20211206,11:00,CYCLE2_DAY1,0 H,14.10124641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1420,57RSYC,30-Apr-22
C1071022,11041003,86,PF-06863135,T,6216725285,6.21673E+11,20220104,12:15,CYCLE3_DAY1,0 H,246.6715828,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1757,91RSYC,11-May-22
C1071022,11041003,86,PF-06863135,T,6216924045,6.21692E+11,20220111,11:47,END_OF_TRT,,733.5358238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1759,109RSYC,25-May-22
C1071022,11041003,86,PF-06863135,T,6216924028,6.21692E+11,20211105,18:20,CYCLE1_DAY1,24 H,654.0190599,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 748,32RSYC,23-Apr-22
C1071022,11041003,86,PF-06863135,T,6216924032,6.21692E+11,20211108,12:00,CYCLE1_DAY4,0 H,844.1694695,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 492,24RSYC,20-Apr-22
C1071022,11041003,86,PF-06863135,T,6216924034,6.21692E+11,20211109,16:15,CYCLE1_DAY4,24 H,17.44538089,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 749,32RSYC,23-Apr-22
C1071022,10151003,87,PF-06863135,T,6518602938,6.5186E+11,20211110,13:50,CYCLE1_DAY1,0 H,285.4757132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 614,63RSYC,2-May-22
C1071022,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,9:20,CYCLE1_DAY8,0 H,787.7978591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 938,65RSYC,3-May-22
C1071022,10151003,87,PF-06863135,T,6518842175,6.51884E+11,20211118,16:05,CYCLE1_DAY8,6 H,364.5081856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 937,64RSYC,3-May-22
C1071022,10151003,87,PF-06863135,T,6518842176,6.51884E+11,20211124,9:30,CYCLE1_DAY15,0 H,875.0700998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1164,104RSYC,22-May-22
C1071022,10151003,87,PF-06863135,T,6518602944,6.5186E+11,20211201,9:29,CYCLE1_DAY22,0 H,64.4915144,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1114,67RSYC,8-May-22
C1071022,10151003,87,PF-06863135,T,6517560136,6.51756E+11,20220426,11:45,CYCLE7_DAY1,0 H,209.4168816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1980,114RSYC,25-Jul-22
C1071022,10151003,87,PF-06863135,T,6521544923,6.52154E+11,20230321,11:08,CYCLE19_DAY1,0 H,625.5531993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2206,145RSYC,4-Jan-24
C1071022,10151003,87,PF-06863135,T,6521544920,6.52154E+11,20230615,11:05,CYCLE22_DAY1,0 H,896.0076414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2266,147RSYC,29-Feb-24
C1071022,10151003,87,PF-06863135,T,6518602952,6.5186E+11,20211111,15:00,CYCLE1_DAY1,24 H,910.4001259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 923,20RSYC,19-Apr-22
C1071022,10151003,87,PF-06863135,T,6518602955,6.5186E+11,20211112,13:00,CYCLE1_DAY4,0 H,144.9266326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 924,20RSYC,19-Apr-22
C1071022,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,15:00,CYCLE1_DAY1,0 H,989.9942799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1413,96RSYC,12-May-22
C1071022,11041004,88,PF-06863135,T,6216923987,6.21692E+11,20211105,22:30,CYCLE1_DAY1,6 H,764.2377674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1412,108RSYC,24-May-22
C1071022,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211112,12:50,CYCLE1_DAY8,0 H,466.9240276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 724,31RSYC,23-Apr-22
C1071022,11041004,88,PF-06863135,T,6216725277,6.21673E+11,20211113,0:45,CYCLE1_DAY8,6 H,540.590382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 723,31RSYC,23-Apr-22
C1071022,11041004,88,PF-06863135,T,6216923997,6.21692E+11,20211118,15:20,CYCLE1_DAY15,0 H,984.8614984,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 745,32RSYC,23-Apr-22
C1071022,11041004,88,PF-06863135,T,6216924048,6.21692E+11,20211124,19:30,END_OF_TRT,,437.1210347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1760,109RSYC,25-May-22
C1071022,11041004,88,PF-06863135,T,6216924027,6.21692E+11,20211106,16:30,CYCLE1_DAY1,24 H,638.3229222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 489,24RSYC,20-Apr-22
C1071022,11041004,88,PF-06863135,T,6216924031,6.21692E+11,20211108,11:40,CYCLE1_DAY4,0 H,134.5574657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 491,24RSYC,20-Apr-22
C1071022,11041004,88,PF-06863135,T,6216924036,6.21692E+11,20211109,14:00,CYCLE1_DAY4,24 H,839.1860416,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 750,32RSYC,23-Apr-22
C1071022,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,13:26,CYCLE1_DAY1,0 H,452.064156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 930,36RSYC,25-Apr-22
C1071022,10741001,89,PF-06863135,T,6518693890,6.51869E+11,20211109,20:05,CYCLE1_DAY1,6 H,2.119932774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 929,36RSYC,25-Apr-22
C1071022,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,11:40,CYCLE1_DAY8,0 H,927.4459169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 932,36RSYC,25-Apr-22
C1071022,10741001,89,PF-06863135,T,6518693891,6.51869E+11,20211119,22:45,CYCLE1_DAY8,6 H,460.8893747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 931,36RSYC,25-Apr-22
C1071022,10741001,89,PF-06863135,T,6517472579,6.51747E+11,20211129,9:35,CYCLE1_DAY15,0 H,987.0353815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 997,39RSYC,26-Apr-22
C1071022,10741001,89,PF-06863135,T,6517472581,6.51747E+11,20211208,15:10,CYCLE1_DAY22,0 H,362.2178331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1968,122RSYC,29-Jul-22
C1071022,10741001,89,PF-06863135,T,6517472583,6.51747E+11,20211215,12:00,CYCLE2_DAY1,0 H,536.467399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 998,39RSYC,26-Apr-22
C1071022,10741001,89,PF-06863135,T,6519029238,6.51903E+11,20220113,15:00,CYCLE3_DAY1,0 H,965.5120472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1654,100RSYC,23-May-22
C1071022,10741001,89,PF-06863135,T,6517472604,6.51747E+11,20220119,13:24,END_OF_TRT,,765.8750155,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1653,100RSYC,23-May-22
C1071022,10741001,89,PF-06863135,T,6518693897,6.51869E+11,20211110,14:41,CYCLE1_DAY1,24 H,336.5687462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1131,94RSYC,12-May-22
C1071022,10741001,89,PF-06863135,T,6518693899,6.51869E+11,20211112,8:30,CYCLE1_DAY4,0 H,983.2080642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 933,36RSYC,25-Apr-22
C1071022,10741001,89,PF-06863135,T,6518693902,6.51869E+11,20211113,10:30,CYCLE1_DAY4,24 H,640.1607316,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 934,36RSYC,25-Apr-22
C1071022,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,10:59,CYCLE1_DAY1,0 H,212.2638895,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 533,25RSYC,22-Apr-22
C1071022,10801001,90,PF-06863135,T,6517433488,6.51743E+11,20211108,16:47,CYCLE1_DAY1,6 H,970.5695456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 532,25RSYC,22-Apr-22
C1071022,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,9:58,CYCLE1_DAY8,0 H,764.1724352,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 973,66RSYC,3-May-22
C1071022,10801001,90,PF-06863135,T,6517433490,6.51743E+11,20211115,16:09,CYCLE1_DAY8,6 H,225.2820947,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 972,66RSYC,3-May-22
C1071022,10801001,90,PF-06863135,T,6518789963,6.51879E+11,20211122,13:36,CYCLE1_DAY15,0 H,501.1265724,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 936,64RSYC,3-May-22
C1071022,10801001,90,PF-06863135,T,6517433494,6.51743E+11,20211129,13:16,CYCLE1_DAY22,0 H,841.7701076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 975,66RSYC,3-May-22
C1071022,10801001,90,PF-06863135,T,6517433495,6.51743E+11,20211207,10:13,CYCLE2_DAY1,0 H,598.1367118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 976,66RSYC,3-May-22
C1071022,10801001,90,PF-06863135,T,6517433518,6.51743E+11,20220104,11:35,END_OF_TRT,,265.931918,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1649,100RSYC,23-May-22
C1071022,10801001,90,PF-06863135,T,6517433504,6.51743E+11,20211109,9:00,CYCLE1_DAY1,24 H,356.1583166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 534,107RSYC,24-May-22
C1071022,10801001,90,PF-06863135,T,6517433505,6.51743E+11,20211111,15:25,CYCLE1_DAY4,0 H,68.40616925,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 846,36RSYC,25-Apr-22
C1071022,10801001,90,PF-06863135,T,6517433508,6.51743E+11,20211112,14:25,CYCLE1_DAY4,24 H,744.7674536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 847,36RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,8:40,CYCLE1_DAY1,0 H,258.013577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 815,34RSYC,24-Apr-22
C1071022,10021003,91,PF-06863135,T,6603529933,6.60353E+11,20211108,19:07,CYCLE1_DAY1,6 H,880.7616714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 816,35RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603529936,6.60353E+11,20211115,13:38,CYCLE1_DAY8,0 H,813.7484799,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 817,35RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603551414,6.60355E+11,20211122,13:20,CYCLE1_DAY15,0 H,175.1328486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 819,35RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603529939,6.60353E+11,20211129,13:43,CYCLE1_DAY22,0 H,537.7018621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 943,65RSYC,3-May-22
C1071022,10021003,91,PF-06863135,T,6603546714,6.60355E+11,20211206,10:55,CYCLE2_DAY1,0 H,252.5284729,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 944,65RSYC,3-May-22
C1071022,10021003,91,PF-06863135,T,6603529945,6.60353E+11,20220105,14:15,CYCLE3_DAY1,0 H,116.6588336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1584,59RSYC,1-May-22
C1071022,10021003,91,PF-06863135,T,6603529948,6.60353E+11,20220201,14:17,CYCLE4_DAY1,0 H,540.8161129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1585,59RSYC,1-May-22
C1071022,10021003,91,PF-06863135,T,6603324925,6.60332E+11,20220426,14:09,CYCLE7_DAY1,0 H,90.93270963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2003,122RSYC,29-Jul-22
C1071022,10021003,91,PF-06863135,T,6603839289,6.60384E+11,20220719,13:56,CYCLE10_DAY1,0 H,241.6428398,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2067,129RSYC,21-Oct-22
C1071022,10021003,91,PF-06863135,T,6603578700,6.60358E+11,20221011,14:16,CYCLE13_DAY1,0 H,386.3595102,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2116,131RSYC,9-Nov-22
C1071022,10021003,91,PF-06863135,T,6604204198,6.6042E+11,20230103,13:22,CYCLE16_DAY1,0 H,810.8477777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2186,141RSYC,17-May-23
C1071022,10021003,91,PF-06863135,T,6604204201,6.6042E+11,20230328,12:50,CYCLE19_DAY1,0 H,914.0621109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2235,142RSYC,18-May-23
C1071022,10021003,91,PF-06863135,T,6604204203,6.6042E+11,20230621,13:00,CYCLE22_DAY1,0 H,792.700207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2255,143RSYC,27-Nov-23
C1071022,10021003,91,PF-06863135,T,6604608950,6.60461E+11,20230912,13:05,CYCLE25_DAY1,0 H,579.4953815,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,10021003,91,PF-06863135,T,6604608951,6.60461E+11,20231205,12:20,CYCLE28_DAY1,0 H,564.1586839,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2342,148RSYC,27-Mar-24
C1071022,10021003,91,PF-06863135,T,6604777914,6.60478E+11,20240227,13:01,CYCLE31_DAY1,0 H,692.9316448,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,10021003,91,PF-06863135,T,6603563111,6.60356E+11,20211109,11:00,CYCLE1_DAY1,24 H,424.3442989,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 821,35RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603563112,6.60356E+11,20211111,10:10,CYCLE1_DAY4,0 H,686.7955727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 822,35RSYC,25-Apr-22
C1071022,10021003,91,PF-06863135,T,6603563113,6.60356E+11,20211112,13:06,CYCLE1_DAY4,24 H,561.9334213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 823,35RSYC,25-Apr-22
C1071022,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211108,13:30,CYCLE1_DAY1,0 H,712.1715788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 712,31RSYC,23-Apr-22
C1071022,10561002,92,PF-06863135,T,6216408040,6.21641E+11,20211109,0:30,CYCLE1_DAY1,6 H,568.2543218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 711,31RSYC,23-Apr-22
C1071022,10561002,92,PF-06863135,T,6216898573,6.2169E+11,20211115,14:20,CYCLE1_DAY8,0 H,200.8669419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 739,32RSYC,23-Apr-22
C1071022,10561002,92,PF-06863135,T,6216898575,6.2169E+11,20211122,9:45,CYCLE1_DAY15,0 H,297.0131035,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 740,32RSYC,23-Apr-22
C1071022,10561002,92,PF-06863135,T,6216898580,6.2169E+11,20211206,10:45,CYCLE2_DAY1,0 H,973.9829952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1406,96RSYC,12-May-22
C1071022,10561002,92,PF-06863135,T,6217026166,6.21703E+11,20220104,11:00,CYCLE3_DAY1,0 H,155.7813336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1775,71RSYC,7-May-22
C1071022,10561002,92,PF-06863135,T,6216898588,6.2169E+11,20220201,10:00,CYCLE4_DAY1,0 H,211.6045723,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1774,71RSYC,7-May-22
C1071022,10561002,92,PF-06863135,T,6216898591,6.2169E+11,20220426,11:30,CYCLE7_DAY1,0 H,107.5704912,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1995,115RSYC,25-Jul-22
C1071022,10561002,92,PF-06863135,T,6216408062,6.21641E+11,20220719,10:35,CYCLE10_DAY1,0 H,495.2352776,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2049,132RSYC,10-Nov-22
C1071022,10561002,92,PF-06863135,T,6218590819,6.21859E+11,20221013,15:30,CYCLE13_DAY1,0 H,948.4542103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2123,131RSYC,9-Nov-22
C1071022,10561002,92,PF-06863135,T,6219498865,6.2195E+11,20230103,8:40,CYCLE16_DAY1,0 H,659.6686415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2179,140RSYC,22-Mar-23
C1071022,10561002,92,PF-06863135,T,6220036109,6.22004E+11,20230328,9:40,CYCLE19_DAY1,0 H,44.42592846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2228,142RSYC,18-May-23
C1071022,10561002,92,PF-06863135,T,6220036106,6.22004E+11,20230620,10:00,CYCLE22_DAY1,0 H,118.0278187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2260,144RSYC,27-Nov-23
C1071022,10561002,92,PF-06863135,T,6220036105,6.22004E+11,20230911,10:55,CYCLE25_DAY1,0 H,995.0237392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2309,147RSYC,29-Feb-24
C1071022,10561002,92,PF-06863135,T,6221375068,6.22138E+11,20231207,10:30,CYCLE28_DAY1,0 H,932.6240933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2348,148RSYC,27-Mar-24
C1071022,10561002,92,PF-06863135,T,6221375069,6.22138E+11,20240229,10:15,CYCLE31_DAY1,0 H,98.93177867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2370,152RSYC,9-Apr-24
C1071022,10561002,92,PF-06863135,T,6216898596,6.2169E+11,20211112,13:00,CYCLE1_DAY4,0 H,465.5440146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 741,32RSYC,23-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,14:15,CYCLE1_DAY1,0 H,412.3986336,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 853,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472606,6.51747E+11,20211108,21:17,CYCLE1_DAY1,6 H,515.4772778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 852,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,12:23,CYCLE1_DAY8,0 H,241.3189325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 855,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472608,6.51747E+11,20211115,19:15,CYCLE1_DAY8,6 H,138.2592105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 854,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472611,6.51747E+11,20211122,16:00,CYCLE1_DAY15,0 H,949.1894617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 689,30RSYC,22-Apr-22
C1071022,10931002,93,PF-06863135,T,6518778272,6.51878E+11,20211129,16:39,CYCLE1_DAY22,0 H,691.849659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1146,107RSYC,24-May-22
C1071022,10931002,93,PF-06863135,T,6518778276,6.51878E+11,20211207,10:31,CYCLE2_DAY1,0 H,236.4106576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1148,107RSYC,24-May-22
C1071022,10931002,93,PF-06863135,T,6518934242,6.51893E+11,20220103,16:45,CYCLE3_DAY1,0 H,57.56163851,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1709,72RSYC,7-May-22
C1071022,10931002,93,PF-06863135,T,6519290787,6.51929E+11,20220131,17:03,CYCLE4_DAY1,0 H,429.5263953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1710,72RSYC,7-May-22
C1071022,10931002,93,PF-06863135,T,6519290794,6.51929E+11,20220425,16:00,CYCLE7_DAY1,0 H,835.5386392,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1989,114RSYC,25-Jul-22
C1071022,10931002,93,PF-06863135,T,6519290796,6.51929E+11,20220718,16:30,CYCLE10_DAY1,0 H,228.0656205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2089,129RSYC,21-Oct-22
C1071022,10931002,93,PF-06863135,T,6519290799,6.51929E+11,20221010,17:10,CYCLE13_DAY1,0 H,59.3301597,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2110,131RSYC,9-Nov-22
C1071022,10931002,93,PF-06863135,T,6521929818,6.52193E+11,20230103,17:56,CYCLE16_DAY1,0 H,764.379719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2172,140RSYC,22-Mar-23
C1071022,10931002,93,PF-06863135,T,6522161150,6.52216E+11,20230327,15:06,CYCLE19_DAY1,0 H,236.9636517,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2221,142RSYC,18-May-23
C1071022,10931002,93,PF-06863135,T,6521929816,6.52193E+11,20230619,14:23,CYCLE22_DAY1,0 H,850.1853069,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2267,144RSYC,27-Nov-23
C1071022,10931002,93,PF-06863135,T,6521929819,6.52193E+11,20230913,17:05,CYCLE25_DAY1,0 H,452.8017715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2304,147RSYC,29-Feb-24
C1071022,10931002,93,PF-06863135,T,6524397935,6.5244E+11,20231204,15:21,CYCLE28_DAY1,0 H,925.1996377,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2329,148RSYC,27-Mar-24
C1071022,10931002,93,PF-06863135,T,6524397936,6.5244E+11,,,CYCLE31_DAY1,0 H,373.09419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2373,152RSYC,9-Apr-24
C1071022,10931002,93,PF-06863135,T,6517472622,6.51747E+11,20211109,15:16,CYCLE1_DAY1,24 H,641.3925642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 859,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472624,6.51747E+11,20211111,10:45,CYCLE1_DAY4,0 H,969.3739605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 860,36RSYC,25-Apr-22
C1071022,10931002,93,PF-06863135,T,6517472627,6.51747E+11,20211112,11:36,CYCLE1_DAY4,24 H,50.70617571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 862,36RSYC,25-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,12:40,CYCLE1_DAY1,0 H,90.34919331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 881,19RSYC,19-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559758,6.51756E+11,20211109,19:20,CYCLE1_DAY1,6 H,26.00285347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 880,19RSYC,19-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559761,6.51756E+11,20211116,8:15,CYCLE1_DAY8,0 H,412.2236066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 882,19RSYC,19-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559763,6.51756E+11,20211123,9:30,CYCLE1_DAY15,0 H,830.1784773,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1028,40RSYC,26-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559765,6.51756E+11,20211130,9:30,CYCLE1_DAY22,0 H,961.8817282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1029,40RSYC,26-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559767,6.51756E+11,20211207,9:30,CYCLE2_DAY1,0 H,955.5567886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1030,40RSYC,26-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559768,6.51756E+11,20220104,8:55,CYCLE3_DAY1,0 H,227.522853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1617,97RSYC,12-May-22
C1071022,10111002,94,PF-06863135,T,6517559770,6.51756E+11,20220201,10:30,CYCLE4_DAY1,0 H,452.8146995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1618,85RSYC,10-May-22
C1071022,10111002,94,PF-06863135,T,6517559772,6.51756E+11,20220426,10:00,CYCLE7_DAY1,0 H,490.6444498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1978,114RSYC,25-Jul-22
C1071022,10111002,94,PF-06863135,T,6517559775,6.51756E+11,20211110,13:15,CYCLE1_DAY1,24 H,975.9971788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 883,19RSYC,19-Apr-22
C1071022,10111002,94,PF-06863135,T,6517559777,6.51756E+11,20211112,10:40,CYCLE1_DAY4,0 H,337.1670712,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 884,19RSYC,19-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,10:10,CYCLE1_DAY1,0 H,885.3807357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 640,29RSYC,22-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650230,6.80165E+11,20211110,16:15,CYCLE1_DAY1,6 H,848.217803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 641,29RSYC,22-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,10:44,CYCLE1_DAY8,0 H,131.654654,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 825,35RSYC,25-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650232,6.80165E+11,20211118,16:54,CYCLE1_DAY8,6 H,256.1767501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 824,35RSYC,25-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650234,6.80165E+11,20211124,11:21,CYCLE1_DAY15,0 H,925.6202381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 827,35RSYC,25-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650236,6.80165E+11,20211201,11:35,CYCLE1_DAY22,0 H,612.5831662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 939,65RSYC,3-May-22
C1071022,11101002,95,PF-06863135,T,6801650238,6.80165E+11,20211208,11:20,CYCLE2_DAY1,0 H,142.4761115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 955,65RSYC,3-May-22
C1071022,11101002,95,PF-06863135,T,6801741157,6.80174E+11,20220105,11:33,CYCLE3_DAY1,0 H,178.6056606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1593,59RSYC,1-May-22
C1071022,11101002,95,PF-06863135,T,6801741158,6.80174E+11,20220202,12:08,CYCLE4_DAY1,0 H,163.7627295,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1594,59RSYC,1-May-22
C1071022,11101002,95,PF-06863135,T,6801830279,6.80183E+11,20220427,12:35,CYCLE7_DAY1,0 H,458.8115054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1962,114RSYC,25-Jul-22
C1071022,11101002,95,PF-06863135,T,6801721367,6.80172E+11,20220720,12:32,CYCLE10_DAY1,0 H,290.9772163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2072,129RSYC,21-Oct-22
C1071022,11101002,95,PF-06863135,T,6802027132,6.80203E+11,20221012,10:43,CYCLE13_DAY1,0 H,931.4512954,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2118,131RSYC,9-Nov-22
C1071022,11101002,95,PF-06863135,T,6802027133,6.80203E+11,20230104,11:25,CYCLE16_DAY1,0 H,859.2146769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2189,141RSYC,17-May-23
C1071022,11101002,95,PF-06863135,T,6802065578,6.80207E+11,20230329,11:15,CYCLE19_DAY1,0 H,168.475313,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2237,145RSYC,4-Jan-24
C1071022,11101002,95,PF-06863135,T,6802065579,6.80207E+11,20230621,10:45,CYCLE22_DAY1,0 H,422.5201805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2274,147RSYC,29-Feb-24
C1071022,11101002,95,PF-06863135,T,6802302903,6.8023E+11,20230913,10:27,CYCLE25_DAY1,0 H,227.1971168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2298,147RSYC,29-Feb-24
C1071022,11101002,95,PF-06863135,T,6802400458,6.8024E+11,20231206,10:40,CYCLE28_DAY1,0 H,478.6914715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2343,148RSYC,27-Mar-24
C1071022,11101002,95,PF-06863135,T,6802400459,6.8024E+11,20240228,10:38,CYCLE31_DAY1,0 H,610.6210136,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,11101002,95,PF-06863135,T,6801650242,6.80165E+11,20211111,9:15,CYCLE1_DAY1,24 H,556.6691995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 645,29RSYC,22-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650244,6.80165E+11,20211115,11:28,CYCLE1_DAY4,0 H,195.4368963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 647,29RSYC,22-Apr-22
C1071022,11101002,95,PF-06863135,T,6801650246,6.80165E+11,20211116,10:17,CYCLE1_DAY4,24 H,70.06799924,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 649,29RSYC,22-Apr-22
C1071022,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,10:30,CYCLE1_DAY1,0 H,552.3924369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 729,32RSYC,23-Apr-22
C1071022,10461002,96,PF-06863135,T,6216756762,6.21676E+11,20211116,18:30,CYCLE1_DAY1,6 H,116.2398503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 728,32RSYC,23-Apr-22
C1071022,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,10:27,CYCLE1_DAY8,0 H,97.74905547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1436,57RSYC,30-Apr-22
C1071022,10461002,96,PF-06863135,T,6217039131,6.21704E+11,20211123,17:30,CYCLE1_DAY8,6 H,7.688136113,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 772,33RSYC,24-Apr-22
C1071022,10461002,96,PF-06863135,T,6217233419,6.21723E+11,20211201,11:35,CYCLE1_DAY15,0 H,394.5984831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1538,58RSYC,1-May-22
C1071022,10461002,96,PF-06863135,T,6216756768,6.21676E+11,20211208,11:05,CYCLE1_DAY22,0 H,643.6925644,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1381,84RSYC,10-May-22
C1071022,10461002,96,PF-06863135,T,6217142651,6.21714E+11,20220114,15:00,END_OF_TRT,,536.6269158,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1814,86RSYC,13-May-22
C1071022,10461002,96,PF-06863135,T,6218478267,6.21848E+11,20211222,11:00,UNPL,9001 H,287.8050304,NG/ML,,Received as 6217340169-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1815,92RSYC,12-May-22
C1071022,10461002,96,PF-06863135,T,6216756775,6.21676E+11,20211117,13:00,CYCLE1_DAY1,24 H,952.9322161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 732,32RSYC,23-Apr-22
C1071022,10461002,96,PF-06863135,T,6216756777,6.21676E+11,20211118,10:25,CYCLE1_DAY4,0 H,753.1472211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 734,32RSYC,23-Apr-22
C1071022,10461002,96,PF-06863135,T,6216756778,6.21676E+11,20211119,12:15,CYCLE1_DAY4,24 H,606.0466726,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 735,32RSYC,23-Apr-22
C1071022,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,10:37,CYCLE1_DAY1,0 H,134.1256955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 771,33RSYC,24-Apr-22
C1071022,10461003,97,PF-06863135,T,6217039129,6.21704E+11,20211123,17:30,CYCLE1_DAY1,6 H,32.39689592,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 770,33RSYC,24-Apr-22
C1071022,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,680.2169033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1440,96RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217039133,6.21704E+11,20211202,19:00,CYCLE1_DAY8,6 H,250.0679859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1439,96RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217368116,6.21737E+11,20211210,10:45,CYCLE1_DAY15,0 H,991.3083765,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1822,92RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217368121,6.21737E+11,20211216,10:20,CYCLE1_DAY22,0 H,360.761764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1823,92RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6216756770,6.21676E+11,20211222,10:10,CYCLE2_DAY1,0 H,434.9393503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1819,92RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217233436,6.21723E+11,20220119,10:50,CYCLE3_DAY1,0 H,735.2525371,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1820,92RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217340180,6.21734E+11,20220216,9:30,CYCLE4_DAY1,0 H,877.4660236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1821,92RSYC,12-May-22
C1071022,10461003,97,PF-06863135,T,6217647296,6.21765E+11,20220511,9:45,CYCLE7_DAY1,0 H,418.1414731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2062,132RSYC,10-Nov-22
C1071022,10461003,97,PF-06863135,T,6217647301,6.21765E+11,20220808,6:00,CYCLE10_DAY1,0 H,122.4679515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2063,132RSYC,10-Nov-22
C1071022,10461003,97,PF-06863135,T,6216756783,6.21676E+11,20220818,12:29,END_OF_TRT,,663.0865413,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2061,132RSYC,10-Nov-22
C1071022,10461003,97,PF-06863135,T,6216756782,6.21676E+11,20211208,9:30,UNPL,9001 H,871.7560628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1383,86RSYC,13-May-22
C1071022,10461003,97,PF-06863135,T,6217039135,6.21704E+11,20211124,12:00,CYCLE1_DAY1,24 H,938.7627199,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 774,33RSYC,24-Apr-22
C1071022,10461003,97,PF-06863135,T,6217283551,6.21728E+11,20211129,10:29,CYCLE1_DAY4,0 H,946.6071502,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1566,59RSYC,1-May-22
C1071022,10461003,97,PF-06863135,T,6217039142,6.21704E+11,20211130,12:10,CYCLE1_DAY4,24 H,362.8298847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1443,96RSYC,12-May-22
C1071022,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,10:15,CYCLE1_DAY1,0 H,78.00955622,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 769,33RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217039128,6.21704E+11,20211118,18:48,CYCLE1_DAY1,6 H,342.0347112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 768,33RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,10:15,CYCLE1_DAY8,0 H,105.6931848,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 805,34RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217233416,6.21723E+11,20211125,17:56,CYCLE1_DAY8,6 H,757.2788272,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 804,34RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217233417,6.21723E+11,20211203,8:00,CYCLE1_DAY15,0 H,543.9194731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1537,58RSYC,1-May-22
C1071022,10461004,98,PF-06863135,T,6217233423,6.21723E+11,20211209,10:50,CYCLE1_DAY22,0 H,172.1629739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1825,92RSYC,12-May-22
C1071022,10461004,98,PF-06863135,T,6217340170,6.21734E+11,20211216,10:20,CYCLE2_DAY1,0 H,794.0063491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1826,92RSYC,12-May-22
C1071022,10461004,98,PF-06863135,T,6217142650,6.21714E+11,20220114,10:50,END_OF_TRT,,136.5477414,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1824,86RSYC,13-May-22
C1071022,10461004,98,PF-06863135,T,6217039134,6.21704E+11,20211119,12:05,CYCLE1_DAY1,24 H,961.7158524,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 773,33RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217039139,6.21704E+11,20211122,10:30,CYCLE1_DAY4,0 H,222.3021691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 776,33RSYC,24-Apr-22
C1071022,10461004,98,PF-06863135,T,6217039140,6.21704E+11,20211123,11:40,CYCLE1_DAY4,24 H,927.1585048,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 777,33RSYC,24-Apr-22
C1071022,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,11:08,CYCLE1_DAY1,0 H,818.6781188,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1536,58RSYC,1-May-22
C1071022,10461005,99,PF-06863135,T,6217233415,6.21723E+11,20211125,18:03,CYCLE1_DAY1,6 H,608.1666435,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1535,56RSYC,30-Apr-22
C1071022,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,12:00,CYCLE1_DAY8,0 H,959.1282775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1379,84RSYC,10-May-22
C1071022,10461005,99,PF-06863135,T,6216756765,6.21676E+11,20211202,18:55,CYCLE1_DAY8,6 H,240.0519543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1378,84RSYC,10-May-22
C1071022,10461005,99,PF-06863135,T,6217368120,6.21737E+11,20211214,6:00,CYCLE1_DAY22,0 H,431.9816415,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1818,92RSYC,12-May-22
C1071022,10461005,99,PF-06863135,T,6217233426,6.21723E+11,20211221,9:40,CYCLE2_DAY1,0 H,782.9992442,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1816,92RSYC,12-May-22
C1071022,10461005,99,PF-06863135,T,6217283548,6.21728E+11,20220118,9:50,CYCLE3_DAY1,0 H,112.6014551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1817,92RSYC,12-May-22
C1071022,10461005,99,PF-06863135,T,6217647291,6.21765E+11,20220510,11:20,CYCLE7_DAY1,0 H,555.7255949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2000,115RSYC,25-Jul-22
C1071022,10461005,99,PF-06863135,T,6217647299,6.21765E+11,20220802,14:30,CYCLE10_DAY1,0 H,24.33053928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2059,132RSYC,10-Nov-22
C1071022,10461005,99,PF-06863135,T,6218022369,6.21802E+11,20220901,12:30,END_OF_TRT,,589.1956701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2060,132RSYC,10-Nov-22
C1071022,10461005,99,PF-06863135,T,6217039136,6.21704E+11,20211126,10:55,CYCLE1_DAY1,24 H,289.8008343,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1441,96RSYC,12-May-22
C1071022,10461005,99,PF-06863135,T,6217233439,6.21723E+11,20211129,10:15,CYCLE1_DAY4,0 H,966.3688705,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 806,34RSYC,24-Apr-22
C1071022,10461005,99,PF-06863135,T,6217233440,6.21723E+11,20211130,11:50,CYCLE1_DAY4,24 H,685.420002,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1540,58RSYC,1-May-22
C1071022,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,11:50,CYCLE1_DAY1,0 H,602.9168618,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 866,36RSYC,25-Apr-22
C1071022,10321002,100,PF-06863135,T,6517509071,6.51751E+11,20211110,19:30,CYCLE1_DAY1,6 H,994.9673736,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 865,36RSYC,25-Apr-22
C1071022,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,8:56,CYCLE1_DAY8,0 H,150.0248052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 868,19RSYC,19-Apr-22
C1071022,10321002,100,PF-06863135,T,6517509072,6.51751E+11,20211117,17:10,CYCLE1_DAY8,6 H,847.1460265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 867,36RSYC,25-Apr-22
C1071022,10321002,100,PF-06863135,T,6517559955,6.51756E+11,20211124,15:38,CYCLE1_DAY15,0 H,60.66824738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1040,40RSYC,26-Apr-22
C1071022,10321002,100,PF-06863135,T,6517559957,6.51756E+11,20211202,15:31,CYCLE1_DAY22,0 H,985.7473522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1042,40RSYC,26-Apr-22
C1071022,10321002,100,PF-06863135,T,6517559960,6.51756E+11,20211209,15:36,CYCLE2_DAY1,0 H,236.1260187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1043,40RSYC,26-Apr-22
C1071022,10321002,100,PF-06863135,T,6517559961,6.51756E+11,20220106,14:47,CYCLE3_DAY1,0 H,279.8937289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1631,85RSYC,10-May-22
C1071022,10321002,100,PF-06863135,T,6517559982,6.51756E+11,20220113,12:21,END_OF_TRT,,78.65750339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1632,100RSYC,23-May-22
C1071022,10321002,100,PF-06863135,T,6517509083,6.51751E+11,20211111,14:21,CYCLE1_DAY1,24 H,897.8965624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 870,19RSYC,19-Apr-22
C1071022,10321002,100,PF-06863135,T,6517559969,6.51756E+11,20211113,9:13,CYCLE1_DAY4,0 H,424.0986575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 885,19RSYC,19-Apr-22
C1071022,10321002,100,PF-06863135,T,6517509087,6.51751E+11,20211114,9:59,CYCLE1_DAY4,24 H,155.8877092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 871,19RSYC,19-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,12:30,CYCLE1_DAY1,0 H,131.2458451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1328,50RSYC,29-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408243,6.21641E+11,20211110,20:05,CYCLE1_DAY1,6 H,880.065536,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1327,50RSYC,29-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,14:01,CYCLE1_DAY8,0 H,749.5217242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1330,50RSYC,29-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408246,6.21641E+11,20211115,21:30,CYCLE1_DAY8,6 H,711.2044358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1329,50RSYC,29-Apr-22
C1071022,11061001,101,PF-06863135,T,6217165073,6.21717E+11,20211123,9:00,CYCLE1_DAY15,0 H,96.1704298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1489,55RSYC,30-Apr-22
C1071022,11061001,101,PF-06863135,T,6217193496,6.21719E+11,20211130,10:00,CYCLE1_DAY22,0 H,366.8654794,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1526,56RSYC,30-Apr-22
C1071022,11061001,101,PF-06863135,T,6217193503,6.21719E+11,20211207,9:00,CYCLE2_DAY1,0 H,877.7692289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1528,56RSYC,30-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408260,6.21641E+11,20211111,14:05,CYCLE1_DAY1,24 H,904.1729689,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1331,50RSYC,29-Apr-22
C1071022,11061001,101,PF-06863135,T,6216408261,6.21641E+11,20211112,11:00,CYCLE1_DAY4,0 H,697.1772396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1332,50RSYC,29-Apr-22
C1071022,11021010,102,PF-06863135,T,6217023819,6.21702E+11,20211110,13:30,CYCLE1_DAY1,0 H,906.0284892,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 751,32RSYC,23-Apr-22
C1071022,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,14:00,CYCLE1_DAY8,0 H,832.8905567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 756,33RSYC,24-Apr-22
C1071022,11021010,102,PF-06863135,T,6217023828,6.21702E+11,20211116,20:05,CYCLE1_DAY8,6 H,403.4262991,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 755,32RSYC,23-Apr-22
C1071022,11021010,102,PF-06863135,T,6217170439,6.21717E+11,20211124,13:30,CYCLE1_DAY15,0 H,444.7952744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 792,34RSYC,24-Apr-22
C1071022,11021010,102,PF-06863135,T,6217170450,6.21717E+11,20211202,17:30,CYCLE1_DAY22,0 H,762.3407904,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1503,55RSYC,30-Apr-22
C1071022,11021010,102,PF-06863135,T,6217142693,6.21714E+11,20211208,10:00,END_OF_TRT,,308.5564541,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1468,109RSYC,25-May-22
C1071022,11021010,102,PF-06863135,T,6217023849,6.21702E+11,20211112,14:50,CYCLE1_DAY4,0 H,357.2440456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1428,57RSYC,30-Apr-22
C1071022,11021010,102,PF-06863135,T,6217136155,6.21714E+11,20211113,15:00,CYCLE1_DAY4,24 H,101.7901951,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 788,34RSYC,24-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,13:50,CYCLE1_DAY1,0 H,555.1022014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1308,76RSYC,4-May-22
C1071022,10511001,103,PF-06863135,T,6216408006,6.21641E+11,20211129,19:00,CYCLE1_DAY1,6 H,638.8322858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1307,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,12:43,CYCLE1_DAY8,0 H,887.5799242,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1310,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408008,6.21641E+11,20211206,19:40,CYCLE1_DAY8,6 H,871.0641026,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1309,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408010,6.21641E+11,20211213,18:15,CYCLE1_DAY15,0 H,253.5762419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1311,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408029,6.21641E+11,20211201,12:44,UNPL,9001 H,732.4256161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1315,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408021,6.21641E+11,20211130,14:20,CYCLE1_DAY1,24 H,733.1926081,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1312,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408023,6.21641E+11,20211202,13:30,CYCLE1_DAY4,0 H,684.6677197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1313,49RSYC,29-Apr-22
C1071022,10511001,103,PF-06863135,T,6216408026,6.21641E+11,20211203,14:25,CYCLE1_DAY4,24 H,456.1261826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1314,49RSYC,29-Apr-22
C1071022,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,9:26,CYCLE1_DAY1,0 H,183.9693211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 900,20RSYC,19-Apr-22
C1071022,10031012,104,PF-06863135,T,6517751562,6.51775E+11,20211115,18:01,CYCLE1_DAY1,6 H,664.2126164,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 899,20RSYC,19-Apr-22
C1071022,10031012,104,PF-06863135,T,6518620843,6.51862E+11,20211130,14:20,CYCLE1_DAY15,0 H,433.7390177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1119,94RSYC,12-May-22
C1071022,10031012,104,PF-06863135,T,6516580433,6.51658E+11,20220114,15:25,END_OF_TRT,,615.5603974,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1934,123RSYC,29-Jul-22
C1071022,10031012,104,PF-06863135,T,6518620862,6.51862E+11,20211116,10:35,CYCLE1_DAY1,24 H,781.5595965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1122,94RSYC,12-May-22
C1071022,10031012,104,PF-06863135,T,6518620866,6.51862E+11,20211117,11:48,CYCLE1_DAY4,0 H,104.1010108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 928,36RSYC,25-Apr-22
C1071022,10031012,104,PF-06863135,T,6518620869,6.51862E+11,20211118,12:52,CYCLE1_DAY4,24 H,868.0176198,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1125,94RSYC,12-May-22
C1071022,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,14:00,CYCLE1_DAY1,0 H,571.5791563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 720,31RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6216725275,6.21673E+11,20211115,23:50,CYCLE1_DAY1,6 H,738.1246826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 719,31RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,10:00,CYCLE1_DAY8,0 H,947.9216297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 722,31RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6216725276,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,133.9326553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 721,31RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6217133150,6.21713E+11,20211129,8:50,CYCLE1_DAY15,0 H,377.5426108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1459,54RSYC,30-Apr-22
C1071022,11041005,105,PF-06863135,T,6216923999,6.21692E+11,20211206,8:30,CYCLE1_DAY22,0 H,911.4902384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1419,57RSYC,30-Apr-22
C1071022,11041005,105,PF-06863135,T,6216924004,6.21692E+11,20211213,10:40,CYCLE2_DAY1,0 H,920.8349761,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1421,57RSYC,30-Apr-22
C1071022,11041005,105,PF-06863135,T,6217133164,6.21713E+11,20220110,10:40,CYCLE3_DAY1,0 H,695.1967353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1761,91RSYC,11-May-22
C1071022,11041005,105,PF-06863135,T,6216924044,6.21692E+11,20220207,10:50,END_OF_TRT,,93.37979789,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1877,86RSYC,13-May-22
C1071022,11041005,105,PF-06863135,T,6216924026,6.21692E+11,20211116,17:50,CYCLE1_DAY1,24 H,692.5648176,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 747,32RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6216725292,6.21673E+11,20211117,18:30,CYCLE1_DAY4,0 H,721.4058481,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 726,32RSYC,23-Apr-22
C1071022,11041005,105,PF-06863135,T,6216725295,6.21673E+11,20211118,18:35,CYCLE1_DAY4,24 H,569.2308842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 727,32RSYC,23-Apr-22
C1071022,11061002,106,PF-06863135,T,6217165069,6.21717E+11,20211122,10:00,CYCLE1_DAY8,0 H,324.4060401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1485,55RSYC,30-Apr-22
C1071022,11061002,106,PF-06863135,T,6217165077,6.21717E+11,20211201,10:00,CYCLE1_DAY15,0 H,870.8483431,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1492,55RSYC,30-Apr-22
C1071022,11061002,106,PF-06863135,T,6217193495,6.21719E+11,20211207,9:00,CYCLE1_DAY22,0 H,709.6951777,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1525,56RSYC,30-Apr-22
C1071022,11061002,106,PF-06863135,T,6217165080,6.21717E+11,20211214,9:00,CYCLE2_DAY1,0 H,528.4185598,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1493,55RSYC,30-Apr-22
C1071022,11061002,106,PF-06863135,T,6217193513,6.21719E+11,20220118,10:00,CYCLE3_DAY1,0 H,190.9529022,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1802,91RSYC,11-May-22
C1071022,11061002,106,PF-06863135,T,6217193522,6.21719E+11,20220215,9:00,CYCLE4_DAY1,0 H,547.1312574,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1803,92RSYC,12-May-22
C1071022,11061002,106,PF-06863135,T,6217193530,6.21719E+11,20220503,10:00,CYCLE7_DAY1,0 H,911.3750088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1999,115RSYC,25-Jul-22
C1071022,11061002,106,PF-06863135,T,6217193529,6.21719E+11,20220802,9:00,CYCLE10_DAY1,0 H,840.3312292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2057,132RSYC,10-Nov-22
C1071022,11061002,106,PF-06863135,T,6219811032,6.21981E+11,20230117,9:00,CYCLE16_DAY1,0 H,450.0588084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2184,141RSYC,17-May-23
C1071022,11061002,106,PF-06863135,T,6219811031,6.21981E+11,20230418,9:00,CYCLE19_DAY1,0 H,555.0793963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2239,143RSYC,27-Nov-23
C1071022,11061002,106,PF-06863135,T,6219804830,6.2198E+11,20231031,9:00,CYCLE25_DAY1,0 H,204.7909856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2349,149RSYC,27-Mar-24
C1071022,11061002,106,PF-06863135,T,6219804831,6.2198E+11,,,END_OF_TRT,,390.2602648,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2350,149RSYC,27-Mar-24
C1071022,11061002,106,PF-06863135,T,6217165092,6.21717E+11,20211118,14:00,CYCLE1_DAY4,0 H,446.4825032,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1801,91RSYC,11-May-22
C1071022,11061002,106,PF-06863135,T,6217193544,6.21719E+11,20211119,10:00,CYCLE1_DAY4,24 H,573.1936056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1531,56RSYC,30-Apr-22
C1071022,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,11:36,CYCLE1_DAY1,0 H,621.1314738,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 779,33RSYC,24-Apr-22
C1071022,10921002,107,PF-06863135,T,6217039323,6.21704E+11,20211115,19:46,CYCLE1_DAY1,6 H,966.3207228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 778,33RSYC,24-Apr-22
C1071022,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,10:56,CYCLE1_DAY8,0 H,942.5291024,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 717,31RSYC,23-Apr-22
C1071022,10921002,107,PF-06863135,T,6216725230,6.21673E+11,20211122,19:00,CYCLE1_DAY8,6 H,569.3369726,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 716,31RSYC,23-Apr-22
C1071022,10921002,107,PF-06863135,T,6216725232,6.21673E+11,20211129,13:44,CYCLE1_DAY15,0 H,299.2160227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 718,31RSYC,23-Apr-22
C1071022,10921002,107,PF-06863135,T,6216725234,6.21673E+11,20211206,11:45,CYCLE1_DAY22,0 H,899.5796795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1370,84RSYC,10-May-22
C1071022,10921002,107,PF-06863135,T,6217039356,6.21704E+11,20211116,11:50,CYCLE1_DAY1,24 H,814.2334841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 780,33RSYC,24-Apr-22
C1071022,10921002,107,PF-06863135,T,6217039362,6.21704E+11,20211118,14:02,CYCLE1_DAY4,0 H,150.6310742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 781,33RSYC,24-Apr-22
C1071022,10921002,107,PF-06863135,T,6217039366,6.21704E+11,20211119,16:00,CYCLE1_DAY4,24 H,708.2626309,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 782,33RSYC,24-Apr-22
C1071022,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,10:36,CYCLE1_DAY1,0 H,569.7022297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 675,30RSYC,22-Apr-22
C1071022,10081001,108,PF-06863135,T,6518075544,6.51808E+11,20211115,23:03,CYCLE1_DAY1,6 H,448.0156168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 674,30RSYC,22-Apr-22
C1071022,10081001,108,PF-06863135,T,6518075565,6.51808E+11,20211124,12:35,END_OF_TRT,,832.4999039,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1089,87RSYC,13-May-22
C1071022,10081001,108,PF-06863135,T,6518075557,6.51808E+11,20211116,17:03,CYCLE1_DAY1,24 H,386.9073826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 676,30RSYC,22-Apr-22
C1071022,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,14:45,CYCLE1_DAY1,0 H,88.83932751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 763,33RSYC,24-Apr-22
C1071022,10561006,109,PF-06863135,T,6217026118,6.21703E+11,20211115,22:30,CYCLE1_DAY1,6 H,550.0552683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 762,33RSYC,24-Apr-22
C1071022,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,10:30,CYCLE1_DAY8,0 H,243.1191814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 765,33RSYC,24-Apr-22
C1071022,10561006,109,PF-06863135,T,6217026120,6.21703E+11,20211123,18:10,CYCLE1_DAY8,6 H,436.8707503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 764,33RSYC,24-Apr-22
C1071022,10561006,109,PF-06863135,T,6216408045,6.21641E+11,20211206,13:30,CYCLE1_DAY22,0 H,291.1227197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1318,49RSYC,29-Apr-22
C1071022,10561006,109,PF-06863135,T,6216898581,6.2169E+11,20211220,10:30,CYCLE2_DAY1,0 H,268.5292447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1407,96RSYC,12-May-22
C1071022,10561006,109,PF-06863135,T,6216408049,6.21641E+11,20220110,10:50,CYCLE3_DAY1,0 H,85.2843562,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1778,71RSYC,7-May-22
C1071022,10561006,109,PF-06863135,T,6216408051,6.21641E+11,20220208,11:20,CYCLE4_DAY1,0 H,313.3521161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1779,71RSYC,7-May-22
C1071022,10561006,109,PF-06863135,T,6216898592,6.2169E+11,20220502,10:45,CYCLE7_DAY1,0 H,617.7503882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1996,115RSYC,25-Jul-22
C1071022,10561006,109,PF-06863135,T,6218590823,6.21859E+11,20220727,11:15,CYCLE10_DAY1,0 H,425.5112578,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2051,132RSYC,10-Nov-22
C1071022,10561006,109,PF-06863135,T,6219498869,6.2195E+11,20230109,9:45,CYCLE16_DAY1,0 H,416.7192674,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2181,141RSYC,17-May-23
C1071022,10561006,109,PF-06863135,T,6220036104,6.22004E+11,20230403,13:20,CYCLE19_DAY1,0 H,238.2707427,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2230,142RSYC,18-May-23
C1071022,10561006,109,PF-06863135,T,6220036099,6.22004E+11,20230627,11:30,CYCLE22_DAY1,0 H,479.4539944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2277,144RSYC,27-Nov-23
C1071022,10561006,109,PF-06863135,T,6220036107,6.22004E+11,20230919,10:36,CYCLE25_DAY1,0 H,767.3879869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2310,147RSYC,29-Feb-24
C1071022,10561006,109,PF-06863135,T,6221375071,6.22138E+11,20240305,9:40,CYCLE31_DAY1,0 H,648.936939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2371,153RSYC,10-Apr-24
C1071022,10561006,109,PF-06863135,T,6216408057,6.21641E+11,20211119,11:05,CYCLE1_DAY4,0 H,500.0397871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 715,31RSYC,23-Apr-22
C1071022,10561006,109,PF-06863135,T,6216898600,6.2169E+11,20211120,12:00,CYCLE1_DAY4,24 H,18.69614979,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 742,32RSYC,23-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,10:06,CYCLE1_DAY1,0 H,772.3653394,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 894,19RSYC,19-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697441,6.5177E+11,20211115,16:58,CYCLE1_DAY1,6 H,799.9455182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 893,19RSYC,19-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,8:35,CYCLE1_DAY8,0 H,71.77029083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 677,30RSYC,22-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697443,6.5177E+11,20211122,15:07,CYCLE1_DAY8,6 H,306.1513788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 895,19RSYC,19-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697446,6.5177E+11,20211129,8:44,CYCLE1_DAY15,0 H,509.373208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1057,41RSYC,26-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697447,6.5177E+11,20211206,8:27,CYCLE1_DAY22,0 H,461.453814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1058,41RSYC,26-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697449,6.5177E+11,20211213,8:48,CYCLE2_DAY1,0 H,460.8937287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1060,41RSYC,26-Apr-22
C1071022,10161001,110,PF-06863135,T,6519057405,6.51906E+11,20220110,8:26,CYCLE3_DAY1,0 H,564.2226683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1602,97RSYC,12-May-22
C1071022,10161001,110,PF-06863135,T,6517697453,6.5177E+11,20220207,9:02,CYCLE4_DAY1,0 H,360.3353687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1601,97RSYC,12-May-22
C1071022,10161001,110,PF-06863135,T,6520019566,6.52002E+11,20220308,8:51,END_OF_TRT,,716.0708483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1886,86RSYC,13-May-22
C1071022,10161001,110,PF-06863135,T,6517697458,6.5177E+11,20211116,10:00,CYCLE1_DAY1,24 H,420.8764807,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 896,19RSYC,19-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697460,6.5177E+11,20211118,9:59,CYCLE1_DAY4,0 H,978.617068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 897,19RSYC,19-Apr-22
C1071022,10161001,110,PF-06863135,T,6517697461,6.5177E+11,20211119,11:09,CYCLE1_DAY4,24 H,510.1523145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 898,20RSYC,19-Apr-22
C1071022,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,10:00,CYCLE1_DAY1,0 H,8.728884396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 913,20RSYC,19-Apr-22
C1071022,11171007,111,PF-06863135,T,6518011605,6.51801E+11,20211115,17:15,CYCLE1_DAY1,6 H,361.041287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 912,63RSYC,2-May-22
C1071022,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,10:59,CYCLE1_DAY8,0 H,580.0871274,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 693,30RSYC,22-Apr-22
C1071022,11171007,111,PF-06863135,T,6517764049,6.51776E+11,20211122,17:01,CYCLE1_DAY8,6 H,714.5621451,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 902,20RSYC,19-Apr-22
C1071022,11171007,111,PF-06863135,T,6517764052,6.51776E+11,20211130,10:09,CYCLE1_DAY15,0 H,902.6078567,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1073,41RSYC,26-Apr-22
C1071022,11171007,111,PF-06863135,T,6517764056,6.51776E+11,20211207,7:39,CYCLE1_DAY22,0 H,228.9724425,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1074,41RSYC,26-Apr-22
C1071022,11171007,111,PF-06863135,T,6517433564,6.51743E+11,20211214,12:19,CYCLE2_DAY1,0 H,527.7693785,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 987,66RSYC,3-May-22
C1071022,11171007,111,PF-06863135,T,6517764065,6.51776E+11,20220111,8:00,CYCLE3_DAY1,0 H,229.9804365,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1727,72RSYC,7-May-22
C1071022,11171007,111,PF-06863135,T,6517433566,6.51743E+11,20220208,11:09,CYCLE4_DAY1,0 H,311.9682637,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1726,72RSYC,7-May-22
C1071022,11171007,111,PF-06863135,T,6517433569,6.51743E+11,20220503,9:00,CYCLE7_DAY1,0 H,578.9910363,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1965,114RSYC,25-Jul-22
C1071022,11171007,111,PF-06863135,T,6520894174,6.52089E+11,20220726,8:46,CYCLE10_DAY1,0 H,449.6653021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2094,127RSYC,19-Oct-22
C1071022,11171007,111,PF-06863135,T,6521348641,6.52135E+11,20221018,7:15,CYCLE13_DAY1,0 H,985.9472031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2141,139RSYC,22-Mar-23
C1071022,11171007,111,PF-06863135,T,6520894175,6.52089E+11,20230113,13:00,CYCLE16_DAY1,0 H,607.5207237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2175,140RSYC,22-Mar-23
C1071022,11171007,111,PF-06863135,T,6521348643,6.52135E+11,20230628,7:15,CYCLE22_DAY1,0 H,975.9852308,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2282,145RSYC,4-Jan-24
C1071022,11171007,111,PF-06863135,T,6517764085,6.51776E+11,20230725,7:15,END_OF_TRT,,304.9044762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2292,145RSYC,4-Jan-24
C1071022,11171007,111,PF-06863135,T,6518011607,6.51801E+11,20211116,12:18,CYCLE1_DAY1,24 H,449.667493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 914,20RSYC,19-Apr-22
C1071022,11171007,111,PF-06863135,T,6517764075,6.51776E+11,20211118,8:00,CYCLE1_DAY4,0 H,14.83383338,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 904,20RSYC,19-Apr-22
C1071022,11171007,111,PF-06863135,T,6517764083,6.51776E+11,20211119,10:15,CYCLE1_DAY4,24 H,28.36409405,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 905,20RSYC,19-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559619,6.51756E+11,20211115,11:00,CYCLE1_DAY1,0 H,720.1888876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 873,19RSYC,19-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559622,6.51756E+11,20211122,12:20,CYCLE1_DAY8,0 H,232.7054115,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 874,19RSYC,19-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559623,6.51756E+11,20211129,8:30,CYCLE1_DAY15,0 H,736.5930837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1014,39RSYC,26-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559626,6.51756E+11,20211206,10:45,CYCLE1_DAY22,0 H,587.1011364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1016,39RSYC,26-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559627,6.51756E+11,20211213,10:30,CYCLE2_DAY1,0 H,988.7053094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1017,39RSYC,26-Apr-22
C1071022,10251001,112,PF-06863135,T,6519204945,6.5192E+11,20220111,10:20,CYCLE3_DAY1,0 H,827.7200706,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1668,101RSYC,13-May-22
C1071022,10251001,112,PF-06863135,T,6517559631,6.51756E+11,20220208,12:25,CYCLE4_DAY1,0 H,17.26856198,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1667,101RSYC,13-May-22
C1071022,10251001,112,PF-06863135,T,6517559634,6.51756E+11,20220503,12:10,CYCLE7_DAY1,0 H,737.1032731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1972,114RSYC,25-Jul-22
C1071022,10251001,112,PF-06863135,T,6517559650,6.51756E+11,20220524,13:10,END_OF_TRT,,828.2129646,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1973,122RSYC,29-Jul-22
C1071022,10251001,112,PF-06863135,T,6517559636,6.51756E+11,20211116,16:43,CYCLE1_DAY1,24 H,262.9618965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 875,19RSYC,19-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559637,6.51756E+11,20211118,12:10,CYCLE1_DAY4,0 H,148.0718142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 876,19RSYC,19-Apr-22
C1071022,10251001,112,PF-06863135,T,6517559639,6.51756E+11,20211119,12:10,CYCLE1_DAY4,24 H,18.11521364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 877,64RSYC,3-May-22
C1071022,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,6:00,CYCLE1_DAY1,0 H,240.6332744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 918,20RSYC,19-Apr-22
C1071022,10151004,113,PF-06863135,T,6518602939,6.5186E+11,20211117,18:20,CYCLE1_DAY1,6 H,765.9796646,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 917,20RSYC,19-Apr-22
C1071022,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,9:30,CYCLE1_DAY8,0 H,6.477206359,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1111,67RSYC,8-May-22
C1071022,10151004,113,PF-06863135,T,6518602941,6.5186E+11,20211124,15:19,CYCLE1_DAY8,6 H,797.1560786,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1110,67RSYC,8-May-22
C1071022,10151004,113,PF-06863135,T,6518602942,6.5186E+11,20211201,12:13,CYCLE1_DAY15,0 H,468.6928606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1112,67RSYC,8-May-22
C1071022,10151004,113,PF-06863135,T,6518602945,6.5186E+11,20211208,11:36,CYCLE1_DAY22,0 H,564.8661508,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1115,97RSYC,12-May-22
C1071022,10151004,113,PF-06863135,T,6518957157,6.51896E+11,20211215,11:20,CYCLE2_DAY1,0 H,963.5269299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1251,87RSYC,13-May-22
C1071022,10151004,113,PF-06863135,T,6518602951,6.5186E+11,20211118,12:20,CYCLE1_DAY1,24 H,165.4188487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 922,20RSYC,19-Apr-22
C1071022,10151004,113,PF-06863135,T,6518602957,6.5186E+11,20211119,13:30,CYCLE1_DAY4,0 H,783.1707707,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 926,20RSYC,19-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602936,6.5186E+11,20211116,15:43,CYCLE1_DAY1,0 H,59.36950908,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 916,20RSYC,19-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,9:30,CYCLE1_DAY8,0 H,565.4771134,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 920,20RSYC,19-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602940,6.5186E+11,20211123,16:40,CYCLE1_DAY8,6 H,210.2530201,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 919,20RSYC,19-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602943,6.5186E+11,20211201,13:10,CYCLE1_DAY15,0 H,963.0913202,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1113,67RSYC,8-May-22
C1071022,10151007,114,PF-06863135,T,6518842177,6.51884E+11,20211208,12:47,CYCLE1_DAY22,0 H,524.8320934,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1165,104RSYC,22-May-22
C1071022,10151007,114,PF-06863135,T,6518957158,6.51896E+11,20211215,12:35,CYCLE2_DAY1,0 H,502.607136,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1252,47RSYC,28-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602950,6.5186E+11,20211117,14:45,CYCLE1_DAY1,24 H,760.7195859,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 921,20RSYC,19-Apr-22
C1071022,10151007,114,PF-06863135,T,6518602956,6.5186E+11,20211119,13:35,CYCLE1_DAY4,0 H,649.9775071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 925,20RSYC,19-Apr-22
C1071022,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,13:45,CYCLE1_DAY1,0 H,538.6598657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 864,36RSYC,25-Apr-22
C1071022,10031011,115,PF-06863135,T,6517473904,6.51747E+11,20211116,21:49,CYCLE1_DAY1,6 H,864.7003219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 863,36RSYC,25-Apr-22
C1071022,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,9:55,CYCLE1_DAY8,0 H,419.7922444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1118,94RSYC,12-May-22
C1071022,10031011,115,PF-06863135,T,6518620839,6.51862E+11,20211129,15:54,CYCLE1_DAY8,6 H,74.75326454,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1117,94RSYC,12-May-22
C1071022,10031011,115,PF-06863135,T,6517889670,6.51789E+11,20211209,13:40,CYCLE1_DAY15,0 H,342.5899214,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1085,41RSYC,26-Apr-22
C1071022,10031011,115,PF-06863135,T,6518620844,6.51862E+11,20211216,14:20,CYCLE1_DAY22,0 H,124.5699933,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1120,94RSYC,12-May-22
C1071022,10031011,115,PF-06863135,T,6519134610,6.51913E+11,20220120,15:40,CYCLE3_DAY1,0 H,704.4292719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1622,85RSYC,10-May-22
C1071022,10031011,115,PF-06863135,T,6516580419,6.51658E+11,20220217,12:12,CYCLE4_DAY1,0 H,688.762018,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1621,85RSYC,10-May-22
C1071022,10031011,115,PF-06863135,T,6519134613,6.51913E+11,20220512,12:28,CYCLE7_DAY1,0 H,657.5986275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1987,114RSYC,25-Jul-22
C1071022,10031011,115,PF-06863135,T,6518620873,6.51862E+11,20221027,10:10,CYCLE13_DAY1,0 H,175.1163891,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2142,139RSYC,22-Mar-23
C1071022,10031011,115,PF-06863135,T,6519134605,6.51913E+11,20230119,13:43,CYCLE16_DAY1,0 H,312.4054076,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2193,141RSYC,17-May-23
C1071022,10031011,115,PF-06863135,T,6523047504,6.52305E+11,20230413,10:57,CYCLE19_DAY1,0 H,743.1569444,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2218,142RSYC,18-May-23
C1071022,10031011,115,PF-06863135,T,6521762365,6.52176E+11,20230710,13:46,CYCLE22_DAY1,0 H,604.4665819,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2330,149RSYC,27-Mar-24
C1071022,10031011,115,PF-06863135,T,6522244539,6.52224E+11,20231002,12:49,CYCLE25_DAY1,0 H,221.8802691,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2331,149RSYC,27-Mar-24
C1071022,10031011,115,PF-06863135,T,6523132945,6.52313E+11,,,CYCLE31_DAY1,0 H,796.6120455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2376,152RSYC,9-Apr-24
C1071022,10031011,115,PF-06863135,T,6518620864,6.51862E+11,20211117,13:55,CYCLE1_DAY1,24 H,267.8965487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 927,20RSYC,19-Apr-22
C1071022,10031011,115,PF-06863135,T,6517472381,6.51747E+11,20211122,10:14,CYCLE1_DAY4,0 H,834.6776993,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 989,66RSYC,3-May-22
C1071022,10031011,115,PF-06863135,T,6518620868,6.51862E+11,20211123,11:47,CYCLE1_DAY4,24 H,883.0974807,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1124,94RSYC,12-May-22
C1071022,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,11:00,CYCLE1_DAY1,0 H,331.7342673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 671,30RSYC,22-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707956,6.80171E+11,20211116,20:40,CYCLE1_DAY1,6 H,119.8088522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 832,35RSYC,25-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,10:00,CYCLE1_DAY8,0 H,351.2677559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 834,35RSYC,25-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707958,6.80171E+11,20211124,19:45,CYCLE1_DAY8,6 H,915.1852545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 833,35RSYC,25-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707960,6.80171E+11,20211130,10:42,CYCLE1_DAY15,0 H,910.9111718,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 941,65RSYC,3-May-22
C1071022,11081005,116,PF-06863135,T,6801707962,6.80171E+11,20211207,8:45,CYCLE1_DAY22,0 H,115.8913138,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 952,65RSYC,3-May-22
C1071022,11081005,116,PF-06863135,T,6801734181,6.80173E+11,20211214,9:30,CYCLE2_DAY1,0 H,946.78569,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 953,65RSYC,3-May-22
C1071022,11081005,116,PF-06863135,T,6801701818,6.8017E+11,20220111,9:26,CYCLE3_DAY1,0 H,298.8730468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1591,59RSYC,1-May-22
C1071022,11081005,116,PF-06863135,T,6801701820,6.8017E+11,20220208,9:50,CYCLE4_DAY1,0 H,266.8529927,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1592,59RSYC,1-May-22
C1071022,11081005,116,PF-06863135,T,6801811838,6.80181E+11,20220509,10:16,CYCLE7_DAY1,0 H,350.8084111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1961,114RSYC,25-Jul-22
C1071022,11081005,116,PF-06863135,T,6801892999,6.80189E+11,20220725,10:02,CYCLE10_DAY1,0 H,971.8945127,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2070,129RSYC,21-Oct-22
C1071022,11081005,116,PF-06863135,T,6801958742,6.80196E+11,20221017,9:53,CYCLE13_DAY1,0 H,910.8870929,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2117,131RSYC,9-Nov-22
C1071022,11081005,116,PF-06863135,T,6802068778,6.80207E+11,20230110,9:43,CYCLE16_DAY1,0 H,44.30256837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2188,141RSYC,17-May-23
C1071022,11081005,116,PF-06863135,T,6802135339,6.80214E+11,20230403,10:05,CYCLE19_DAY1,0 H,679.8816594,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2236,143RSYC,27-Nov-23
C1071022,11081005,116,PF-06863135,T,6802256362,6.80226E+11,20230626,9:43,CYCLE22_DAY1,0 H,319.2978486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2275,144RSYC,27-Nov-23
C1071022,11081005,116,PF-06863135,T,6802256364,6.80226E+11,20230919,10:16,CYCLE25_DAY1,0 H,52.16507537,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2297,154RSYC,11-Apr-24
C1071022,11081005,116,PF-06863135,T,6802408400,6.80241E+11,20231213,10:37,CYCLE28_DAY1,0 H,113.173624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2344,148RSYC,27-Mar-24
C1071022,11081005,116,PF-06863135,T,6802408402,6.80241E+11,20240110,10:50,END_OF_TRT,,642.5692292,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2345,149RSYC,27-Mar-24
C1071022,11081005,116,PF-06863135,T,6801707964,6.80171E+11,20211117,14:50,CYCLE1_DAY1,24 H,118.6503248,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 835,35RSYC,25-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707966,6.80171E+11,20211119,8:50,CYCLE1_DAY4,0 H,716.8609561,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 836,35RSYC,25-Apr-22
C1071022,11081005,116,PF-06863135,T,6801707968,6.80171E+11,20211120,13:50,CYCLE1_DAY4,24 H,718.4259937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 837,35RSYC,25-Apr-22
C1071022,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,14:10,CYCLE1_DAY1,0 H,302.7987747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 798,34RSYC,24-Apr-22
C1071022,11021009,117,PF-06863135,T,6217184360,6.21718E+11,20211116,20:25,CYCLE1_DAY1,6 H,408.3278657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 797,34RSYC,24-Apr-22
C1071022,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,15:30,CYCLE1_DAY8,0 H,717.8693353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1544,58RSYC,1-May-22
C1071022,11021009,117,PF-06863135,T,6217233478,6.21723E+11,20211126,22:00,CYCLE1_DAY8,6 H,865.5066945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1543,58RSYC,1-May-22
C1071022,11021009,117,PF-06863135,T,6217170441,6.21717E+11,20211203,13:30,CYCLE1_DAY15,0 H,925.4741339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1499,55RSYC,30-Apr-22
C1071022,11021009,117,PF-06863135,T,6217170452,6.21717E+11,20211210,13:40,CYCLE1_DAY22,0 H,130.9549438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1504,55RSYC,30-Apr-22
C1071022,11021009,117,PF-06863135,T,6217170453,6.21717E+11,20211217,13:35,CYCLE2_DAY1,0 H,371.5841516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1505,55RSYC,30-Apr-22
C1071022,11021009,117,PF-06863135,T,6217170477,6.21717E+11,20220114,13:00,CYCLE3_DAY1,0 H,349.704374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1842,93RSYC,12-May-22
C1071022,11021009,117,PF-06863135,T,6217656226,6.21766E+11,20220308,10:30,END_OF_TRT,,428.0316891,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1880,86RSYC,13-May-22
C1071022,11021009,117,PF-06863135,T,6217136152,6.21714E+11,20211117,14:20,CYCLE1_DAY1,24 H,956.258615,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 785,33RSYC,24-Apr-22
C1071022,11021009,117,PF-06863135,T,6217233480,6.21723E+11,20211122,16:00,CYCLE1_DAY4,0 H,455.8525186,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 811,34RSYC,24-Apr-22
C1071022,11021009,117,PF-06863135,T,6217118744,6.21712E+11,20211123,16:30,CYCLE1_DAY4,24 H,920.35088,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 784,33RSYC,24-Apr-22
C1071022,10151005,118,PF-06863135,T,6518602937,6.5186E+11,20211123,10:05,CYCLE1_DAY1,0 H,977.6311439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1109,67RSYC,8-May-22
C1071022,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,10:00,CYCLE1_DAY8,0 H,85.80843167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1187,104RSYC,22-May-22
C1071022,10151005,118,PF-06863135,T,6518911702,6.51891E+11,20211129,15:44,CYCLE1_DAY8,6 H,411.581841,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1186,104RSYC,22-May-22
C1071022,10151005,118,PF-06863135,T,6518957153,6.51896E+11,20211206,10:50,CYCLE1_DAY15,0 H,377.6017713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1247,47RSYC,28-Apr-22
C1071022,10151005,118,PF-06863135,T,6518957155,6.51896E+11,20211213,10:10,CYCLE1_DAY22,0 H,364.9151931,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1249,47RSYC,28-Apr-22
C1071022,10151005,118,PF-06863135,T,6518602953,6.5186E+11,20211124,13:00,CYCLE1_DAY1,24 H,915.6669876,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1116,94RSYC,12-May-22
C1071022,11061005,119,PF-06863135,T,6217165063,6.21717E+11,20211119,16:05,CYCLE1_DAY1,0 H,91.36056222,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1482,55RSYC,30-Apr-22
C1071022,11061005,119,PF-06863135,T,6217165072,6.21717E+11,20211126,12:30,CYCLE1_DAY8,0 H,665.3133625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1488,105RSYC,22-May-22
C1071022,11061005,119,PF-06863135,T,6217165074,6.21717E+11,20211202,11:30,CYCLE1_DAY15,0 H,93.99436772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1490,55RSYC,30-Apr-22
C1071022,11061005,119,PF-06863135,T,6217193498,6.21719E+11,20211209,11:10,CYCLE1_DAY22,0 H,73.13438886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1527,56RSYC,30-Apr-22
C1071022,11061005,119,PF-06863135,T,6217165088,6.21717E+11,20211123,15:00,CYCLE1_DAY4,0 H,670.6571052,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1494,55RSYC,30-Apr-22
C1071022,11061005,119,PF-06863135,T,6217193548,6.21719E+11,20211124,16:10,CYCLE1_DAY4,24 H,298.1623182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1532,56RSYC,30-Apr-22
C1071022,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,13:45,CYCLE1_DAY1,0 H,639.1667239,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 850,36RSYC,25-Apr-22
C1071022,10741004,120,PF-06863135,T,6517472574,6.51747E+11,20211119,23:45,CYCLE1_DAY1,6 H,578.1055468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 849,36RSYC,25-Apr-22
C1071022,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,8:45,CYCLE1_DAY8,0 H,814.0053531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 995,88RSYC,11-May-22
C1071022,10741004,120,PF-06863135,T,6517472577,6.51747E+11,20211130,18:35,CYCLE1_DAY8,6 H,343.8041411,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 994,66RSYC,3-May-22
C1071022,10741004,120,PF-06863135,T,6518693893,6.51869E+11,20211207,12:45,CYCLE1_DAY15,0 H,265.8192772,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1128,94RSYC,12-May-22
C1071022,10741004,120,PF-06863135,T,6519029235,6.51903E+11,20211213,8:57,CYCLE1_DAY22,0 H,303.6145182,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1263,47RSYC,28-Apr-22
C1071022,10741004,120,PF-06863135,T,6519029237,6.51903E+11,20211221,8:23,CYCLE2_DAY1,0 H,825.1989681,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1265,47RSYC,28-Apr-22
C1071022,10741004,120,PF-06863135,T,6518988296,6.51899E+11,20220118,11:26,CYCLE3_DAY1,0 H,307.1208073,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1655,100RSYC,23-May-22
C1071022,10741004,120,PF-06863135,T,6519158559,6.51916E+11,20220215,12:04,CYCLE4_DAY1,0 H,132.0915634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1656,100RSYC,23-May-22
C1071022,10741004,120,PF-06863135,T,6517472588,6.51747E+11,20220510,12:15,CYCLE7_DAY1,0 H,283.5422719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1969,114RSYC,25-Jul-22
C1071022,10741004,120,PF-06863135,T,6518807210,6.51881E+11,20220804,11:13,CYCLE10_DAY1,0 H,847.783764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2083,129RSYC,21-Oct-22
C1071022,10741004,120,PF-06863135,T,6520917899,6.52092E+11,20221026,10:18,CYCLE13_DAY1,0 H,16.40419221,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2143,139RSYC,22-Mar-23
C1071022,10741004,120,PF-06863135,T,6521628791,6.52163E+11,20221207,12:47,END_OF_TRT,,885.0723726,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2133,139RSYC,22-Mar-23
C1071022,10741004,120,PF-06863135,T,6517472591,6.51747E+11,20211120,17:40,CYCLE1_DAY1,24 H,547.1375153,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 851,36RSYC,25-Apr-22
C1071022,10741004,120,PF-06863135,T,6517472593,6.51747E+11,20211122,10:10,CYCLE1_DAY4,0 H,568.7800559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1001,39RSYC,26-Apr-22
C1071022,10741004,120,PF-06863135,T,6518693901,6.51869E+11,20211123,15:27,CYCLE1_DAY4,24 H,777.8034636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1133,94RSYC,12-May-22
C1071022,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,11:54,CYCLE1_DAY1,0 H,295.7924148,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1066,41RSYC,26-Apr-22
C1071022,10031013,121,PF-06863135,T,6517751560,6.51775E+11,20211122,18:35,CYCLE1_DAY1,6 H,286.5640979,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1065,41RSYC,26-Apr-22
C1071022,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,11:20,CYCLE1_DAY8,0 H,869.5217072,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1935,120RSYC,28-Jul-22
C1071022,10031013,121,PF-06863135,T,6518620838,6.51862E+11,20211202,16:55,CYCLE1_DAY8,6 H,65.40102823,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1936,123RSYC,29-Jul-22
C1071022,10031013,121,PF-06863135,T,6516580394,6.51658E+11,20211210,16:45,CYCLE1_DAY15,0 H,111.920488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1937,123RSYC,29-Jul-22
C1071022,10031013,121,PF-06863135,T,6518620845,6.51862E+11,20211217,14:15,CYCLE1_DAY22,0 H,839.667294,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1121,94RSYC,12-May-22
C1071022,10031013,121,PF-06863135,T,6518620848,6.51862E+11,20211222,15:33,CYCLE2_DAY1,0 H,146.3829666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1938,124RSYC,29-Jul-22
C1071022,10031013,121,PF-06863135,T,6517751582,6.51775E+11,20220121,15:42,CYCLE3_DAY1,0 H,213.4952571,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1623,85RSYC,10-May-22
C1071022,10031013,121,PF-06863135,T,6517473941,6.51747E+11,20211123,12:32,CYCLE1_DAY1,24 H,211.0274849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1006,39RSYC,26-Apr-22
C1071022,10031013,121,PF-06863135,T,6517473946,6.51747E+11,20211124,12:30,CYCLE1_DAY4,0 H,748.5233863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1007,39RSYC,26-Apr-22
C1071022,10031013,121,PF-06863135,T,6518620870,6.51862E+11,20211125,11:45,CYCLE1_DAY4,24 H,738.7057074,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1126,94RSYC,12-May-22
C1071022,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211119,15:05,CYCLE1_DAY1,0 H,855.3731016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1094,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343087,6.51834E+11,20211120,0:20,CYCLE1_DAY1,6 H,916.8578677,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1093,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,13:13,CYCLE1_DAY8,0 H,533.1135163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1096,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343089,6.51834E+11,20211126,17:00,CYCLE1_DAY8,6 H,962.5010267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1095,87RSYC,13-May-22
C1071022,11281001,122,PF-06863135,T,6518343091,6.51834E+11,20211203,11:06,CYCLE1_DAY15,0 H,859.6698864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1097,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343107,6.51834E+11,20211210,17:35,END_OF_TRT,,278.0358368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1101,107RSYC,24-May-22
C1071022,11281001,122,PF-06863135,T,6518343099,6.51834E+11,20211120,16:05,CYCLE1_DAY1,24 H,929.8956245,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1098,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343100,6.51834E+11,20211122,11:45,CYCLE1_DAY4,0 H,753.6572125,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1099,67RSYC,8-May-22
C1071022,11281001,122,PF-06863135,T,6518343103,6.51834E+11,20211123,14:25,CYCLE1_DAY4,24 H,831.4513949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1100,67RSYC,8-May-22
C1071022,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,13:20,CYCLE1_DAY1,0 H,265.9371026,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 761,33RSYC,24-Apr-22
C1071022,10561004,123,PF-06863135,T,6217026113,6.21703E+11,20211122,21:00,CYCLE1_DAY1,6 H,180.8017108,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 760,64RSYC,3-May-22
C1071022,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,14:00,CYCLE1_DAY8,0 H,584.93534,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1403,95RSYC,13-May-22
C1071022,10561004,123,PF-06863135,T,6216898571,6.2169E+11,20211129,22:20,CYCLE1_DAY8,6 H,35.00520193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1402,95RSYC,13-May-22
C1071022,10561004,123,PF-06863135,T,6216898576,6.2169E+11,20211206,14:30,CYCLE1_DAY15,0 H,780.8936775,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1405,96RSYC,12-May-22
C1071022,10561004,123,PF-06863135,T,6216408046,6.21641E+11,20211213,11:05,CYCLE1_DAY22,0 H,85.46134944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1319,49RSYC,29-Apr-22
C1071022,10561004,123,PF-06863135,T,6216898582,6.2169E+11,20211221,10:45,CYCLE2_DAY1,0 H,288.5499498,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1408,96RSYC,12-May-22
C1071022,10561004,123,PF-06863135,T,6216408050,6.21641E+11,20220117,13:20,CYCLE3_DAY1,0 H,477.7993387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1776,71RSYC,7-May-22
C1071022,10561004,123,PF-06863135,T,6216408052,6.21641E+11,20220216,12:35,CYCLE4_DAY1,0 H,64.93312281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1777,71RSYC,7-May-22
C1071022,10561004,123,PF-06863135,T,6216408054,6.21641E+11,20220512,10:00,CYCLE7_DAY1,0 H,211.3010732,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1992,115RSYC,25-Jul-22
C1071022,10561004,123,PF-06863135,T,6216898603,6.2169E+11,20220803,12:00,CYCLE10_DAY1,0 H,777.2221417,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2050,132RSYC,10-Nov-22
C1071022,10561004,123,PF-06863135,T,6218590830,6.21859E+11,20221025,11:15,CYCLE13_DAY1,0 H,616.9334783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2153,139RSYC,22-Mar-23
C1071022,10561004,123,PF-06863135,T,6219498867,6.2195E+11,20230116,13:30,CYCLE16_DAY1,0 H,174.2295847,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2180,140RSYC,22-Mar-23
C1071022,10561004,123,PF-06863135,T,6220036100,6.22004E+11,20230412,12:40,CYCLE19_DAY1,0 H,465.0788432,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2229,142RSYC,18-May-23
C1071022,10561004,123,PF-06863135,T,6220036101,6.22004E+11,20230719,10:20,CYCLE22_DAY1,0 H,760.5725219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2278,147RSYC,29-Feb-24
C1071022,10561004,123,PF-06863135,T,6220036103,6.22004E+11,20231019,15:25,CYCLE25_DAY1,0 H,239.9661094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2317,147RSYC,29-Feb-24
C1071022,10561004,123,PF-06863135,T,6222181788,6.22218E+11,20240111,12:15,CYCLE28_DAY1,0 H,21.01165653,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2351,152RSYC,9-Apr-24
C1071022,10561004,123,PF-06863135,T,6216408055,6.21641E+11,20211123,15:00,CYCLE1_DAY1,24 H,17.74470982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 714,31RSYC,23-Apr-22
C1071022,10561004,123,PF-06863135,T,6217026189,6.21703E+11,20211126,14:00,CYCLE1_DAY4,24 H,611.2933713,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1433,57RSYC,30-Apr-22
C1071022,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,14:10,CYCLE1_DAY1,0 H,318.2029281,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1534,56RSYC,30-Apr-22
C1071022,10291001,125,PF-06863135,T,6217232417,6.21723E+11,20211122,20:51,CYCLE1_DAY1,6 H,929.3710009,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1533,56RSYC,30-Apr-22
C1071022,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,10:13,CYCLE1_DAY8,0 H,68.35302665,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1294,84RSYC,10-May-22
C1071022,10291001,125,PF-06863135,T,6216407838,6.21641E+11,20211129,19:40,CYCLE1_DAY8,6 H,22.76915615,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1293,84RSYC,10-May-22
C1071022,10291001,125,PF-06863135,T,6216407840,6.21641E+11,20211206,8:10,CYCLE1_DAY15,0 H,621.1933268,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1295,84RSYC,10-May-22
C1071022,10291001,125,PF-06863135,T,6217232422,6.21723E+11,20211213,13:12,CYCLE1_DAY22,0 H,524.041809,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1748,90RSYC,11-May-22
C1071022,10291001,125,PF-06863135,T,6216407844,6.21641E+11,20211220,8:46,CYCLE2_DAY1,0 H,117.4089284,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1746,90RSYC,11-May-22
C1071022,10291001,125,PF-06863135,T,6216407846,6.21641E+11,20220117,8:20,CYCLE3_DAY1,0 H,273.5526774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1747,90RSYC,11-May-22
C1071022,10291001,125,PF-06863135,T,6217230872,6.21723E+11,20220214,8:38,CYCLE4_DAY1,0 H,71.45920028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1876,80RSYC,4-May-22
C1071022,10291001,125,PF-06863135,T,6218182028,6.21818E+11,20220331,10:30,END_OF_TRT,,661.3386935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1916,123RSYC,29-Jul-22
C1071022,10291001,125,PF-06863135,T,6217183327,6.21718E+11,20211123,15:40,UNPL,9001 H,482.4351867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1516,56RSYC,30-Apr-22
C1071022,10291001,125,PF-06863135,T,6217183332,6.21718E+11,20211124,16:30,UNPL,9002 H,369.4375781,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1517,56RSYC,30-Apr-22
C1071022,10291001,125,PF-06863135,T,6216407851,6.21641E+11,20211123,15:40,CYCLE1_DAY1,24 H,726.5307368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1296,49RSYC,29-Apr-22
C1071022,10291001,125,PF-06863135,T,6217262392,6.21726E+11,20211125,8:20,CYCLE1_DAY4,0 H,327.7266783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1548,58RSYC,1-May-22
C1071022,10291001,125,PF-06863135,T,6217262394,6.21726E+11,20211126,13:14,CYCLE1_DAY4,24 H,482.9997299,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1549,58RSYC,1-May-22
C1071022,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,17:15,CYCLE1_DAY1,0 H,868.061566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 808,34RSYC,24-Apr-22
C1071022,11021008,126,PF-06863135,T,6217233477,6.21723E+11,20211122,23:30,CYCLE1_DAY1,6 H,102.188712,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 807,34RSYC,24-Apr-22
C1071022,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,15:55,CYCLE1_DAY8,0 H,987.0927161,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1427,57RSYC,30-Apr-22
C1071022,11021008,126,PF-06863135,T,6217023824,6.21702E+11,20211202,23:45,CYCLE1_DAY8,6 H,416.307315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1426,57RSYC,30-Apr-22
C1071022,11021008,126,PF-06863135,T,6217170438,6.21717E+11,20211208,13:30,CYCLE1_DAY15,0 H,161.6655487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1498,110RSYC,25-May-22
C1071022,11021008,126,PF-06863135,T,6216756805,6.21676E+11,20211215,15:35,CYCLE1_DAY22,0 H,549.2743172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1385,81RSYC,4-May-22
C1071022,11021008,126,PF-06863135,T,6217023838,6.21702E+11,20211222,17:00,CYCLE2_DAY1,0 H,373.8811948,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1843,93RSYC,12-May-22
C1071022,11021008,126,PF-06863135,T,6216756820,6.21676E+11,20220224,10:35,END_OF_TRT,,62.22525014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1881,109RSYC,25-May-22
C1071022,11021008,126,PF-06863135,T,6217170509,6.21717E+11,20211123,17:30,CYCLE1_DAY1,24 H,263.4208983,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 796,34RSYC,24-Apr-22
C1071022,11021008,126,PF-06863135,T,6217136156,6.21714E+11,20211126,18:30,CYCLE1_DAY4,24 H,518.7844522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1466,54RSYC,30-Apr-22
C1071022,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,9:26,CYCLE1_DAY1,0 H,34.6833907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 692,30RSYC,22-Apr-22
C1071022,10401002,127,PF-06863135,T,6518727314,6.51873E+11,20211123,16:48,CYCLE1_DAY1,6 H,648.7897762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 691,30RSYC,22-Apr-22
C1071022,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,8:42,CYCLE1_DAY8,0 H,565.2898985,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1139,94RSYC,12-May-22
C1071022,10401002,127,PF-06863135,T,6518727316,6.51873E+11,20211130,15:15,CYCLE1_DAY8,6 H,24.32233901,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1138,94RSYC,12-May-22
C1071022,10401002,127,PF-06863135,T,6518926328,6.51893E+11,20211214,9:30,CYCLE1_DAY22,0 H,238.0508742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1196,105RSYC,22-May-22
C1071022,10401002,127,PF-06863135,T,6518926331,6.51893E+11,20211222,16:01,CYCLE2_DAY1,0 H,677.2112556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1197,105RSYC,22-May-22
C1071022,10401002,127,PF-06863135,T,6519180202,6.51918E+11,20220119,10:50,CYCLE3_DAY1,0 H,869.2484376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1723,72RSYC,7-May-22
C1071022,10401002,127,PF-06863135,T,6517560306,6.51756E+11,20220216,8:19,CYCLE4_DAY1,0 H,974.9680493,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1722,72RSYC,7-May-22
C1071022,10401002,127,PF-06863135,T,6517560309,6.51756E+11,20220511,12:12,CYCLE7_DAY1,0 H,549.368156,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1981,114RSYC,25-Jul-22
C1071022,10401002,127,PF-06863135,T,6518806949,6.51881E+11,20220817,7:35,CYCLE10_DAY1,0 H,426.7027297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2092,127RSYC,19-Oct-22
C1071022,10401002,127,PF-06863135,T,6520956319,6.52096E+11,20221109,8:04,CYCLE13_DAY1,0 H,484.3885166,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2144,139RSYC,22-Mar-23
C1071022,10401002,127,PF-06863135,T,6521647793,6.52165E+11,20230201,7:44,CYCLE16_DAY1,0 H,856.3700887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2194,141RSYC,17-May-23
C1071022,10401002,127,PF-06863135,T,6521647794,6.52165E+11,20230426,11:23,CYCLE19_DAY1,0 H,363.5474479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2248,143RSYC,27-Nov-23
C1071022,10401002,127,PF-06863135,T,6523034190,6.52303E+11,20230719,10:12,CYCLE22_DAY1,0 H,116.884724,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2283,145RSYC,4-Jan-24
C1071022,10401002,127,PF-06863135,T,6524124734,6.52412E+11,20231025,7:42,CYCLE25_DAY1,0 H,905.0555938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2332,149RSYC,27-Mar-24
C1071022,10401002,127,PF-06863135,T,6524124735,6.52412E+11,20240117,8:50,CYCLE28_DAY1,0 H,672.5796843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2356,148RSYC,27-Mar-24
C1071022,10401002,127,PF-06863135,T,6518712782,6.51871E+11,20211124,9:20,CYCLE1_DAY1,24 H,800.3677197,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1137,94RSYC,12-May-22
C1071022,10401002,127,PF-06863135,T,6518712786,6.51871E+11,20211126,10:40,CYCLE1_DAY4,0 H,542.8897552,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 690,30RSYC,22-Apr-22
C1071022,10401002,127,PF-06863135,T,6517560314,6.51756E+11,20211127,11:30,CYCLE1_DAY4,24 H,818.8286178,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1053,40RSYC,26-Apr-22
C1071022,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,10:40,CYCLE1_DAY1,0 H,661.4552276,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 685,30RSYC,22-Apr-22
C1071022,10101006,128,PF-06863135,T,6518706273,6.51871E+11,20211123,17:55,CYCLE1_DAY1,6 H,194.6879763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 686,30RSYC,22-Apr-22
C1071022,10101006,128,PF-06863135,T,6518558179,6.51856E+11,20211130,8:33,CYCLE1_DAY8,0 H,953.1341446,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1108,67RSYC,8-May-22
C1071022,10101006,128,PF-06863135,T,6518706279,6.51871E+11,20211207,9:35,CYCLE1_DAY15,0 H,50.04501937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1134,94RSYC,12-May-22
C1071022,10101006,128,PF-06863135,T,6518447644,6.51845E+11,20211215,10:32,CYCLE1_DAY22,0 H,819.0432797,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1103,67RSYC,8-May-22
C1071022,10101006,128,PF-06863135,T,6518447645,6.51845E+11,20211221,13:00,CYCLE2_DAY1,0 H,688.755187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1104,67RSYC,8-May-22
C1071022,10101006,128,PF-06863135,T,6517559663,6.51756E+11,20220119,9:56,CYCLE3_DAY1,0 H,719.8436187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1615,97RSYC,12-May-22
C1071022,10101006,128,PF-06863135,T,6517559666,6.51756E+11,20220216,10:44,CYCLE4_DAY1,0 H,70.14123586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1616,97RSYC,12-May-22
C1071022,10101006,128,PF-06863135,T,6517559668,6.51756E+11,20220511,9:18,CYCLE7_DAY1,0 H,770.8494586,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1975,114RSYC,25-Jul-22
C1071022,10101006,128,PF-06863135,T,6521315622,6.52132E+11,20221026,13:00,CYCLE13_DAY1,0 H,372.5610779,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2145,143RSYC,27-Nov-23
C1071022,10101006,128,PF-06863135,T,6521315620,6.52132E+11,20230412,11:55,CYCLE19_DAY1,0 H,385.144805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2216,142RSYC,18-May-23
C1071022,10101006,128,PF-06863135,T,6522542259,6.52254E+11,20230705,10:36,CYCLE22_DAY1,0 H,983.2151717,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2284,145RSYC,4-Jan-24
C1071022,10101006,128,PF-06863135,T,6524996224,6.525E+11,,,CYCLE31_DAY1,0 H,903.4706505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2374,152RSYC,9-Apr-24
C1071022,10101006,128,PF-06863135,T,6526011931,6.52601E+11,20240124,11:54,UNPL,9001 H,722.3379908,NG/ML,,Received as 6524145852-02; visit revised from C28D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2357,148RSYC,27-Mar-24
C1071022,10101006,128,PF-06863135,T,6518558185,6.51856E+11,20211124,11:56,CYCLE1_DAY1,24 H,675.9904464,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 684,30RSYC,22-Apr-22
C1071022,10101006,128,PF-06863135,T,6518706291,6.51871E+11,20211126,10:50,CYCLE1_DAY4,0 H,657.1682928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 687,30RSYC,22-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,13:56,CYCLE1_DAY1,0 H,912.5912632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1022,39RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559687,6.51756E+11,20211123,20:05,CYCLE1_DAY1,6 H,814.7210858,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1021,39RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,12:35,CYCLE1_DAY8,0 H,386.8538092,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1024,39RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559690,6.51756E+11,20211130,18:49,CYCLE1_DAY8,6 H,162.0956522,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1023,39RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559692,6.51756E+11,20211206,8:54,CYCLE1_DAY15,0 H,237.5582662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1025,39RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559693,6.51756E+11,20211213,8:12,CYCLE1_DAY22,0 H,330.423033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1026,40RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559695,6.51756E+11,20211220,8:07,CYCLE2_DAY1,0 H,693.2516604,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1027,40RSYC,26-Apr-22
C1071022,10131001,129,PF-06863135,T,6517559697,6.51756E+11,20220117,7:59,CYCLE3_DAY1,0 H,832.4334459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1619,85RSYC,10-May-22
C1071022,10131001,129,PF-06863135,T,6517559700,6.51756E+11,20220215,9:39,CYCLE4_DAY1,0 H,31.78658835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1620,85RSYC,10-May-22
C1071022,10131001,129,PF-06863135,T,6517559701,6.51756E+11,20220509,8:05,CYCLE7_DAY1,0 H,758.1952223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1977,114RSYC,25-Jul-22
C1071022,10131001,129,PF-06863135,T,6520266800,6.52027E+11,20220801,8:26,CYCLE10_DAY1,0 H,349.9757177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2080,129RSYC,21-Oct-22
C1071022,10131001,129,PF-06863135,T,6517559703,6.51756E+11,20211124,13:51,CYCLE1_DAY1,24 H,326.2144165,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 688,30RSYC,22-Apr-22
C1071022,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,11:26,CYCLE1_DAY1,0 H,194.6137709,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 969,66RSYC,3-May-22
C1071022,10801002,130,PF-06863135,T,6517433487,6.51743E+11,20211129,17:41,CYCLE1_DAY1,6 H,715.1138237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 968,65RSYC,3-May-22
C1071022,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,10:09,CYCLE1_DAY8,0 H,349.4612434,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1152,107RSYC,24-May-22
C1071022,10801002,130,PF-06863135,T,6518789961,6.51879E+11,20211206,16:13,CYCLE1_DAY8,6 H,162.8113374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1151,107RSYC,24-May-22
C1071022,10801002,130,PF-06863135,T,6517433492,6.51743E+11,20211213,9:22,CYCLE1_DAY15,0 H,518.7859341,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 974,66RSYC,3-May-22
C1071022,10801002,130,PF-06863135,T,6518918013,6.51892E+11,20211220,10:26,CYCLE1_DAY22,0 H,508.0692769,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1190,105RSYC,22-May-22
C1071022,10801002,130,PF-06863135,T,6518918015,6.51892E+11,20211227,10:19,CYCLE2_DAY1,0 H,12.7354575,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1191,105RSYC,22-May-22
C1071022,10801002,130,PF-06863135,T,6517433517,6.51743E+11,20220110,14:10,END_OF_TRT,,326.081303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1650,100RSYC,23-May-22
C1071022,10801002,130,PF-06863135,T,6517433503,6.51743E+11,20211130,11:40,CYCLE1_DAY1,24 H,923.4427349,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 977,66RSYC,3-May-22
C1071022,10801002,130,PF-06863135,T,6517433506,6.51743E+11,20211202,11:43,CYCLE1_DAY4,0 H,508.1548699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 978,66RSYC,3-May-22
C1071022,10801002,130,PF-06863135,T,6517433507,6.51743E+11,20211203,11:00,CYCLE1_DAY4,24 H,586.7020254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 979,66RSYC,3-May-22
C1071022,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,11:15,CYCLE1_DAY1,0 H,358.4111607,NG/ML,,Received as 6216170971-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1289,76RSYC,4-May-22
C1071022,11001001,131,PF-06863135,T,6216170946,6.21617E+11,20211123,18:01,CYCLE1_DAY1,6 H,518.2467357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1277,89RSYC,11-May-22
C1071022,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,12:15,CYCLE1_DAY8,0 H,55.99770697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1477,55RSYC,30-Apr-22
C1071022,11001001,131,PF-06863135,T,6217163742,6.21716E+11,20211203,17:45,CYCLE1_DAY8,6 H,723.598386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1476,110RSYC,25-May-22
C1071022,11001001,131,PF-06863135,T,6217163744,6.21716E+11,20211210,16:20,CYCLE1_DAY15,0 H,683.8467062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1478,55RSYC,30-Apr-22
C1071022,11001001,131,PF-06863135,T,6216170952,6.21617E+11,20211217,14:00,CYCLE1_DAY22,0 H,629.8324532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1785,71RSYC,7-May-22
C1071022,11001001,131,PF-06863135,T,6217163751,6.21716E+11,20211224,11:50,CYCLE2_DAY1,0 H,674.0360783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1786,71RSYC,7-May-22
C1071022,11001001,131,PF-06863135,T,6216170962,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,609.8711549,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1284,89RSYC,11-May-22
C1071022,11001001,131,PF-06863135,T,6216170965,6.21617E+11,20211129,10:01,CYCLE1_DAY4,0 H,695.0858982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1287,89RSYC,11-May-22
C1071022,11001001,131,PF-06863135,T,6217183920,6.21718E+11,20211130,15:00,CYCLE1_DAY4,24 H,557.2321032,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1519,56RSYC,30-Apr-22
C1071022,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,11:45,CYCLE1_DAY1,0 H,749.0123866,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1279,76RSYC,4-May-22
C1071022,11001002,132,PF-06863135,T,6216170947,6.21617E+11,20211123,18:15,CYCLE1_DAY1,6 H,681.4904791,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1278,89RSYC,11-May-22
C1071022,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,11:30,CYCLE1_DAY8,0 H,284.5685194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1281,89RSYC,11-May-22
C1071022,11001002,132,PF-06863135,T,6216170949,6.21617E+11,20211130,17:15,CYCLE1_DAY8,6 H,418.5031505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1280,89RSYC,11-May-22
C1071022,11001002,132,PF-06863135,T,6217163745,6.21716E+11,20211207,13:00,CYCLE1_DAY15,0 H,745.4420657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1479,55RSYC,30-Apr-22
C1071022,11001002,132,PF-06863135,T,6217163748,6.21716E+11,20211214,10:30,CYCLE1_DAY22,0 H,56.79020796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1480,55RSYC,30-Apr-22
C1071022,11001002,132,PF-06863135,T,6216170954,6.21617E+11,20211221,12:15,CYCLE2_DAY1,0 H,978.8791656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1787,71RSYC,7-May-22
C1071022,11001002,132,PF-06863135,T,6217468784,6.21747E+11,20220120,13:00,CYCLE3_DAY1,0 H,970.2213559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1788,71RSYC,7-May-22
C1071022,11001002,132,PF-06863135,T,6216170963,6.21617E+11,20211124,12:20,CYCLE1_DAY1,24 H,882.2488835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1285,89RSYC,11-May-22
C1071022,11001002,132,PF-06863135,T,6216170964,6.21617E+11,20211125,11:01,CYCLE1_DAY4,0 H,843.6049875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1286,89RSYC,11-May-22
C1071022,11001002,132,PF-06863135,T,6217183957,6.21718E+11,20211126,12:15,CYCLE1_DAY4,24 H,360.8650162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1520,56RSYC,30-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,11:45,CYCLE1_DAY1,0 H,213.1812305,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 708,31RSYC,23-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407903,6.21641E+11,20211123,19:04,CYCLE1_DAY1,6 H,53.01052247,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 707,31RSYC,23-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,12:35,CYCLE1_DAY8,0 H,534.2547303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1300,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407905,6.21641E+11,20211130,18:45,CYCLE1_DAY8,6 H,775.9237047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1299,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407908,6.21641E+11,20211207,13:00,CYCLE1_DAY15,0 H,307.9049118,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1301,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407910,6.21641E+11,20211214,13:30,CYCLE1_DAY22,0 H,450.3564238,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1302,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407912,6.21641E+11,20211227,12:55,CYCLE2_DAY1,0 H,277.2303887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1303,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407914,6.21641E+11,20220117,13:25,CYCLE3_DAY1,0 H,54.77597551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1798,91RSYC,11-May-22
C1071022,10371002,133,PF-06863135,T,6216407916,6.21641E+11,20220214,8:55,CYCLE4_DAY1,0 H,237.9290501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1799,91RSYC,11-May-22
C1071022,10371002,133,PF-06863135,T,6216407918,6.21641E+11,20220509,11:55,CYCLE7_DAY1,0 H,92.02682366,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1991,114RSYC,25-Jul-22
C1071022,10371002,133,PF-06863135,T,6216407926,6.21641E+11,20220801,13:15,CYCLE10_DAY1,0 H,70.204171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2056,132RSYC,10-Nov-22
C1071022,10371002,133,PF-06863135,T,6219054603,6.21905E+11,20221024,12:55,CYCLE13_DAY1,0 H,96.84557483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2154,140RSYC,22-Mar-23
C1071022,10371002,133,PF-06863135,T,6219054602,6.21905E+11,20230116,13:25,CYCLE16_DAY1,0 H,685.3869083,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2176,140RSYC,22-Mar-23
C1071022,10371002,133,PF-06863135,T,6219054604,6.21905E+11,20230412,12:00,CYCLE19_DAY1,0 H,953.1294265,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2232,142RSYC,18-May-23
C1071022,10371002,133,PF-06863135,T,6220666023,6.22067E+11,20230710,9:10,CYCLE22_DAY1,0 H,263.6312109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2279,144RSYC,27-Nov-23
C1071022,10371002,133,PF-06863135,T,6220666022,6.22067E+11,20231002,13:20,CYCLE25_DAY1,0 H,878.1893806,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2318,147RSYC,29-Feb-24
C1071022,10371002,133,PF-06863135,T,6220666026,6.22067E+11,20231227,13:30,CYCLE28_DAY1,0 H,78.32248459,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2352,148RSYC,27-Mar-24
C1071022,10371002,133,PF-06863135,T,6222511475,6.22251E+11,,,CYCLE31_DAY1,0 H,174.0672263,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,10371002,133,PF-06863135,T,6216407919,6.21641E+11,20211124,13:05,CYCLE1_DAY1,24 H,276.1894877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 709,31RSYC,23-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407922,6.21641E+11,20211126,12:50,CYCLE1_DAY4,0 H,183.5918453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1304,49RSYC,29-Apr-22
C1071022,10371002,133,PF-06863135,T,6216407923,6.21641E+11,20211127,12:55,CYCLE1_DAY4,24 H,872.1260406,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1305,49RSYC,29-Apr-22
C1071022,11061004,134,PF-06863135,T,6217193486,6.21719E+11,20211122,15:00,CYCLE1_DAY1,0 H,759.1768004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1524,56RSYC,30-Apr-22
C1071022,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,10:00,CYCLE1_DAY8,0 H,574.8946969,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1487,55RSYC,30-Apr-22
C1071022,11061004,134,PF-06863135,T,6217165070,6.21717E+11,20211129,20:00,CYCLE1_DAY8,6 H,18.18157499,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1486,55RSYC,30-Apr-22
C1071022,11061004,134,PF-06863135,T,6217165076,6.21717E+11,20211207,10:30,CYCLE1_DAY15,0 H,448.9767354,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1491,55RSYC,30-Apr-22
C1071022,11061004,134,PF-06863135,T,6217193504,6.21719E+11,20211220,9:00,CYCLE2_DAY1,0 H,272.6217825,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1800,91RSYC,11-May-22
C1071022,11061004,134,PF-06863135,T,6217193533,6.21719E+11,20211124,17:00,CYCLE1_DAY1,24 H,782.055546,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1529,56RSYC,30-Apr-22
C1071022,11061004,134,PF-06863135,T,6217165091,6.21717E+11,20211125,13:00,CYCLE1_DAY4,0 H,38.92728816,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1495,55RSYC,30-Apr-22
C1071022,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,10:25,CYCLE1_DAY1,0 H,941.7944112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 683,30RSYC,22-Apr-22
C1071022,10101005,135,PF-06863135,T,6518706272,6.51871E+11,20211124,20:10,CYCLE1_DAY1,6 H,997.2005016,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 682,30RSYC,22-Apr-22
C1071022,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,8:00,CYCLE1_DAY8,0 H,307.6803189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1107,67RSYC,8-May-22
C1071022,10101005,135,PF-06863135,T,6518558178,6.51856E+11,20211201,16:20,CYCLE1_DAY8,6 H,574.8693012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1106,67RSYC,8-May-22
C1071022,10101005,135,PF-06863135,T,6518447643,6.51845E+11,20211208,8:00,CYCLE1_DAY15,0 H,934.8372617,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1102,67RSYC,8-May-22
C1071022,10101005,135,PF-06863135,T,6518706281,6.51871E+11,20211215,11:05,CYCLE1_DAY22,0 H,852.3113358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1135,94RSYC,12-May-22
C1071022,10101005,135,PF-06863135,T,6518922661,6.51892E+11,20211221,12:32,CYCLE2_DAY1,0 H,878.1817478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1195,105RSYC,22-May-22
C1071022,10101005,135,PF-06863135,T,6518877336,6.51888E+11,20220119,8:50,CYCLE3_DAY1,0 H,81.83594727,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1614,97RSYC,12-May-22
C1071022,10101005,135,PF-06863135,T,6517559665,6.51756E+11,20220214,8:05,CYCLE4_DAY1,0 H,45.93274822,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1613,97RSYC,12-May-22
C1071022,10101005,135,PF-06863135,T,6517559667,6.51756E+11,20220510,9:13,CYCLE7_DAY1,0 H,959.7989412,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1974,114RSYC,25-Jul-22
C1071022,10101005,135,PF-06863135,T,6517559684,6.51756E+11,20220524,13:40,END_OF_TRT,,333.0900728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1976,114RSYC,25-Jul-22
C1071022,10101005,135,PF-06863135,T,6518558184,6.51856E+11,20211125,12:25,CYCLE1_DAY1,24 H,233.5226441,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 681,30RSYC,22-Apr-22
C1071022,10101005,135,PF-06863135,T,6518706293,6.51871E+11,20211128,13:20,CYCLE1_DAY4,0 H,928.2056857,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1136,94RSYC,12-May-22
C1071022,10101005,135,PF-06863135,T,6518447648,6.51845E+11,20211129,12:30,CYCLE1_DAY4,24 H,746.3705701,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1105,87RSYC,13-May-22
C1071022,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,9:45,CYCLE1_DAY1,0 H,426.5933328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1435,57RSYC,30-Apr-22
C1071022,10461006,136,PF-06863135,T,6217039130,6.21704E+11,20211124,18:20,CYCLE1_DAY1,6 H,676.6360673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1434,57RSYC,30-Apr-22
C1071022,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,11:30,CYCLE1_DAY8,0 H,382.3664033,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1438,57RSYC,30-Apr-22
C1071022,10461006,136,PF-06863135,T,6217039132,6.21704E+11,20211202,18:40,CYCLE1_DAY8,6 H,202.8934869,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1437,57RSYC,30-Apr-22
C1071022,10461006,136,PF-06863135,T,6217283550,6.21728E+11,20211125,12:20,CYCLE1_DAY1,24 H,179.628641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 812,34RSYC,24-Apr-22
C1071022,10461006,136,PF-06863135,T,6217039138,6.21704E+11,20211129,10:23,CYCLE1_DAY4,0 H,811.8593435,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 775,33RSYC,24-Apr-22
C1071022,10461006,136,PF-06863135,T,6217039141,6.21704E+11,20211130,15:00,CYCLE1_DAY4,24 H,557.9387382,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1442,108RSYC,24-May-22
C1071022,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,9:25,CYCLE1_DAY1,0 H,919.6122768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1226,87RSYC,13-May-22
C1071022,10161004,137,PF-06863135,T,6518935555,6.51894E+11,20211124,16:38,CYCLE1_DAY1,6 H,335.4343025,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1225,46RSYC,28-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,10:21,CYCLE1_DAY8,0 H,93.01158552,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1055,40RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697444,6.5177E+11,20211202,16:58,CYCLE1_DAY8,6 H,318.3828655,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1054,40RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697445,6.5177E+11,20211208,10:20,CYCLE1_DAY15,0 H,395.8222606,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1056,41RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697448,6.5177E+11,20211216,10:03,CYCLE1_DAY22,0 H,488.8431386,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1059,41RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697450,6.5177E+11,20211222,10:19,CYCLE2_DAY1,0 H,35.37110849,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1061,41RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6519082806,6.51908E+11,20220118,10:54,CYCLE3_DAY1,0 H,307.4788098,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1605,97RSYC,12-May-22
C1071022,10161004,137,PF-06863135,T,6517697471,6.5177E+11,20220225,8:47,END_OF_TRT,,838.2659801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1888,87RSYC,13-May-22
C1071022,10161004,137,PF-06863135,T,6517697457,6.5177E+11,20211125,10:55,CYCLE1_DAY1,24 H,559.6652922,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1062,41RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6517697459,6.5177E+11,20211127,11:03,CYCLE1_DAY4,0 H,630.3619439,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1063,41RSYC,26-Apr-22
C1071022,10161004,137,PF-06863135,T,6518935578,6.51894E+11,20211128,10:06,CYCLE1_DAY4,24 H,381.7129744,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1241,47RSYC,28-Apr-22
C1071022,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,12:30,CYCLE1_DAY1,0 H,158.5873878,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1272,76RSYC,4-May-22
C1071022,10251004,138,PF-06863135,T,6519212001,6.51921E+11,20211217,18:30,CYCLE1_DAY1,6 H,756.7032472,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1675,101RSYC,13-May-22
C1071022,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,7:33,CYCLE1_DAY8,0 H,597.4219311,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1269,89RSYC,11-May-22
C1071022,10251004,138,PF-06863135,T,6519158571,6.51916E+11,20211227,17:09,CYCLE1_DAY8,6 H,683.5136742,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1268,89RSYC,11-May-22
C1071022,10251004,138,PF-06863135,T,6517559624,6.51756E+11,20220104,8:00,CYCLE1_DAY15,0 H,654.0345977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1672,101RSYC,13-May-22
C1071022,10251004,138,PF-06863135,T,6519138066,6.51914E+11,20220111,9:30,CYCLE1_DAY22,0 H,747.2969719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1673,101RSYC,13-May-22
C1071022,10251004,138,PF-06863135,T,6519158572,6.51916E+11,20220118,11:50,CYCLE2_DAY1,0 H,590.0674956,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1674,109RSYC,25-May-22
C1071022,10251004,138,PF-06863135,T,6517559630,6.51756E+11,20220215,13:30,CYCLE3_DAY1,0 H,775.4331882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1671,101RSYC,13-May-22
C1071022,10251004,138,PF-06863135,T,6519204946,6.5192E+11,20220315,13:25,CYCLE4_DAY1,0 H,647.8909975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1901,81RSYC,4-May-22
C1071022,10251004,138,PF-06863135,T,6519204948,6.5192E+11,20220906,10:11,CYCLE10_DAY1,0 H,206.7569304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2086,129RSYC,21-Oct-22
C1071022,10251004,138,PF-06863135,T,6517559649,6.51756E+11,20230207,11:50,END_OF_TRT,,263.7197112,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2195,141RSYC,17-May-23
C1071022,10251004,138,PF-06863135,T,6520939733,6.52094E+11,20220621,12:35,UNPL,9001 H,660.027966,NG/ML,,Received as 6517559633-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2268,145RSYC,4-Jan-24
C1071022,10251004,138,PF-06863135,T,6519211968,6.51921E+11,20211218,12:35,CYCLE1_DAY1,24 H,365.1016353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1271,89RSYC,11-May-22
C1071022,10251004,138,PF-06863135,T,6519206322,6.51921E+11,20211220,11:14,CYCLE1_DAY4,0 H,997.7124944,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1270,89RSYC,11-May-22
C1071022,10251004,138,PF-06863135,T,6519219388,6.51922E+11,20211221,8:40,CYCLE1_DAY4,24 H,762.8843141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1273,89RSYC,11-May-22
C1071022,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,10:34,CYCLE1_DAY1,0 H,124.2734298,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1222,87RSYC,13-May-22
C1071022,10161002,139,PF-06863135,T,6518935553,6.51894E+11,20211129,17:11,CYCLE1_DAY1,6 H,437.3856205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1221,46RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,8:49,CYCLE1_DAY8,0 H,297.8744331,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1230,46RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6518935558,6.51894E+11,20211206,15:54,CYCLE1_DAY8,6 H,712.942374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1229,46RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6518935563,6.51894E+11,20211213,8:21,CYCLE1_DAY15,0 H,387.4813478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1234,46RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6518935571,6.51894E+11,20211220,8:02,CYCLE1_DAY22,0 H,904.7582462,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1236,47RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6519057401,6.51906E+11,20211229,9:27,CYCLE2_DAY1,0 H,417.6930008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1267,89RSYC,11-May-22
C1071022,10161002,139,PF-06863135,T,6519057403,6.51906E+11,20220126,8:30,CYCLE3_DAY1,0 H,455.1887346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1603,97RSYC,12-May-22
C1071022,10161002,139,PF-06863135,T,6517697472,6.5177E+11,20220228,10:57,END_OF_TRT,,59.305093,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1887,87RSYC,13-May-22
C1071022,10161002,139,PF-06863135,T,6518935574,6.51894E+11,20211130,11:48,CYCLE1_DAY1,24 H,501.5870635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1238,47RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6518981611,6.51898E+11,20211202,10:31,CYCLE1_DAY4,0 H,784.0953168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1259,47RSYC,28-Apr-22
C1071022,10161002,139,PF-06863135,T,6517697462,6.5177E+11,20211203,10:02,CYCLE1_DAY4,24 H,386.3064419,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1064,41RSYC,26-Apr-22
C1071022,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,10:40,CYCLE1_DAY1,0 H,363.358376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1321,76RSYC,4-May-22
C1071022,10711001,140,PF-06863135,T,6216408107,6.21641E+11,20211130,16:40,CYCLE1_DAY1,6 H,179.167267,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1320,49RSYC,29-Apr-22
C1071022,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,9:00,CYCLE1_DAY8,0 H,271.8678168,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1323,49RSYC,29-Apr-22
C1071022,10711001,140,PF-06863135,T,6216408110,6.21641E+11,20211210,18:00,CYCLE1_DAY8,6 H,471.8007507,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1322,49RSYC,29-Apr-22
C1071022,10711001,140,PF-06863135,T,6216408138,6.21641E+11,20211222,12:30,END_OF_TRT,,868.8329545,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1326,108RSYC,24-May-22
C1071022,10711001,140,PF-06863135,T,6216408124,6.21641E+11,20211201,10:40,CYCLE1_DAY1,24 H,83.37975656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1324,49RSYC,29-Apr-22
C1071022,10711001,140,PF-06863135,T,6216408126,6.21641E+11,20211203,12:50,CYCLE1_DAY4,0 H,342.2431082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1325,49RSYC,29-Apr-22
C1071022,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,10:18,CYCLE1_DAY1,0 H,336.8769488,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1005,39RSYC,26-Apr-22
C1071022,10031014,141,PF-06863135,T,6517473908,6.51747E+11,20211206,16:40,CYCLE1_DAY1,6 H,867.6121593,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1004,39RSYC,26-Apr-22
C1071022,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,9:43,CYCLE1_DAY8,0 H,584.4406135,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1939,123RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6516580387,6.51658E+11,20211223,16:12,CYCLE1_DAY8,6 H,540.0182693,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1940,123RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6518620842,6.51862E+11,20211229,11:57,CYCLE1_DAY15,0 H,931.0278456,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1941,123RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6517751574,6.51775E+11,20220105,11:08,CYCLE1_DAY22,0 H,839.8135409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1942,123RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6517751579,6.51775E+11,20220113,10:20,CYCLE2_DAY1,0 H,561.285731,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1943,124RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6516580412,6.51658E+11,20220209,12:05,CYCLE3_DAY1,0 H,832.3467476,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1624,85RSYC,10-May-22
C1071022,10031014,141,PF-06863135,T,6518620856,6.51862E+11,20220309,12:32,CYCLE4_DAY1,0 H,827.8901328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1893,81RSYC,4-May-22
C1071022,10031014,141,PF-06863135,T,6517751595,6.51775E+11,20220601,10:20,CYCLE7_DAY1,0 H,741.6049169,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2012,122RSYC,29-Jul-22
C1071022,10031014,141,PF-06863135,T,6517751598,6.51775E+11,20220825,9:53,CYCLE10_DAY1,0 H,229.2667246,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2081,131RSYC,9-Nov-22
C1071022,10031014,141,PF-06863135,T,6517472383,6.51747E+11,20211207,9:13,CYCLE1_DAY1,24 H,397.0300373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 990,86RSYC,13-May-22
C1071022,10031014,141,PF-06863135,T,6517472382,6.51747E+11,20211214,11:50,CYCLE1_DAY4,0 H,400.9197304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1966,126RSYC,1-Aug-22
C1071022,10031014,141,PF-06863135,T,6517473939,6.51747E+11,20211215,12:38,CYCLE1_DAY4,24 H,874.3357632,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1971,114RSYC,25-Jul-22
C1071022,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,15:10,CYCLE1_DAY1,0 H,155.0668506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1143,95RSYC,13-May-22
C1071022,10931003,142,PF-06863135,T,6518778264,6.51878E+11,20211129,21:17,CYCLE1_DAY1,6 H,537.0041548,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1142,95RSYC,13-May-22
C1071022,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,13:22,CYCLE1_DAY8,0 H,187.3377968,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1145,95RSYC,13-May-22
C1071022,10931003,142,PF-06863135,T,6518778267,6.51878E+11,20211206,19:15,CYCLE1_DAY8,6 H,669.5884716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1144,95RSYC,13-May-22
C1071022,10931003,142,PF-06863135,T,6518934232,6.51893E+11,20211213,13:47,CYCLE1_DAY15,0 H,685.4568075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1208,46RSYC,28-Apr-22
C1071022,10931003,142,PF-06863135,T,6518934233,6.51893E+11,20211220,12:18,CYCLE1_DAY22,0 H,997.9730469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1209,46RSYC,28-Apr-22
C1071022,10931003,142,PF-06863135,T,6518934238,6.51893E+11,20211227,14:16,CYCLE2_DAY1,0 H,754.679633,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1712,72RSYC,7-May-22
C1071022,10931003,142,PF-06863135,T,6518934244,6.51893E+11,20220126,13:23,CYCLE3_DAY1,0 H,757.9116656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1713,72RSYC,7-May-22
C1071022,10931003,142,PF-06863135,T,6519290804,6.51929E+11,20220216,9:59,END_OF_TRT,,610.7327628,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1714,122RSYC,29-Jul-22
C1071022,10931003,142,PF-06863135,T,6518934248,6.51893E+11,20211130,15:17,CYCLE1_DAY1,24 H,214.5317072,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1210,46RSYC,28-Apr-22
C1071022,10931003,142,PF-06863135,T,6518934251,6.51893E+11,20211202,14:15,CYCLE1_DAY4,0 H,551.312452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1213,46RSYC,28-Apr-22
C1071022,10931003,142,PF-06863135,T,6518934254,6.51893E+11,20211203,14:30,CYCLE1_DAY4,24 H,666.8347885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1216,87RSYC,13-May-22
C1071022,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,11:15,CYCLE1_DAY1,0 H,924.584755,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1150,107RSYC,24-May-22
C1071022,10801003,143,PF-06863135,T,6518789960,6.51879E+11,20211206,17:45,CYCLE1_DAY1,6 H,786.4363404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1149,87RSYC,13-May-22
C1071022,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,10:40,CYCLE1_DAY8,0 H,942.3283458,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 971,66RSYC,3-May-22
C1071022,10801003,143,PF-06863135,T,6517433489,6.51743E+11,20211213,17:10,CYCLE1_DAY8,6 H,516.1102652,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 970,66RSYC,3-May-22
C1071022,10801003,143,PF-06863135,T,6518918011,6.51892E+11,20211220,10:10,CYCLE1_DAY15,0 H,862.3187739,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1189,105RSYC,22-May-22
C1071022,10801003,143,PF-06863135,T,6518789966,6.51879E+11,20211227,8:40,CYCLE1_DAY22,0 H,111.8928369,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1153,107RSYC,24-May-22
C1071022,10801003,143,PF-06863135,T,6518789967,6.51879E+11,20220103,9:40,CYCLE2_DAY1,0 H,317.6357624,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1651,100RSYC,23-May-22
C1071022,10801003,143,PF-06863135,T,6519494494,6.51949E+11,20220215,8:18,END_OF_TRT,,131.4895184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1652,100RSYC,23-May-22
C1071022,10801003,143,PF-06863135,T,6518918024,6.51892E+11,20211207,12:00,CYCLE1_DAY1,24 H,665.7732142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1192,105RSYC,22-May-22
C1071022,10801003,143,PF-06863135,T,6518918028,6.51892E+11,20211209,13:17,CYCLE1_DAY4,0 H,415.3880676,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1193,105RSYC,22-May-22
C1071022,10801003,143,PF-06863135,T,6518918029,6.51892E+11,20211210,13:32,CYCLE1_DAY4,24 H,323.6162263,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1194,105RSYC,22-May-22
C1071022,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,10:45,CYCLE1_DAY1,0 H,824.5277992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1199,105RSYC,22-May-22
C1071022,10741002,144,PF-06863135,T,6518931447,6.51893E+11,20211130,18:19,CYCLE1_DAY1,6 H,852.664587,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1198,105RSYC,22-May-22
C1071022,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,9:05,CYCLE1_DAY8,0 H,884.5018842,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1244,47RSYC,28-Apr-22
C1071022,10741002,144,PF-06863135,T,6518935637,6.51894E+11,20211208,17:40,CYCLE1_DAY8,6 H,189.7822784,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1243,47RSYC,28-Apr-22
C1071022,10741002,144,PF-06863135,T,6517472578,6.51747E+11,20211214,9:58,CYCLE1_DAY15,0 H,212.4779036,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 996,39RSYC,26-Apr-22
C1071022,10741002,144,PF-06863135,T,6518693896,6.51869E+11,20211222,9:27,CYCLE1_DAY22,0 H,535.3464479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1130,94RSYC,12-May-22
C1071022,10741002,144,PF-06863135,T,6519029236,6.51903E+11,20211229,10:47,CYCLE2_DAY1,0 H,19.04680067,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1264,47RSYC,28-Apr-22
C1071022,10741002,144,PF-06863135,T,6517472605,6.51747E+11,20220126,10:05,END_OF_TRT,,812.2356746,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1657,100RSYC,23-May-22
C1071022,10741002,144,PF-06863135,T,6517472590,6.51747E+11,20211201,12:28,CYCLE1_DAY1,24 H,110.9626457,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 999,39RSYC,26-Apr-22
C1071022,10741002,144,PF-06863135,T,6518693900,6.51869E+11,20211203,9:32,CYCLE1_DAY4,0 H,482.1528967,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1132,94RSYC,12-May-22
C1071022,10741002,144,PF-06863135,T,6517472594,6.51747E+11,20211204,12:23,CYCLE1_DAY4,24 H,811.6890881,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1002,39RSYC,26-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,11:04,CYCLE1_DAY1,0 H,992.6335111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1344,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725161,6.21673E+11,20211130,17:40,CYCLE1_DAY1,6 H,514.8128497,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1343,87RSYC,13-May-22
C1071022,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,10:30,CYCLE1_DAY8,0 H,810.5398762,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1347,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725163,6.21673E+11,20211207,17:15,CYCLE1_DAY8,6 H,131.4030523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1346,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725165,6.21673E+11,20211215,10:30,CYCLE1_DAY15,0 H,659.7379147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1349,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725169,6.21673E+11,20211229,11:30,CYCLE2_DAY1,0 H,136.048137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1740,90RSYC,11-May-22
C1071022,10051001,145,PF-06863135,T,6216725170,6.21673E+11,20220128,11:00,CYCLE3_DAY1,0 H,229.4987175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1741,90RSYC,11-May-22
C1071022,10051001,145,PF-06863135,T,6217930298,6.21793E+11,20220225,10:00,CYCLE4_DAY1,0 H,357.6761194,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1742,90RSYC,11-May-22
C1071022,10051001,145,PF-06863135,T,6216725182,6.21673E+11,20220812,10:00,CYCLE10_DAY1,0 H,271.4672523,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2046,132RSYC,10-Nov-22
C1071022,10051001,145,PF-06863135,T,6217309165,6.21731E+11,20221028,10:30,CYCLE13_DAY1,0 H,800.6723896,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2155,140RSYC,22-Mar-23
C1071022,10051001,145,PF-06863135,T,6218988074,6.21899E+11,20220603,12:00,UNPL,9001 H,703.0004086,NG/ML,,Received as 6217930299-09,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2017,115RSYC,25-Jul-22
C1071022,10051001,145,PF-06863135,T,6216725177,6.21673E+11,20211201,11:40,CYCLE1_DAY1,24 H,163.1427129,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1351,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725179,6.21673E+11,20211203,10:30,CYCLE1_DAY4,0 H,960.2325007,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1353,50RSYC,29-Apr-22
C1071022,10051001,145,PF-06863135,T,6216725180,6.21673E+11,20211204,11:10,CYCLE1_DAY4,24 H,329.2639636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1354,50RSYC,29-Apr-22
C1071022,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,11:10,CYCLE1_DAY1,0 H,645.1945975,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1562,58RSYC,1-May-22
C1071022,10461007,146,PF-06863135,T,6217283542,6.21728E+11,20211130,17:45,CYCLE1_DAY1,6 H,12.79127489,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1561,58RSYC,1-May-22
C1071022,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,8:00,CYCLE1_DAY8,0 H,59.85324094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1564,58RSYC,1-May-22
C1071022,10461007,146,PF-06863135,T,6217283543,6.21728E+11,20211206,18:14,CYCLE1_DAY8,6 H,971.227521,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1563,58RSYC,1-May-22
C1071022,10461007,146,PF-06863135,T,6217368115,6.21737E+11,20211213,10:50,CYCLE1_DAY15,0 H,65.28680722,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1829,92RSYC,12-May-22
C1071022,10461007,146,PF-06863135,T,6217340171,6.21734E+11,20211227,14:05,CYCLE2_DAY1,0 H,50.6081477,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1828,92RSYC,12-May-22
C1071022,10461007,146,PF-06863135,T,6217142649,6.21714E+11,20220112,16:45,END_OF_TRT,,765.385071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1827,86RSYC,13-May-22
C1071022,10461007,146,PF-06863135,T,6217233438,6.21723E+11,20211201,12:18,CYCLE1_DAY1,24 H,219.1727576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1539,58RSYC,1-May-22
C1071022,10461007,146,PF-06863135,T,6217133173,6.21713E+11,20211202,11:15,CYCLE1_DAY4,0 H,879.7129401,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1462,54RSYC,30-Apr-22
C1071022,10461007,146,PF-06863135,T,6217133177,6.21713E+11,20211203,11:35,CYCLE1_DAY4,24 H,612.071037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1463,54RSYC,30-Apr-22
C1071022,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,11:00,CYCLE1_DAY1,0 H,855.7632965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1471,54RSYC,30-Apr-22
C1071022,11001005,147,PF-06863135,T,6217163736,6.21716E+11,20211130,17:00,CYCLE1_DAY1,6 H,908.6967805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1470,54RSYC,30-Apr-22
C1071022,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,10:15,CYCLE1_DAY8,0 H,127.701804,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1475,105RSYC,22-May-22
C1071022,11001005,147,PF-06863135,T,6217163741,6.21716E+11,20211206,18:20,CYCLE1_DAY8,6 H,344.9700767,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1474,54RSYC,30-Apr-22
C1071022,11001005,147,PF-06863135,T,6216170950,6.21617E+11,20211213,9:30,CYCLE1_DAY15,0 H,888.689658,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1282,89RSYC,11-May-22
C1071022,11001005,147,PF-06863135,T,6216170953,6.21617E+11,20211220,9:35,CYCLE1_DAY22,0 H,72.04865962,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1789,71RSYC,7-May-22
C1071022,11001005,147,PF-06863135,T,6217163753,6.21716E+11,20211227,9:30,CYCLE2_DAY1,0 H,196.9320068,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1790,71RSYC,7-May-22
C1071022,11001005,147,PF-06863135,T,6217468785,6.21747E+11,20220124,10:30,CYCLE3_DAY1,0 H,932.8486101,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1792,71RSYC,7-May-22
C1071022,11001005,147,PF-06863135,T,6217366245,6.21737E+11,20220222,11:20,CYCLE4_DAY1,0 H,369.8806131,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1791,71RSYC,7-May-22
C1071022,11001005,147,PF-06863135,T,6216170961,6.21617E+11,20220516,11:15,CYCLE7_DAY1,0 H,476.4105935,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2054,132RSYC,10-Nov-22
C1071022,11001005,147,PF-06863135,T,6217183911,6.21718E+11,20220808,11:00,CYCLE10_DAY1,0 H,627.3577829,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2055,132RSYC,10-Nov-22
C1071022,11001005,147,PF-06863135,T,6219556971,6.21956E+11,20221031,13:35,CYCLE13_DAY1,0 H,53.22298364,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2164,140RSYC,22-Mar-23
C1071022,11001005,147,PF-06863135,T,6216170951,6.21617E+11,20211201,11:00,CYCLE1_DAY1,24 H,541.1128373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1283,89RSYC,11-May-22
C1071022,11001005,147,PF-06863135,T,6216170967,6.21617E+11,20211202,15:00,CYCLE1_DAY4,0 H,732.4669344,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1288,84RSYC,10-May-22
C1071022,11001005,147,PF-06863135,T,6217163749,6.21716E+11,20211203,11:00,CYCLE1_DAY4,24 H,148.7298348,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1481,55RSYC,30-Apr-22
C1071022,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,12:00,CYCLE1_DAY1,0 H,179.3506977,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2096,141RSYC,17-May-23
C1071022,10901004,148,PF-06863135,T,6519266723,6.51927E+11,20211130,19:20,CYCLE1_DAY1,6 H,96.72903303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1902,81RSYC,4-May-22
C1071022,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,11:00,CYCLE1_DAY8,0 H,701.164715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 981,66RSYC,3-May-22
C1071022,10901004,148,PF-06863135,T,6517433524,6.51743E+11,20211209,16:30,CYCLE1_DAY8,6 H,170.195079,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 980,66RSYC,3-May-22
C1071022,10901004,148,PF-06863135,T,6518828367,6.51883E+11,20211214,11:20,CYCLE1_DAY15,0 H,163.1980254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1162,108RSYC,24-May-22
C1071022,10901004,148,PF-06863135,T,6517433527,6.51743E+11,20211221,12:50,CYCLE1_DAY22,0 H,641.9049721,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 983,66RSYC,3-May-22
C1071022,10901004,148,PF-06863135,T,6517433530,6.51743E+11,20211228,16:40,CYCLE2_DAY1,0 H,875.9388287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1678,101RSYC,13-May-22
C1071022,10901004,148,PF-06863135,T,6517433532,6.51743E+11,20220125,11:30,CYCLE3_DAY1,0 H,899.5763684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1677,101RSYC,13-May-22
C1071022,10901004,148,PF-06863135,T,6519231707,6.51923E+11,20220222,13:25,CYCLE4_DAY1,0 H,12.42052293,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1679,101RSYC,13-May-22
C1071022,10901004,148,PF-06863135,T,6517433535,6.51743E+11,20220517,11:33,CYCLE7_DAY1,0 H,339.580815,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1964,114RSYC,25-Jul-22
C1071022,10901004,148,PF-06863135,T,6518807251,6.51881E+11,20220809,12:22,CYCLE10_DAY1,0 H,787.0940259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2087,127RSYC,19-Oct-22
C1071022,10901004,148,PF-06863135,T,6518807252,6.51881E+11,20221101,15:00,CYCLE13_DAY1,0 H,496.9498601,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2146,139RSYC,22-Mar-23
C1071022,10901004,148,PF-06863135,T,6522393540,6.52239E+11,20230124,15:45,CYCLE16_DAY1,0 H,221.6370204,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2249,143RSYC,27-Nov-23
C1071022,10901004,148,PF-06863135,T,6522242183,6.52224E+11,20230418,14:00,CYCLE19_DAY1,0 H,677.0112554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2220,142RSYC,18-May-23
C1071022,10901004,148,PF-06863135,T,6522242179,6.52224E+11,20230711,13:05,CYCLE22_DAY1,0 H,965.1166728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2285,145RSYC,4-Jan-24
C1071022,10901004,148,PF-06863135,T,6525460187,6.52546E+11,20240228,13:41,END_OF_TRT,,736.0289764,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2365,152RSYC,9-Apr-24
C1071022,10901004,148,PF-06863135,T,6517433548,6.51743E+11,20211210,11:22,UNPL,9002 H,831.1574843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 986,86RSYC,13-May-22
C1071022,10901004,148,PF-06863135,T,6515447313,6.51545E+11,20211201,13:10,CYCLE1_DAY1,24 H,849.6060042,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1676,109RSYC,25-May-22
C1071022,10901004,148,PF-06863135,T,6517433540,6.51743E+11,20211203,14:55,CYCLE1_DAY4,0 H,903.0816099,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 984,88RSYC,11-May-22
C1071022,10901004,148,PF-06863135,T,6517433542,6.51743E+11,20211204,14:20,CYCLE1_DAY4,24 H,148.259503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 985,66RSYC,3-May-22
C1071022,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,8:00,CYCLE1_DAY1,0 H,503.5682787,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1357,76RSYC,4-May-22
C1071022,10041001,149,PF-06863135,T,6216725194,6.21673E+11,20211201,18:25,CYCLE1_DAY1,6 H,345.2060794,NG/ML,11,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1356,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,7:45,CYCLE1_DAY8,0 H,268.5410605,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1359,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725196,6.21673E+11,20211209,19:40,CYCLE1_DAY8,6 H,688.2704483,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1358,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725199,6.21673E+11,20211216,8:00,CYCLE1_DAY15,0 H,321.2796708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1360,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725200,6.21673E+11,20211223,7:30,CYCLE1_DAY22,0 H,249.5305249,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1361,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725203,6.21673E+11,20211230,9:30,CYCLE2_DAY1,0 H,477.3031531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1737,72RSYC,7-May-22
C1071022,10041001,149,PF-06863135,T,6216725204,6.21673E+11,20220127,9:00,CYCLE3_DAY1,0 H,297.7503017,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1738,90RSYC,11-May-22
C1071022,10041001,149,PF-06863135,T,6216725207,6.21673E+11,20220224,9:35,CYCLE4_DAY1,0 H,45.82092137,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1739,90RSYC,11-May-22
C1071022,10041001,149,PF-06863135,T,6216725208,6.21673E+11,20220519,9:30,CYCLE7_DAY1,0 H,790.9471304,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1993,115RSYC,25-Jul-22
C1071022,10041001,149,PF-06863135,T,6217233005,6.21723E+11,20220811,9:10,CYCLE10_DAY1,0 H,970.5249329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2045,132RSYC,10-Nov-22
C1071022,10041001,149,PF-06863135,T,6216725210,6.21673E+11,20211202,13:30,CYCLE1_DAY1,24 H,596.623103,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1362,84RSYC,10-May-22
C1071022,10041001,149,PF-06863135,T,6216725213,6.21673E+11,20211206,7:05,CYCLE1_DAY4,0 H,974.3192649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1363,84RSYC,10-May-22
C1071022,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,9:14,CYCLE1_DAY1,0 H,752.3022824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1220,87RSYC,13-May-22
C1071022,10161006,150,PF-06863135,T,6518935552,6.51894E+11,20211201,17:42,CYCLE1_DAY1,6 H,645.2382899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1219,87RSYC,13-May-22
C1071022,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,9:35,CYCLE1_DAY8,0 H,192.0142719,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1232,46RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518935560,6.51894E+11,20211208,16:52,CYCLE1_DAY8,6 H,285.7414996,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1231,46RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518935562,6.51894E+11,20211215,10:07,CYCLE1_DAY15,0 H,590.4815795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1233,46RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518935569,6.51894E+11,20211222,10:15,CYCLE1_DAY22,0 H,827.0447328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1235,46RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518972840,6.51897E+11,20211230,10:15,CYCLE2_DAY1,0 H,298.4080886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1604,97RSYC,12-May-22
C1071022,10161006,150,PF-06863135,T,6518935573,6.51894E+11,20211202,11:50,CYCLE1_DAY1,24 H,150.1233233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1237,47RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518981610,6.51898E+11,20211204,10:16,CYCLE1_DAY4,0 H,539.2504982,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1258,47RSYC,28-Apr-22
C1071022,10161006,150,PF-06863135,T,6518935581,6.51894E+11,20211205,11:40,CYCLE1_DAY4,24 H,468.0336362,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1242,47RSYC,28-Apr-22
C1071022,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,16:35,CYCLE1_DAY1,0 H,181.32875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1141,95RSYC,13-May-22
C1071022,10901005,151,PF-06863135,T,6518772457,6.51877E+11,20211202,23:45,CYCLE1_DAY1,6 H,709.8421013,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1140,95RSYC,13-May-22
C1071022,10901005,151,PF-06863135,T,6518877869,6.51888E+11,20211203,17:30,CYCLE1_DAY1,24 H,577.6411041,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1177,104RSYC,22-May-22
C1071022,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,10:55,CYCLE1_DAY1,0 H,917.3447224,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1456,54RSYC,30-Apr-22
C1071022,10461008,152,PF-06863135,T,6217133144,6.21713E+11,20211202,18:32,CYCLE1_DAY1,6 H,75.31498582,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1455,54RSYC,30-Apr-22
C1071022,10461008,152,PF-06863135,T,6217368118,6.21737E+11,20211214,6:00,CYCLE1_DAY15,0 H,159.0590619,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1833,93RSYC,12-May-22
C1071022,10461008,152,PF-06863135,T,6217233424,6.21723E+11,20211221,6:00,CYCLE1_DAY22,0 H,892.0698227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1831,92RSYC,12-May-22
C1071022,10461008,152,PF-06863135,T,6217233428,6.21723E+11,20211228,10:20,CYCLE2_DAY1,0 H,903.2944479,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1832,93RSYC,12-May-22
C1071022,10461008,152,PF-06863135,T,6217142648,6.21714E+11,20220111,12:10,END_OF_TRT,,294.690228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1830,86RSYC,13-May-22
C1071022,10461008,152,PF-06863135,T,6217133170,6.21713E+11,20211203,11:15,CYCLE1_DAY1,24 H,20.59871448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1461,54RSYC,30-Apr-22
C1071022,10461008,152,PF-06863135,T,6217368128,6.21737E+11,20211206,10:54,CYCLE1_DAY4,0 H,543.1824503,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1579,59RSYC,1-May-22
C1071022,10461008,152,PF-06863135,T,6217283552,6.21728E+11,20211207,11:20,CYCLE1_DAY4,24 H,822.5811061,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1567,97RSYC,12-May-22
C1071022,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,11:35,CYCLE1_DAY1,0 H,728.5616909,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1367,76RSYC,4-May-22
C1071022,10921005,153,PF-06863135,T,6216725229,6.21673E+11,20211202,21:55,CYCLE1_DAY1,6 H,522.3761699,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1366,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,11:31,CYCLE1_DAY8,0 H,170.7307143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1369,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6216725231,6.21673E+11,20211210,17:53,CYCLE1_DAY8,6 H,869.0192714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1368,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6217039333,6.21704E+11,20211217,12:46,CYCLE1_DAY15,0 H,258.5455468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1447,54RSYC,30-Apr-22
C1071022,10921005,153,PF-06863135,T,6216725235,6.21673E+11,20211223,16:30,CYCLE1_DAY22,0 H,25.60367301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1371,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6216725236,6.21673E+11,20211230,12:23,CYCLE2_DAY1,0 H,771.0624106,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1753,91RSYC,11-May-22
C1071022,10921005,153,PF-06863135,T,6216725239,6.21673E+11,20220127,12:59,CYCLE3_DAY1,0 H,194.4245655,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1754,91RSYC,11-May-22
C1071022,10921005,153,PF-06863135,T,6217039355,6.21704E+11,20220224,15:50,CYCLE4_DAY1,0 H,669.2007766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1755,91RSYC,11-May-22
C1071022,10921005,153,PF-06863135,T,6217142484,6.21714E+11,20220818,14:30,CYCLE10_DAY1,0 H,159.62899,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2048,132RSYC,10-Nov-22
C1071022,10921005,153,PF-06863135,T,6219074084,6.21907E+11,20221110,11:05,CYCLE13_DAY1,0 H,526.4103104,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2156,140RSYC,22-Mar-23
C1071022,10921005,153,PF-06863135,T,6219074083,6.21907E+11,20230427,13:10,END_OF_TRT,,696.4024345,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2238,143RSYC,27-Nov-23
C1071022,10921005,153,PF-06863135,T,6216725253,6.21673E+11,20211203,12:00,UNPL,9001 H,313.0137864,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1374,108RSYC,24-May-22
C1071022,10921005,153,PF-06863135,T,6216725244,6.21673E+11,20211203,15:20,CYCLE1_DAY1,24 H,263.3862844,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1372,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6216725247,6.21673E+11,20211207,10:35,CYCLE1_DAY4,0 H,56.62690641,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1373,84RSYC,10-May-22
C1071022,10921005,153,PF-06863135,T,6217039367,6.21704E+11,20211208,15:10,CYCLE1_DAY4,24 H,13.88034577,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1450,54RSYC,30-Apr-22
C1071022,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,16:30,CYCLE1_DAY1,0 H,313.9944011,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1542,58RSYC,1-May-22
C1071022,11021013,154,PF-06863135,T,6217233476,6.21723E+11,20211202,23:25,CYCLE1_DAY1,6 H,842.1363642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1541,58RSYC,1-May-22
C1071022,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,15:00,CYCLE1_DAY8,0 H,17.60716946,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1555,58RSYC,1-May-22
C1071022,11021013,154,PF-06863135,T,6217280311,6.21728E+11,20211213,21:35,CYCLE1_DAY8,6 H,507.7030465,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1554,58RSYC,1-May-22
C1071022,11021013,154,PF-06863135,T,6217170437,6.21717E+11,20211220,16:05,CYCLE1_DAY15,0 H,593.6533175,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1497,55RSYC,30-Apr-22
C1071022,11021013,154,PF-06863135,T,6217170451,6.21717E+11,20211227,14:40,CYCLE1_DAY22,0 H,238.7109753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1854,93RSYC,12-May-22
C1071022,11021013,154,PF-06863135,T,6217023834,6.21702E+11,20220103,14:00,CYCLE2_DAY1,0 H,791.4247453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1853,93RSYC,12-May-22
C1071022,11021013,154,PF-06863135,T,6217170474,6.21717E+11,20220131,13:50,CYCLE3_DAY1,0 H,212.8953661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1855,93RSYC,12-May-22
C1071022,11021013,154,PF-06863135,T,6217170489,6.21717E+11,20220228,14:30,CYCLE4_DAY1,0 H,895.8114656,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1883,80RSYC,4-May-22
C1071022,11021013,154,PF-06863135,T,6217656228,6.21766E+11,20220628,13:00,END_OF_TRT,,235.0861209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2043,128RSYC,21-Oct-22
C1071022,11021013,154,PF-06863135,T,6217170507,6.21717E+11,20211203,16:25,CYCLE1_DAY1,24 H,286.5160973,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1512,56RSYC,30-Apr-22
C1071022,11021013,154,PF-06863135,T,6217184365,6.21718E+11,20211208,11:30,CYCLE1_DAY4,24 H,448.5859478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1522,56RSYC,30-Apr-22
C1071022,10151008,155,PF-06863135,T,6518957152,6.51896E+11,20211207,16:37,CYCLE1_DAY1,0 H,474.0697315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1246,87RSYC,13-May-22
C1071022,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,10:06,CYCLE1_DAY8,0 H,80.87011998,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1183,104RSYC,22-May-22
C1071022,10151008,155,PF-06863135,T,6518911699,6.51891E+11,20211215,16:20,CYCLE1_DAY8,6 H,309.237625,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1182,104RSYC,22-May-22
C1071022,10151008,155,PF-06863135,T,6518957154,6.51896E+11,20211221,10:40,CYCLE1_DAY15,0 H,923.8942774,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1248,47RSYC,28-Apr-22
C1071022,10151008,155,PF-06863135,T,6518957156,6.51896E+11,20211228,9:57,CYCLE1_DAY22,0 H,446.4420209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1250,47RSYC,28-Apr-22
C1071022,10151008,155,PF-06863135,T,6518842178,6.51884E+11,20220104,10:40,CYCLE2_DAY1,0 H,432.3890964,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1662,101RSYC,13-May-22
C1071022,10151008,155,PF-06863135,T,6518911726,6.51891E+11,20220201,11:56,CYCLE3_DAY1,0 H,778.5522697,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1663,101RSYC,13-May-22
C1071022,10151008,155,PF-06863135,T,6517560134,6.51756E+11,20220301,9:55,CYCLE4_DAY1,0 H,520.1259662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1898,81RSYC,4-May-22
C1071022,10151008,155,PF-06863135,T,6518957177,6.51896E+11,20220525,9:02,CYCLE7_DAY1,0 H,621.0373576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1986,114RSYC,25-Jul-22
C1071022,10151008,155,PF-06863135,T,6518957179,6.51896E+11,20211208,16:00,CYCLE1_DAY1,24 H,333.2499452,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1254,47RSYC,28-Apr-22
C1071022,10151008,155,PF-06863135,T,6518957181,6.51896E+11,20211210,12:43,CYCLE1_DAY4,0 H,41.00865325,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1256,47RSYC,28-Apr-22
C1071022,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,9:00,CYCLE1_DAY1,0 H,193.9332236,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 946,65RSYC,3-May-22
C1071022,10021004,156,PF-06863135,T,6603529934,6.60353E+11,20211203,17:15,CYCLE1_DAY1,6 H,746.3217678,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 947,65RSYC,3-May-22
C1071022,10021004,156,PF-06863135,T,6603324912,6.60332E+11,20211213,9:15,CYCLE1_DAY8,0 H,540.7351804,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 945,65RSYC,3-May-22
C1071022,10021004,156,PF-06863135,T,6603529937,6.60353E+11,20211220,12:10,CYCLE1_DAY15,0 H,720.448662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 948,65RSYC,3-May-22
C1071022,10021004,156,PF-06863135,T,6603626210,6.60363E+11,20211229,9:38,CYCLE1_DAY22,0 H,798.7313812,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1588,59RSYC,1-May-22
C1071022,10021004,156,PF-06863135,T,6603578696,6.60358E+11,20211204,11:43,CYCLE1_DAY1,24 H,760.4289765,NG/ML,9,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 949,,
C1071022,10021004,156,PF-06863135,T,6603529964,6.60353E+11,20211206,9:40,CYCLE1_DAY4,0 H,363.2380928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1586,59RSYC,1-May-22
C1071022,10021004,156,PF-06863135,T,6603529965,6.60353E+11,20211207,11:45,CYCLE1_DAY4,24 H,240.7742132,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1587,59RSYC,1-May-22
C1071022,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,14:30,CYCLE1_DAY1,0 H,98.66344986,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1334,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725127,6.21673E+11,20211203,21:45,CYCLE1_DAY1,6 H,863.9103754,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1333,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,9:30,CYCLE1_DAY8,0 H,669.7697737,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1336,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725129,6.21673E+11,20211210,17:00,CYCLE1_DAY8,6 H,819.8721171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1335,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725133,6.21673E+11,20211223,11:30,CYCLE1_DAY22,0 H,926.4291636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1337,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725135,6.21673E+11,20211230,13:40,CYCLE2_DAY1,0 H,44.6600883,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1809,92RSYC,12-May-22
C1071022,10971001,157,PF-06863135,T,6216725137,6.21673E+11,20220127,13:45,CYCLE3_DAY1,0 H,542.2522778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1810,92RSYC,12-May-22
C1071022,10971001,157,PF-06863135,T,6216725142,6.21673E+11,20211204,16:30,CYCLE1_DAY1,24 H,373.6189643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1338,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725144,6.21673E+11,20211206,13:00,CYCLE1_DAY4,0 H,183.3614353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1339,50RSYC,29-Apr-22
C1071022,10971001,157,PF-06863135,T,6216725146,6.21673E+11,20211207,15:00,CYCLE1_DAY4,24 H,609.5867798,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1340,50RSYC,29-Apr-22
C1071022,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,9:00,CYCLE1_DAY1,0 H,771.8811754,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1454,54RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6217133142,6.21713E+11,20211206,22:15,CYCLE1_DAY1,6 H,206.7924839,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1453,54RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,9:00,CYCLE1_DAY8,0 H,559.7369303,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1458,54RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6217133145,6.21713E+11,20211213,19:00,CYCLE1_DAY8,6 H,221.9737826,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1457,54RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6216725278,6.21673E+11,20211220,12:00,CYCLE1_DAY15,0 H,804.2020374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1375,84RSYC,10-May-22
C1071022,11041006,158,PF-06863135,T,6216725281,6.21673E+11,20211227,9:35,CYCLE1_DAY22,0 H,988.5807805,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1762,91RSYC,11-May-22
C1071022,11041006,158,PF-06863135,T,6217133155,6.21713E+11,20220103,11:45,CYCLE2_DAY1,0 H,4.388623649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1764,91RSYC,11-May-22
C1071022,11041006,158,PF-06863135,T,6217133161,6.21713E+11,20220131,12:10,CYCLE3_DAY1,0 H,589.537282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1765,91RSYC,11-May-22
C1071022,11041006,158,PF-06863135,T,6216725305,6.21673E+11,20220207,11:29,END_OF_TRT,,909.3493054,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1763,109RSYC,25-May-22
C1071022,11041006,158,PF-06863135,T,6217133169,6.21713E+11,20211207,16:15,CYCLE1_DAY1,24 H,100.1578506,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1460,54RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6216924030,6.21692E+11,20211208,8:15,CYCLE1_DAY4,0 H,893.6604551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1423,57RSYC,30-Apr-22
C1071022,11041006,158,PF-06863135,T,6216924035,6.21692E+11,20211209,17:05,CYCLE1_DAY4,24 H,273.4665484,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1424,57RSYC,30-Apr-22
C1071022,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,11:55,CYCLE1_DAY1,0 H,311.3106961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1365,76RSYC,4-May-22
C1071022,10921004,159,PF-06863135,T,6216725228,6.21673E+11,20211206,18:49,CYCLE1_DAY1,6 H,705.6641945,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1364,84RSYC,10-May-22
C1071022,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,13:16,CYCLE1_DAY8,0 H,705.57556,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1445,96RSYC,12-May-22
C1071022,10921004,159,PF-06863135,T,6217039329,6.21704E+11,20211213,20:33,CYCLE1_DAY8,6 H,379.0856086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1444,96RSYC,12-May-22
C1071022,10921004,159,PF-06863135,T,6217039332,6.21704E+11,20211220,16:07,CYCLE1_DAY15,0 H,103.6278573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1446,54RSYC,30-Apr-22
C1071022,10921004,159,PF-06863135,T,6217039339,6.21704E+11,20211227,15:56,CYCLE1_DAY22,0 H,449.7391843,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1448,54RSYC,30-Apr-22
C1071022,10921004,159,PF-06863135,T,6217039345,6.21704E+11,20220103,16:06,CYCLE2_DAY1,0 H,19.06716852,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1751,91RSYC,11-May-22
C1071022,10921004,159,PF-06863135,T,6217039353,6.21704E+11,20220131,14:55,CYCLE3_DAY1,0 H,299.7518802,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1752,91RSYC,11-May-22
C1071022,10921004,159,PF-06863135,T,6216725259,6.21673E+11,20220216,14:30,END_OF_TRT,,788.5416373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1750,109RSYC,25-May-22
C1071022,10921004,159,PF-06863135,T,6217039371,6.21704E+11,20211207,17:00,UNPL,9001 H,262.5817376,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1451,105RSYC,22-May-22
C1071022,10921004,159,PF-06863135,T,6217039357,6.21704E+11,20211207,12:05,CYCLE1_DAY1,24 H,651.9493639,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1449,54RSYC,30-Apr-22
C1071022,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,12:53,CYCLE1_DAY1,0 H,224.6248218,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1387,95RSYC,13-May-22
C1071022,11301001,160,PF-06863135,T,6216756836,6.21676E+11,20211213,20:19,CYCLE1_DAY1,6 H,544.0594716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1386,95RSYC,13-May-22
C1071022,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211220,17:12,CYCLE1_DAY8,0 H,995.1520111,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1391,95RSYC,13-May-22
C1071022,11301001,160,PF-06863135,T,6216756838,6.21676E+11,20211221,1:00,CYCLE1_DAY8,6 H,468.4436591,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1390,95RSYC,13-May-22
C1071022,11301001,160,PF-06863135,T,6216756840,6.21676E+11,20211228,15:45,CYCLE1_DAY15,0 H,283.4022792,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1864,80RSYC,4-May-22
C1071022,11301001,160,PF-06863135,T,6217347400,6.21735E+11,20220104,14:30,CYCLE1_DAY22,0 H,560.001748,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1865,80RSYC,4-May-22
C1071022,11301001,160,PF-06863135,T,6216756848,6.21676E+11,20211214,14:30,CYCLE1_DAY1,24 H,226.3087568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1394,95RSYC,13-May-22
C1071022,11301001,160,PF-06863135,T,6217347402,6.21735E+11,20211216,13:00,CYCLE1_DAY4,0 H,966.6946213,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1575,59RSYC,1-May-22
C1071022,11301001,160,PF-06863135,T,6217347403,6.21735E+11,20211217,12:57,CYCLE1_DAY4,24 H,519.9644014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1576,97RSYC,12-May-22
C1071022,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,12:00,CYCLE1_DAY1,0 H,138.9572776,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1473,54RSYC,30-Apr-22
C1071022,11001006,161,PF-06863135,T,6217163737,6.21716E+11,20211206,19:00,CYCLE1_DAY1,6 H,513.1560835,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1472,54RSYC,30-Apr-22
C1071022,11001006,161,PF-06863135,T,6217163747,6.21716E+11,20211228,9:30,CYCLE1_DAY22,0 H,697.6043741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1796,71RSYC,7-May-22
C1071022,11001006,161,PF-06863135,T,6216170955,6.21617E+11,20220104,10:00,CYCLE2_DAY1,0 H,578.2638576,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1793,71RSYC,7-May-22
C1071022,11001006,161,PF-06863135,T,6216170956,6.21617E+11,20220201,11:45,CYCLE3_DAY1,0 H,392.5117142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1794,71RSYC,7-May-22
C1071022,11001006,161,PF-06863135,T,6217366241,6.21737E+11,20220301,11:40,CYCLE4_DAY1,0 H,96.53233455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1878,80RSYC,4-May-22
C1071022,11001006,161,PF-06863135,T,6217366226,6.21737E+11,20220104,17:30,UNPL,9002 H,103.0519416,NG/ML,,Visit revised from C1D8,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1797,71RSYC,7-May-22
C1071022,11001006,161,PF-06863135,T,6217183915,6.21718E+11,20211207,13:00,CYCLE1_DAY1,24 H,293.5281174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1518,56RSYC,30-Apr-22
C1071022,11001006,161,PF-06863135,T,6216170966,6.21617E+11,20211209,9:50,CYCLE1_DAY4,0 H,803.4719317,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1795,71RSYC,7-May-22
C1071022,11001006,161,PF-06863135,T,6217183961,6.21718E+11,20211210,12:15,CYCLE1_DAY4,24 H,721.7136398,NG/ML,,Received as 6216170972-08,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1290,87RSYC,13-May-22
C1071022,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,9:10,CYCLE1_DAY1,0 H,203.2398589,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1078,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517769655,6.51777E+11,20211206,18:00,CYCLE1_DAY1,6 H,654.9350961,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1077,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,8:39,CYCLE1_DAY8,0 H,20.18700938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1080,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517769659,6.51777E+11,20211216,16:35,CYCLE1_DAY8,6 H,394.1102516,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1079,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517769665,6.51777E+11,20211223,10:00,CYCLE1_DAY15,0 H,519.9494151,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1081,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517769667,6.51777E+11,20211230,10:20,CYCLE1_DAY22,0 H,253.7531142,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1720,125RSYC,31-Jul-22
C1071022,10981005,162,PF-06863135,T,6517768785,6.51777E+11,20220203,9:07,CYCLE3_DAY1,0 H,40.35264346,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1719,72RSYC,7-May-22
C1071022,10981005,162,PF-06863135,T,6517768788,6.51777E+11,20220303,13:50,CYCLE4_DAY1,0 H,15.35875651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1906,81RSYC,4-May-22
C1071022,10981005,162,PF-06863135,T,6518807320,6.51881E+11,20220817,9:05,CYCLE10_DAY1,0 H,971.1588515,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2091,127RSYC,19-Oct-22
C1071022,10981005,162,PF-06863135,T,6520972523,6.52097E+11,20221108,9:25,CYCLE13_DAY1,0 H,505.1220659,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2147,139RSYC,22-Mar-23
C1071022,10981005,162,PF-06863135,T,6522975588,6.52298E+11,20230404,9:28,END_OF_TRT,,3.337641672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2224,142RSYC,18-May-23
C1071022,10981005,162,PF-06863135,T,6520939738,6.52094E+11,20220531,10:20,UNPL,9001 H,642.548884,NG/ML,,Received as 6517769687-04,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2015,115RSYC,25-Jul-22
C1071022,10981005,162,PF-06863135,T,6517755818,6.51776E+11,20211207,13:55,CYCLE1_DAY1,24 H,208.5576471,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1070,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517755821,6.51776E+11,20211209,6:00,CYCLE1_DAY4,0 H,594.6693259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1071,41RSYC,26-Apr-22
C1071022,10981005,162,PF-06863135,T,6517755825,6.51776E+11,20211210,12:10,CYCLE1_DAY4,24 H,70.4416535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1072,41RSYC,26-Apr-22
C1071022,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,14:20,CYCLE1_DAY1,0 H,768.6030907,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1203,105RSYC,22-May-22
C1071022,10931005,163,PF-06863135,T,6518934226,6.51893E+11,20211206,20:40,CYCLE1_DAY1,6 H,339.6531874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1202,105RSYC,22-May-22
C1071022,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,11:11,CYCLE1_DAY8,0 H,436.8202467,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1205,105RSYC,22-May-22
C1071022,10931005,163,PF-06863135,T,6518934229,6.51893E+11,20211213,17:00,CYCLE1_DAY8,6 H,695.7552741,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1204,105RSYC,22-May-22
C1071022,10931005,163,PF-06863135,T,6518934230,6.51893E+11,20211221,16:27,CYCLE1_DAY15,0 H,956.7511531,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1206,46RSYC,28-Apr-22
C1071022,10931005,163,PF-06863135,T,6518934234,6.51893E+11,20211229,15:00,CYCLE1_DAY22,0 H,207.5687389,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1716,72RSYC,7-May-22
C1071022,10931005,163,PF-06863135,T,6518934237,6.51893E+11,20220104,14:00,CYCLE2_DAY1,0 H,874.5039409,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1715,72RSYC,7-May-22
C1071022,10931005,163,PF-06863135,T,6518778282,6.51878E+11,20220201,15:20,CYCLE3_DAY1,0 H,775.1813647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1711,72RSYC,7-May-22
C1071022,10931005,163,PF-06863135,T,6518934247,6.51893E+11,20220301,14:35,CYCLE4_DAY1,0 H,618.9847836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1905,81RSYC,4-May-22
C1071022,10931005,163,PF-06863135,T,6517472620,6.51747E+11,20220524,15:36,CYCLE7_DAY1,0 H,98.90866285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1970,114RSYC,25-Jul-22
C1071022,10931005,163,PF-06863135,T,6518807286,6.51881E+11,20220816,14:50,CYCLE10_DAY1,0 H,158.0191453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2090,127RSYC,19-Oct-22
C1071022,10931005,163,PF-06863135,T,6521929820,6.52193E+11,20230718,11:50,CYCLE22_DAY1,0 H,254.5971886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2286,148RSYC,27-Mar-24
C1071022,10931005,163,PF-06863135,T,6518934250,6.51893E+11,20211207,14:30,CYCLE1_DAY1,24 H,528.3127053,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1212,87RSYC,13-May-22
C1071022,10931005,163,PF-06863135,T,6518934252,6.51893E+11,20211209,13:51,CYCLE1_DAY4,0 H,325.0355887,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1214,46RSYC,28-Apr-22
C1071022,10931005,163,PF-06863135,T,6518934256,6.51893E+11,20211210,14:10,CYCLE1_DAY4,24 H,272.9005357,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1218,46RSYC,28-Apr-22
C1071022,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,12:55,CYCLE1_DAY1,0 H,576.8350634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1012,39RSYC,26-Apr-22
C1071022,10251002,164,PF-06863135,T,6517559620,6.51756E+11,20211206,19:00,CYCLE1_DAY1,6 H,860.915673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1011,39RSYC,26-Apr-22
C1071022,10251002,164,PF-06863135,T,6517559621,6.51756E+11,20211213,11:35,CYCLE1_DAY8,0 H,934.0277932,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1013,39RSYC,26-Apr-22
C1071022,10251002,164,PF-06863135,T,6515447223,6.51545E+11,20211220,8:45,CYCLE1_DAY15,0 H,760.5132898,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 961,65RSYC,3-May-22
C1071022,10251002,164,PF-06863135,T,6517559625,6.51756E+11,20211227,8:24,CYCLE1_DAY22,0 H,95.18918547,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1015,39RSYC,26-Apr-22
C1071022,10251002,164,PF-06863135,T,6517559628,6.51756E+11,20220103,9:30,CYCLE2_DAY1,0 H,818.6615949,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1669,101RSYC,13-May-22
C1071022,10251002,164,PF-06863135,T,6517559629,6.51756E+11,20220201,8:40,CYCLE3_DAY1,0 H,56.39038636,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1670,101RSYC,13-May-22
C1071022,10251002,164,PF-06863135,T,6517559632,6.51756E+11,20220301,9:20,CYCLE4_DAY1,0 H,571.9446251,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1900,81RSYC,4-May-22
C1071022,10251002,164,PF-06863135,T,6519204947,6.5192E+11,20220524,8:10,CYCLE7_DAY1,0 H,369.5434223,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1988,114RSYC,25-Jul-22
C1071022,10251002,164,PF-06863135,T,6517559641,6.51756E+11,20220816,7:55,CYCLE10_DAY1,0 H,205.9086647,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2085,127RSYC,19-Oct-22
C1071022,10251002,164,PF-06863135,T,6521799628,6.5218E+11,20221108,8:35,CYCLE13_DAY1,0 H,393.4304939,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2148,139RSYC,22-Mar-23
C1071022,10251002,164,PF-06863135,T,6521699573,6.5217E+11,20230505,13:30,CYCLE19_DAY1,0 H,689.7330532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2250,143RSYC,27-Nov-23
C1071022,10251002,164,PF-06863135,T,6521699574,6.5217E+11,20230801,10:50,CYCLE22_DAY1,0 H,344.5987012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2293,145RSYC,4-Jan-24
C1071022,10251002,164,PF-06863135,T,6517559635,6.51756E+11,20211207,13:20,CYCLE1_DAY1,24 H,758.1568933,NG/ML,12; Damaged sample tube,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1018,,
C1071022,10251002,164,PF-06863135,T,6517559638,6.51756E+11,20211209,9:15,CYCLE1_DAY4,0 H,969.2646566,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1019,39RSYC,26-Apr-22
C1071022,10251002,164,PF-06863135,T,6517559640,6.51756E+11,20211210,12:10,CYCLE1_DAY4,24 H,701.9413207,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1020,39RSYC,26-Apr-22
C1071022,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,12:00,CYCLE1_DAY1,0 H,709.8492856,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1431,57RSYC,30-Apr-22
C1071022,10561008,165,PF-06863135,T,6217026117,6.21703E+11,20211207,18:45,CYCLE1_DAY1,6 H,761.8475094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1430,57RSYC,30-Apr-22
C1071022,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,12:20,CYCLE1_DAY8,0 H,904.7623034,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1317,49RSYC,29-Apr-22
C1071022,10561008,165,PF-06863135,T,6216408041,6.21641E+11,20211213,19:15,CYCLE1_DAY8,6 H,408.9258885,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1316,49RSYC,29-Apr-22
C1071022,10561008,165,PF-06863135,T,6216898574,6.2169E+11,20211220,15:35,CYCLE1_DAY15,0 H,23.5272273,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1404,96RSYC,12-May-22
C1071022,10561008,165,PF-06863135,T,6217026145,6.21703E+11,20220103,16:10,CYCLE2_DAY1,0 H,673.8012634,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1782,71RSYC,7-May-22
C1071022,10561008,165,PF-06863135,T,6216898586,6.2169E+11,20220201,9:50,CYCLE3_DAY1,0 H,665.7276469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1780,71RSYC,7-May-22
C1071022,10561008,165,PF-06863135,T,6216898589,6.2169E+11,20220301,10:50,CYCLE4_DAY1,0 H,199.5884192,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1781,71RSYC,7-May-22
C1071022,10561008,165,PF-06863135,T,6216898590,6.2169E+11,20220524,11:30,CYCLE7_DAY1,0 H,819.3766682,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1994,122RSYC,29-Jul-22
C1071022,10561008,165,PF-06863135,T,6216898602,6.2169E+11,20220816,14:30,CYCLE10_DAY1,0 H,170.6637085,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2052,132RSYC,10-Nov-22
C1071022,10561008,165,PF-06863135,T,6218590818,6.21859E+11,20221107,13:30,CYCLE13_DAY1,0 H,209.7204501,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2157,140RSYC,22-Mar-23
C1071022,10561008,165,PF-06863135,T,6219498870,6.2195E+11,20230407,11:00,END_OF_TRT,,213.4401438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2231,142RSYC,18-May-23
C1071022,10561008,165,PF-06863135,T,6216898594,6.2169E+11,20211208,12:45,CYCLE1_DAY1,24 H,372.4656877,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1409,96RSYC,12-May-22
C1071022,10561008,165,PF-06863135,T,6216898597,6.2169E+11,20211210,12:10,CYCLE1_DAY4,0 H,743.6665228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1410,96RSYC,12-May-22
C1071022,10561008,165,PF-06863135,T,6216898599,6.2169E+11,20211211,13:30,CYCLE1_DAY4,24 H,194.5107262,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1411,96RSYC,12-May-22
C1071022,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,16:50,CYCLE1_DAY1,0 H,97.61245193,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1201,105RSYC,22-May-22
C1071022,10931004,166,PF-06863135,T,6518934225,6.51893E+11,20211207,23:04,CYCLE1_DAY1,6 H,522.0777066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1200,105RSYC,22-May-22
C1071022,10931004,166,PF-06863135,T,6518934231,6.51893E+11,20211221,13:50,CYCLE1_DAY15,0 H,167.09504,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1207,46RSYC,28-Apr-22
C1071022,10931004,166,PF-06863135,T,6517472612,6.51747E+11,20211228,13:28,CYCLE1_DAY22,0 H,634.7186494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1003,39RSYC,26-Apr-22
C1071022,10931004,166,PF-06863135,T,6518778285,6.51878E+11,20220524,10:50,CYCLE7_DAY1,0 H,828.842894,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1984,114RSYC,25-Jul-22
C1071022,10931004,166,PF-06863135,T,6518934249,6.51893E+11,20211208,16:55,CYCLE1_DAY1,24 H,898.3666685,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1211,46RSYC,28-Apr-22
C1071022,10931004,166,PF-06863135,T,6518934253,6.51893E+11,20211210,13:00,CYCLE1_DAY4,0 H,766.932388,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1215,46RSYC,28-Apr-22
C1071022,10931004,166,PF-06863135,T,6518934255,6.51893E+11,20211211,12:26,CYCLE1_DAY4,24 H,770.7918396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1217,87RSYC,13-May-22
C1071022,10741003,167,PF-06863135,T,6518693889,6.51869E+11,20211207,12:50,CYCLE1_DAY1,0 H,912.0361037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1127,94RSYC,12-May-22
C1071022,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,10:15,CYCLE1_DAY8,0 H,306.5921162,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1261,47RSYC,28-Apr-22
C1071022,10741003,167,PF-06863135,T,6519029233,6.51903E+11,20211215,17:37,CYCLE1_DAY8,6 H,769.5472595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1260,47RSYC,28-Apr-22
C1071022,10741003,167,PF-06863135,T,6519029234,6.51903E+11,20211223,8:48,CYCLE1_DAY15,0 H,437.4930529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1262,47RSYC,28-Apr-22
C1071022,10741003,167,PF-06863135,T,6518693895,6.51869E+11,20211228,10:00,CYCLE1_DAY22,0 H,312.4191486,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1129,94RSYC,12-May-22
C1071022,10741003,167,PF-06863135,T,6518988295,6.51899E+11,20220105,17:00,CYCLE2_DAY1,0 H,663.2135976,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1658,109RSYC,25-May-22
C1071022,10741003,167,PF-06863135,T,6519123788,6.51912E+11,20220202,11:38,CYCLE3_DAY1,0 H,356.3523734,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1659,109RSYC,25-May-22
C1071022,10741003,167,PF-06863135,T,6517472587,6.51747E+11,20220302,13:41,CYCLE4_DAY1,0 H,846.7112383,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1897,81RSYC,4-May-22
C1071022,10741003,167,PF-06863135,T,6517472589,6.51747E+11,20220525,13:01,CYCLE7_DAY1,0 H,237.4620563,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2014,122RSYC,29-Jul-22
C1071022,10741003,167,PF-06863135,T,6520917900,6.52092E+11,20221122,12:40,CYCLE13_DAY1,0 H,30.04203778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2134,139RSYC,22-Mar-23
C1071022,10741003,167,PF-06863135,T,6520917901,6.52092E+11,20230215,13:04,CYCLE16_DAY1,0 H,724.8124012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2196,141RSYC,17-May-23
C1071022,10741003,167,PF-06863135,T,6522652197,6.52265E+11,20230517,13:12,CYCLE19_DAY1,0 H,778.1422608,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2251,145RSYC,4-Jan-24
C1071022,10741003,167,PF-06863135,T,6522652198,6.52265E+11,20230816,12:35,CYCLE22_DAY1,0 H,5.723254728,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2302,147RSYC,29-Feb-24
C1071022,10741003,167,PF-06863135,T,6523537652,6.52354E+11,20231108,13:15,CYCLE25_DAY1,0 H,372.3075031,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2333,149RSYC,27-Mar-24
C1071022,10741003,167,PF-06863135,T,6524974340,6.52497E+11,20240207,13:33,CYCLE28_DAY1,0 H,491.4510163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2358,148RSYC,27-Mar-24
C1071022,10741003,167,PF-06863135,T,6518807209,6.51881E+11,20220824,11:10,UNPL,9001 H,476.8642754,NG/ML,,Visit revised from C10D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2084,129RSYC,21-Oct-22
C1071022,10741003,167,PF-06863135,T,6517472592,6.51747E+11,20211210,7:45,CYCLE1_DAY4,0 H,687.3829596,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1000,39RSYC,26-Apr-22
C1071022,10741003,167,PF-06863135,T,6519029241,6.51903E+11,20211211,10:25,CYCLE1_DAY4,24 H,49.8506981,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1266,89RSYC,11-May-22
C1071022,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,11:00,CYCLE1_DAY1,0 H,263.8931453,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1415,96RSYC,12-May-22
C1071022,11041007,168,PF-06863135,T,6216923988,6.21692E+11,20211209,21:15,CYCLE1_DAY1,6 H,694.4414384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1414,96RSYC,12-May-22
C1071022,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,14:00,CYCLE1_DAY8,0 H,310.5819209,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1417,57RSYC,30-Apr-22
C1071022,11041007,168,PF-06863135,T,6216923992,6.21692E+11,20211220,21:20,CYCLE1_DAY8,6 H,101.587484,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1416,57RSYC,30-Apr-22
C1071022,11041007,168,PF-06863135,T,6217338965,6.21734E+11,20220106,14:50,CYCLE1_DAY22,0 H,561.07746,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1769,71RSYC,7-May-22
C1071022,11041007,168,PF-06863135,T,6216725282,6.21673E+11,20220112,14:45,CYCLE2_DAY1,0 H,167.5758831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1766,91RSYC,11-May-22
C1071022,11041007,168,PF-06863135,T,6216924016,6.21692E+11,20220208,12:46,CYCLE3_DAY1,0 H,999.8911963,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1767,91RSYC,11-May-22
C1071022,11041007,168,PF-06863135,T,6216924019,6.21692E+11,20220310,14:45,CYCLE4_DAY1,0 H,47.56692037,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1908,123RSYC,29-Jul-22
C1071022,11041007,168,PF-06863135,T,6217133181,6.21713E+11,20220317,15:15,END_OF_TRT,,895.6041469,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1909,120RSYC,28-Jul-22
C1071022,11041007,168,PF-06863135,T,6216924025,6.21692E+11,20211210,15:15,CYCLE1_DAY1,24 H,140.3285004,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1422,57RSYC,30-Apr-22
C1071022,11041007,168,PF-06863135,T,6217133176,6.21713E+11,20211215,14:30,CYCLE1_DAY4,0 H,865.6491708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1768,71RSYC,7-May-22
C1071022,11041007,168,PF-06863135,T,6217133178,6.21713E+11,20211216,15:30,CYCLE1_DAY4,24 H,427.9140167,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1464,54RSYC,30-Apr-22
C1071022,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,11:25,CYCLE1_DAY1,0 H,391.2447913,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1035,40RSYC,26-Apr-22
C1071022,10321005,169,PF-06863135,T,6517559952,6.51756E+11,20211209,17:30,CYCLE1_DAY1,6 H,60.79774455,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1034,66RSYC,3-May-22
C1071022,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,10:06,CYCLE1_DAY8,0 H,78.20001339,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1037,40RSYC,26-Apr-22
C1071022,10321005,169,PF-06863135,T,6517559953,6.51756E+11,20211216,17:27,CYCLE1_DAY8,6 H,777.3377355,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1036,40RSYC,26-Apr-22
C1071022,10321005,169,PF-06863135,T,6517509075,6.51751E+11,20211222,14:52,CYCLE1_DAY15,0 H,721.4375527,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1009,66RSYC,3-May-22
C1071022,10321005,169,PF-06863135,T,6517509076,6.51751E+11,20211229,14:37,CYCLE1_DAY22,0 H,768.0262554,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1633,85RSYC,10-May-22
C1071022,10321005,169,PF-06863135,T,6517509079,6.51751E+11,20220106,13:29,CYCLE2_DAY1,0 H,118.156551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1634,100RSYC,23-May-22
C1071022,10321005,169,PF-06863135,T,6517509091,6.51751E+11,20220111,1:14,END_OF_TRT,,734.4622384,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1635,100RSYC,23-May-22
C1071022,10321005,169,PF-06863135,T,6517559967,6.51756E+11,20211210,11:35,CYCLE1_DAY1,24 H,88.44930149,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1044,107RSYC,24-May-22
C1071022,10321005,169,PF-06863135,T,6517509085,6.51751E+11,20211212,9:05,CYCLE1_DAY4,0 H,432.0113514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1010,39RSYC,26-Apr-22
C1071022,10321005,169,PF-06863135,T,6517559972,6.51756E+11,20211213,10:04,CYCLE1_DAY4,24 H,893.4395683,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1048,66RSYC,3-May-22
C1071022,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,13:15,CYCLE1_DAY1,0 H,255.9477745,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1342,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725160,6.21673E+11,20211209,19:15,CYCLE1_DAY1,6 H,167.1231917,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1341,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725162,6.21673E+11,20211217,12:00,CYCLE1_DAY8,0 H,615.9154854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1345,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725164,6.21673E+11,20211223,10:00,CYCLE1_DAY15,0 H,656.1806008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1348,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725166,6.21673E+11,20211231,10:30,CYCLE1_DAY22,0 H,28.58261494,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1743,90RSYC,11-May-22
C1071022,10051002,170,PF-06863135,T,6216725168,6.21673E+11,20220110,10:00,CYCLE2_DAY1,0 H,744.7112315,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1744,90RSYC,11-May-22
C1071022,10051002,170,PF-06863135,T,6216725183,6.21673E+11,20220211,7:00,CYCLE3_DAY1,0 H,313.6405698,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1745,90RSYC,11-May-22
C1071022,10051002,170,PF-06863135,T,6217930297,6.21793E+11,20220311,10:00,CYCLE4_DAY1,0 H,331.6751443,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1875,80RSYC,4-May-22
C1071022,10051002,170,PF-06863135,T,6217930300,6.21793E+11,20220606,12:00,CYCLE7_DAY1,0 H,851.8230082,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2018,115RSYC,25-Jul-22
C1071022,10051002,170,PF-06863135,T,6217309164,6.21731E+11,20220901,13:00,CYCLE10_DAY1,0 H,954.5994543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2047,132RSYC,10-Nov-22
C1071022,10051002,170,PF-06863135,T,6219609252,6.21961E+11,20221116,9:40,END_OF_TRT,,900.5959573,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2158,140RSYC,22-Mar-23
C1071022,10051002,170,PF-06863135,T,6216725176,6.21673E+11,20211210,13:20,CYCLE1_DAY1,24 H,835.8405328,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1350,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725178,6.21673E+11,20211213,11:00,CYCLE1_DAY4,0 H,407.124539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1352,50RSYC,29-Apr-22
C1071022,10051002,170,PF-06863135,T,6216725181,6.21673E+11,20211214,12:05,CYCLE1_DAY4,24 H,703.570159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1355,50RSYC,29-Apr-22
C1071022,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,10:00,CYCLE1_DAY1,0 H,609.0653444,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1571,59RSYC,1-May-22
C1071022,11021012,171,PF-06863135,T,6217283562,6.21728E+11,20211209,23:05,CYCLE1_DAY1,6 H,794.0514509,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1570,59RSYC,1-May-22
C1071022,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,17:20,CYCLE1_DAY8,0 H,519.0591144,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1551,58RSYC,1-May-22
C1071022,11021012,171,PF-06863135,T,6217280300,6.21728E+11,20211220,23:20,CYCLE1_DAY8,6 H,217.6260684,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1550,58RSYC,1-May-22
C1071022,11021012,171,PF-06863135,T,6217023833,6.21702E+11,20211227,13:55,CYCLE1_DAY15,0 H,1.527490519,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1850,93RSYC,12-May-22
C1071022,11021012,171,PF-06863135,T,6217170444,6.21717E+11,20220103,14:00,CYCLE1_DAY22,0 H,897.8932358,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1851,93RSYC,12-May-22
C1071022,11021012,171,PF-06863135,T,6216756808,6.21676E+11,20220110,16:05,CYCLE2_DAY1,0 H,311.4427649,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1849,93RSYC,12-May-22
C1071022,11021012,171,PF-06863135,T,6217170473,6.21717E+11,20220207,13:30,CYCLE3_DAY1,0 H,725.6224584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1852,93RSYC,12-May-22
C1071022,11021012,171,PF-06863135,T,6217170483,6.21717E+11,20220307,13:45,CYCLE4_DAY1,0 H,274.4402324,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1882,80RSYC,4-May-22
C1071022,11021012,171,PF-06863135,T,6217170498,6.21717E+11,20220530,13:45,CYCLE7_DAY1,0 H,670.3377733,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2021,115RSYC,25-Jul-22
C1071022,11021012,171,PF-06863135,T,6217142670,6.21714E+11,20220823,14:00,CYCLE10_DAY1,0 H,351.4900763,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2065,132RSYC,10-Nov-22
C1071022,11021012,171,PF-06863135,T,6218384025,6.21838E+11,20221114,14:30,CYCLE13_DAY1,0 H,234.9171514,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2165,140RSYC,22-Mar-23
C1071022,11021012,171,PF-06863135,T,6219958816,6.21996E+11,20230206,14:30,CYCLE16_DAY1,0 H,73.46296854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2211,142RSYC,18-May-23
C1071022,11021012,171,PF-06863135,T,6219958823,6.21996E+11,20230406,16:00,END_OF_TRT,,459.5111492,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2233,142RSYC,18-May-23
C1071022,11021012,171,PF-06863135,T,6217170503,6.21717E+11,20211210,17:00,CYCLE1_DAY1,24 H,116.5265746,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1510,56RSYC,30-Apr-22
C1071022,11021012,171,PF-06863135,T,6217280324,6.21728E+11,20211214,11:00,CYCLE1_DAY4,0 H,587.7500911,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1558,58RSYC,1-May-22
C1071022,11021012,171,PF-06863135,T,6217280337,6.21728E+11,20211215,17:40,CYCLE1_DAY4,24 H,643.8004391,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1560,58RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,10:00,CYCLE1_DAY1,0 H,779.7946482,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1578,59RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6217360199,6.21736E+11,20211209,23:30,CYCLE1_DAY1,6 H,373.1410535,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1577,59RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,17:15,CYCLE1_DAY8,0 H,486.2412296,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1553,58RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6217280308,6.21728E+11,20211220,23:15,CYCLE1_DAY8,6 H,373.3222884,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1552,58RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6216756803,6.21676E+11,20211227,14:20,CYCLE1_DAY15,0 H,153.1994314,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1860,80RSYC,4-May-22
C1071022,11021015,172,PF-06863135,T,6216756806,6.21676E+11,20220104,15:30,CYCLE1_DAY22,0 H,637.6980144,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1861,80RSYC,4-May-22
C1071022,11021015,172,PF-06863135,T,6217170455,6.21717E+11,20220111,15:50,CYCLE2_DAY1,0 H,788.8457568,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1863,80RSYC,4-May-22
C1071022,11021015,172,PF-06863135,T,6217023848,6.21702E+11,20220211,13:10,CYCLE3_DAY1,0 H,410.5635199,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1862,80RSYC,4-May-22
C1071022,11021015,172,PF-06863135,T,6217170491,6.21717E+11,20220311,15:40,CYCLE4_DAY1,0 H,73.31281863,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1910,123RSYC,29-Jul-22
C1071022,11021015,172,PF-06863135,T,6217170496,6.21717E+11,20220603,14:00,CYCLE7_DAY1,0 H,813.4635146,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2023,115RSYC,25-Jul-22
C1071022,11021015,172,PF-06863135,T,6217142671,6.21714E+11,20220826,17:00,CYCLE10_DAY1,0 H,886.9142208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2106,131RSYC,9-Nov-22
C1071022,11021015,172,PF-06863135,T,6219958815,6.21996E+11,20230210,12:50,CYCLE16_DAY1,0 H,104.566301,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2197,141RSYC,17-May-23
C1071022,11021015,172,PF-06863135,T,6219265231,6.21927E+11,20230509,15:00,CYCLE19_DAY1,0 H,876.7849373,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2242,143RSYC,27-Nov-23
C1071022,11021015,172,PF-06863135,T,6221060211,6.22106E+11,20230731,14:47,CYCLE22_DAY1,0 H,324.494232,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2295,145RSYC,4-Jan-24
C1071022,11021015,172,PF-06863135,T,6221060212,6.22106E+11,20231023,15:30,CYCLE25_DAY1,0 H,793.7540109,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2319,147RSYC,29-Feb-24
C1071022,11021015,172,PF-06863135,T,6217170510,6.21717E+11,20211210,17:30,CYCLE1_DAY1,24 H,156.5815399,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1514,56RSYC,30-Apr-22
C1071022,11021015,172,PF-06863135,T,6217280322,6.21728E+11,20211214,10:15,CYCLE1_DAY4,0 H,73.82474353,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1557,58RSYC,1-May-22
C1071022,11021015,172,PF-06863135,T,6217233482,6.21723E+11,20211215,18:00,CYCLE1_DAY4,24 H,231.533323,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1546,58RSYC,1-May-22
C1071022,10151009,173,PF-06863135,T,6518957151,6.51896E+11,20211214,13:00,CYCLE1_DAY1,0 H,992.7499778,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1245,87RSYC,13-May-22
C1071022,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,9:45,CYCLE1_DAY8,0 H,244.4567163,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1185,104RSYC,22-May-22
C1071022,10151009,173,PF-06863135,T,6518911700,6.51891E+11,20211221,16:28,CYCLE1_DAY8,6 H,618.4032172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1184,104RSYC,22-May-22
C1071022,10151009,173,PF-06863135,T,6518911704,6.51891E+11,20211228,10:33,CYCLE1_DAY15,0 H,963.762715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1188,104RSYC,22-May-22
C1071022,10151009,173,PF-06863135,T,6518911712,6.51891E+11,20220104,10:13,CYCLE1_DAY22,0 H,120.7736747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1665,101RSYC,13-May-22
C1071022,10151009,173,PF-06863135,T,6518911713,6.51891E+11,20220111,12:40,CYCLE2_DAY1,0 H,425.5093814,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1666,101RSYC,13-May-22
C1071022,10151009,173,PF-06863135,T,6518842179,6.51884E+11,20220208,11:35,CYCLE3_DAY1,0 H,723.6654796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1664,101RSYC,13-May-22
C1071022,10151009,173,PF-06863135,T,6518957171,6.51896E+11,20220308,11:45,CYCLE4_DAY1,0 H,854.2044008,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1899,81RSYC,4-May-22
C1071022,10151009,173,PF-06863135,T,6521544921,6.52154E+11,20230718,12:30,UNPL,9001 H,45.66751667,NG/ML,,Visit revised from C22D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2287,148RSYC,27-Mar-24
C1071022,10151009,173,PF-06863135,T,6518957178,6.51896E+11,20211215,15:02,CYCLE1_DAY1,24 H,745.3719875,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1253,47RSYC,28-Apr-22
C1071022,10151009,173,PF-06863135,T,6518957180,6.51896E+11,20211217,11:35,CYCLE1_DAY4,0 H,150.7456468,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1255,47RSYC,28-Apr-22
C1071022,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,11:00,CYCLE1_DAY1,0 H,176.1948955,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1170,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6518877855,6.51888E+11,20211210,17:50,CYCLE1_DAY1,6 H,718.9390668,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1169,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,13:00,CYCLE1_DAY8,0 H,371.5148151,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1174,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6518877858,6.51888E+11,20211217,19:00,CYCLE1_DAY8,6 H,627.0917801,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1173,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6517433525,6.51743E+11,20211223,11:28,CYCLE1_DAY15,0 H,126.2317285,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 982,66RSYC,3-May-22
C1071022,10901007,174,PF-06863135,T,6518828368,6.51883E+11,20211230,14:57,CYCLE1_DAY22,0 H,31.47032174,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1680,101RSYC,13-May-22
C1071022,10901007,174,PF-06863135,T,6519019919,6.51902E+11,20220203,11:21,CYCLE3_DAY1,0 H,726.2228505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1681,101RSYC,13-May-22
C1071022,10901007,174,PF-06863135,T,6517433533,6.51743E+11,20220303,12:10,CYCLE4_DAY1,0 H,608.6269635,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1903,81RSYC,4-May-22
C1071022,10901007,174,PF-06863135,T,6518807250,6.51881E+11,20220818,10:16,CYCLE10_DAY1,0 H,512.244333,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2088,127RSYC,19-Oct-22
C1071022,10901007,174,PF-06863135,T,6518877868,6.51888E+11,20211211,11:50,CYCLE1_DAY1,24 H,834.0426266,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1176,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6518877870,6.51888E+11,20211213,15:05,CYCLE1_DAY4,0 H,797.773096,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1178,104RSYC,22-May-22
C1071022,10901007,174,PF-06863135,T,6518805056,6.51881E+11,20211214,15:10,CYCLE1_DAY4,24 H,588.0147066,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1160,108RSYC,24-May-22
C1071022,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,14:30,CYCLE1_DAY1,0 H,523.8414319,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1484,55RSYC,30-Apr-22
C1071022,11061006,175,PF-06863135,T,6217165064,6.21717E+11,20211213,20:00,CYCLE1_DAY1,6 H,860.9522655,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1483,55RSYC,30-Apr-22
C1071022,11061006,175,PF-06863135,T,6217356187,6.21736E+11,20211220,9:00,CYCLE1_DAY8,0 H,644.363122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1808,92RSYC,12-May-22
C1071022,11061006,175,PF-06863135,T,6217193491,6.21719E+11,20211227,10:00,CYCLE1_DAY15,0 H,953.2816926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1805,92RSYC,12-May-22
C1071022,11061006,175,PF-06863135,T,6217193500,6.21719E+11,20220103,10:00,CYCLE1_DAY22,0 H,849.9436448,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1806,92RSYC,12-May-22
C1071022,11061006,175,PF-06863135,T,6217165067,6.21717E+11,20220124,8:00,END_OF_TRT,,893.0059045,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1804,86RSYC,13-May-22
C1071022,11061006,175,PF-06863135,T,6217193534,6.21719E+11,20211214,9:00,CYCLE1_DAY1,24 H,220.385893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1530,56RSYC,30-Apr-22
C1071022,11061006,175,PF-06863135,T,6217266048,6.21727E+11,20211217,16:00,CYCLE1_DAY4,24 H,323.2601559,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1807,92RSYC,12-May-22
C1071022,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,16:30,CYCLE1_DAY1,0 H,428.968953,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1868,80RSYC,4-May-22
C1071022,11301002,176,PF-06863135,T,6217347397,6.21735E+11,20211213,23:00,CYCLE1_DAY1,6 H,986.1202938,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1867,80RSYC,4-May-22
C1071022,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,16:20,CYCLE1_DAY8,0 H,50.38241677,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1573,59RSYC,1-May-22
C1071022,11301002,176,PF-06863135,T,6217347398,6.21735E+11,20211220,23:00,CYCLE1_DAY8,6 H,72.23501838,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1572,59RSYC,1-May-22
C1071022,11301002,176,PF-06863135,T,6217347399,6.21735E+11,20211228,14:45,CYCLE1_DAY15,0 H,109.212491,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1866,80RSYC,4-May-22
C1071022,11301002,176,PF-06863135,T,6217347401,6.21735E+11,20211214,16:55,CYCLE1_DAY1,24 H,778.3408768,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1574,59RSYC,1-May-22
C1071022,11301002,176,PF-06863135,T,6216756850,6.21676E+11,20211216,16:30,CYCLE1_DAY4,0 H,567.4822753,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1396,95RSYC,13-May-22
C1071022,11301002,176,PF-06863135,T,6216756853,6.21676E+11,20211217,16:55,CYCLE1_DAY4,24 H,878.3047611,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1399,95RSYC,13-May-22
C1071022,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,10:59,CYCLE1_DAY1,0 H,383.1114609,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1224,87RSYC,13-May-22
C1071022,10161007,177,PF-06863135,T,6518935554,6.51894E+11,20211213,18:30,CYCLE1_DAY1,6 H,236.1661766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1223,46RSYC,28-Apr-22
C1071022,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,9:43,CYCLE1_DAY8,0 H,664.9500402,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1228,46RSYC,28-Apr-22
C1071022,10161007,177,PF-06863135,T,6518935557,6.51894E+11,20211221,16:07,CYCLE1_DAY8,6 H,916.2930086,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1227,46RSYC,28-Apr-22
C1071022,10161007,177,PF-06863135,T,6518935564,6.51894E+11,20211228,8:58,CYCLE1_DAY15,0 H,193.2998253,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1607,97RSYC,12-May-22
C1071022,10161007,177,PF-06863135,T,6518935567,6.51894E+11,20220103,10:15,CYCLE1_DAY22,0 H,208.6610189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1608,97RSYC,12-May-22
C1071022,10161007,177,PF-06863135,T,6519158770,6.51916E+11,20220110,9:30,CYCLE2_DAY1,0 H,649.5457621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1609,97RSYC,12-May-22
C1071022,10161007,177,PF-06863135,T,6517697451,6.5177E+11,20220207,10:10,CYCLE3_DAY1,0 H,812.9225788,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1606,97RSYC,12-May-22
C1071022,10161007,177,PF-06863135,T,6518914774,6.51891E+11,20220308,15:11,END_OF_TRT,,487.8616539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1889,87RSYC,13-May-22
C1071022,10161007,177,PF-06863135,T,6518935576,6.51894E+11,20211214,12:44,CYCLE1_DAY1,24 H,817.4214595,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1239,47RSYC,28-Apr-22
C1071022,10161007,177,PF-06863135,T,6518972843,6.51897E+11,20211216,12:10,CYCLE1_DAY4,0 H,833.7167071,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1257,47RSYC,28-Apr-22
C1071022,10161007,177,PF-06863135,T,6518935577,6.51894E+11,20211217,13:06,CYCLE1_DAY4,24 H,467.3595505,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1240,47RSYC,28-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,9:10,CYCLE1_DAY1,0 H,789.1397424,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1033,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559951,6.51756E+11,20211214,18:48,CYCLE1_DAY1,6 H,784.9006287,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1032,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,9:08,CYCLE1_DAY8,0 H,568.5079404,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1039,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559954,6.51756E+11,20211221,18:09,CYCLE1_DAY8,6 H,434.9275368,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1038,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559956,6.51756E+11,20211227,15:30,CYCLE1_DAY15,0 H,154.8585853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1041,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559958,6.51756E+11,20220103,14:48,CYCLE1_DAY22,0 H,621.9639246,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1636,85RSYC,10-May-22
C1071022,10321004,178,PF-06863135,T,6517559959,6.51756E+11,20220110,13:55,CYCLE2_DAY1,0 H,265.0930075,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1637,85RSYC,10-May-22
C1071022,10321004,178,PF-06863135,T,6519136785,6.51914E+11,20220207,14:33,CYCLE3_DAY1,0 H,2.09594952,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1638,85RSYC,10-May-22
C1071022,10321004,178,PF-06863135,T,6518150045,6.51815E+11,20220307,11:56,CYCLE4_DAY1,0 H,774.1760122,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1895,81RSYC,4-May-22
C1071022,10321004,178,PF-06863135,T,6517559981,6.51756E+11,20220502,12:56,END_OF_TRT,,826.4988216,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1979,114RSYC,25-Jul-22
C1071022,10321004,178,PF-06863135,T,6517559968,6.51756E+11,20211215,12:58,CYCLE1_DAY1,24 H,942.1409824,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1045,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559970,6.51756E+11,20211217,9:36,CYCLE1_DAY4,0 H,994.3155661,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1046,40RSYC,26-Apr-22
C1071022,10321004,178,PF-06863135,T,6517559971,6.51756E+11,20211218,13:08,CYCLE1_DAY4,24 H,79.76118187,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1047,40RSYC,26-Apr-22
C1071022,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,10:00,CYCLE1_DAY1,0 H,61.03526795,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1569,59RSYC,1-May-22
C1071022,11021014,179,PF-06863135,T,6217283561,6.21728E+11,20211214,23:20,CYCLE1_DAY1,6 H,843.4950997,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1568,110RSYC,25-May-22
C1071022,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,963.9329047,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2022,122RSYC,29-Jul-22
C1071022,11021014,179,PF-06863135,T,6217280306,6.21728E+11,20211223,23:30,CYCLE1_DAY8,6 H,52.92397259,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1859,80RSYC,4-May-22
C1071022,11021014,179,PF-06863135,T,6217170442,6.21717E+11,20211230,13:40,CYCLE1_DAY15,0 H,723.5495028,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1857,93RSYC,12-May-22
C1071022,11021014,179,PF-06863135,T,6217136147,6.21714E+11,20220106,13:45,CYCLE1_DAY22,0 H,549.9558326,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1856,93RSYC,12-May-22
C1071022,11021014,179,PF-06863135,T,6217170454,6.21717E+11,20220113,14:00,CYCLE2_DAY1,0 H,785.8195147,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1858,80RSYC,4-May-22
C1071022,11021014,179,PF-06863135,T,6217170497,6.21717E+11,20220602,16:30,CYCLE7_DAY1,0 H,275.0900133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2044,128RSYC,21-Oct-22
C1071022,11021014,179,PF-06863135,T,6217004156,6.217E+11,20220825,13:44,CYCLE10_DAY1,0 H,525.5091275,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2105,134RSYC,11-Nov-22
C1071022,11021014,179,PF-06863135,T,6218384028,6.21838E+11,20221124,15:40,CYCLE13_DAY1,0 H,312.5682172,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2166,140RSYC,22-Mar-23
C1071022,11021014,179,PF-06863135,T,6219958819,6.21996E+11,20230216,14:50,CYCLE16_DAY1,0 H,567.7218438,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2198,141RSYC,17-May-23
C1071022,11021014,179,PF-06863135,T,6219265228,6.21927E+11,20230511,14:22,CYCLE19_DAY1,0 H,428.1352687,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2241,143RSYC,27-Nov-23
C1071022,11021014,179,PF-06863135,T,6221060210,6.22106E+11,20230817,13:59,CYCLE22_DAY1,0 H,380.1914254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2296,145RSYC,4-Jan-24
C1071022,11021014,179,PF-06863135,T,6221060209,6.22106E+11,20231109,15:00,CYCLE25_DAY1,0 H,558.3749297,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2353,150RSYC,28-Mar-24
C1071022,11021014,179,PF-06863135,T,6221060215,6.22106E+11,20240201,15:15,CYCLE28_DAY1,0 H,372.093447,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2362,152RSYC,9-Apr-24
C1071022,11021014,179,PF-06863135,T,6217170508,6.21717E+11,20211215,17:20,CYCLE1_DAY1,24 H,603.8530775,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1513,56RSYC,30-Apr-22
C1071022,11021014,179,PF-06863135,T,6217023852,6.21702E+11,20211220,17:25,CYCLE1_DAY4,0 H,261.1661397,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1429,57RSYC,30-Apr-22
C1071022,11021014,179,PF-06863135,T,6217280336,6.21728E+11,20211221,17:25,CYCLE1_DAY4,24 H,826.3772317,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1559,97RSYC,12-May-22
C1071022,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211214,17:25,CYCLE1_DAY1,0 H,924.575965,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1155,107RSYC,24-May-22
C1071022,10901009,180,PF-06863135,T,6518805047,6.51881E+11,20211215,0:40,CYCLE1_DAY1,6 H,19.58790254,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1154,107RSYC,24-May-22
C1071022,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,10:40,CYCLE1_DAY8,0 H,993.9769539,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1159,108RSYC,24-May-22
C1071022,10901009,180,PF-06863135,T,6518805051,6.51881E+11,20211220,16:04,CYCLE1_DAY8,6 H,689.8153621,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1158,108RSYC,24-May-22
C1071022,10901009,180,PF-06863135,T,6518883085,6.51888E+11,20211228,10:02,CYCLE1_DAY15,0 H,799.0734846,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1181,104RSYC,22-May-22
C1071022,10901009,180,PF-06863135,T,6518877863,6.51888E+11,20220104,9:47,CYCLE1_DAY22,0 H,865.3835084,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1693,106RSYC,23-May-22
C1071022,10901009,180,PF-06863135,T,6517433529,6.51743E+11,20220111,11:59,CYCLE2_DAY1,0 H,751.1909487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1692,106RSYC,23-May-22
C1071022,10901009,180,PF-06863135,T,6518877872,6.51888E+11,20211217,8:40,CYCLE1_DAY4,0 H,263.8250012,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1179,104RSYC,22-May-22
C1071022,10901009,180,PF-06863135,T,6518805057,6.51881E+11,20211218,10:32,CYCLE1_DAY4,24 H,293.2385228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1161,108RSYC,24-May-22
C1071022,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,10:30,CYCLE1_DAY1,0 H,17.41129171,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1581,59RSYC,1-May-22
C1071022,11021011,181,PF-06863135,T,6217417530,6.21742E+11,20211215,22:00,CYCLE1_DAY1,6 H,487.2413614,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1580,59RSYC,1-May-22
C1071022,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211223,17:00,CYCLE1_DAY8,0 H,768.5742143,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2020,122RSYC,29-Jul-22
C1071022,11021011,181,PF-06863135,T,6217280305,6.21728E+11,20211224,0:00,CYCLE1_DAY8,6 H,853.8427021,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1848,93RSYC,12-May-22
C1071022,11021011,181,PF-06863135,T,6216756804,6.21676E+11,20211230,15:25,CYCLE1_DAY15,0 H,935.4265783,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1844,93RSYC,12-May-22
C1071022,11021011,181,PF-06863135,T,6217136145,6.21714E+11,20220106,14:20,CYCLE1_DAY22,0 H,623.8895716,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1845,93RSYC,12-May-22
C1071022,11021011,181,PF-06863135,T,6217170458,6.21717E+11,20220113,11:20,CYCLE2_DAY1,0 H,739.5074496,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1846,93RSYC,12-May-22
C1071022,11021011,181,PF-06863135,T,6217170475,6.21717E+11,20220210,13:30,CYCLE3_DAY1,0 H,885.4269708,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1847,93RSYC,12-May-22
C1071022,11021011,181,PF-06863135,T,6217170487,6.21717E+11,20220310,15:15,CYCLE4_DAY1,0 H,556.8792227,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1911,123RSYC,29-Jul-22
C1071022,11021011,181,PF-06863135,T,6217170500,6.21717E+11,20220609,15:50,CYCLE7_DAY1,0 H,905.1591919,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2042,131RSYC,9-Nov-22
C1071022,11021011,181,PF-06863135,T,6218384032,6.21838E+11,20220905,15:40,CYCLE10_DAY1,0 H,430.7915854,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2104,131RSYC,9-Nov-22
C1071022,11021011,181,PF-06863135,T,6219265227,6.21927E+11,20221128,14:45,CYCLE13_DAY1,0 H,345.7186094,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2167,140RSYC,22-Mar-23
C1071022,11021011,181,PF-06863135,T,6219958820,6.21996E+11,20230220,14:20,CYCLE16_DAY1,0 H,973.3917612,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2199,141RSYC,17-May-23
C1071022,11021011,181,PF-06863135,T,6219958822,6.21996E+11,20230515,14:00,CYCLE19_DAY1,0 H,389.4852041,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2240,143RSYC,27-Nov-23
C1071022,11021011,181,PF-06863135,T,6219958826,6.21996E+11,20230829,16:10,END_OF_TRT,,742.176179,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2312,147RSYC,29-Feb-24
C1071022,11021011,181,PF-06863135,T,6217170505,6.21717E+11,20211216,16:00,CYCLE1_DAY1,24 H,816.2833921,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1511,56RSYC,30-Apr-22
C1071022,11021011,181,PF-06863135,T,6217280321,6.21728E+11,20211220,17:30,CYCLE1_DAY4,0 H,71.40242228,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1556,58RSYC,1-May-22
C1071022,11021011,181,PF-06863135,T,6217233483,6.21723E+11,20211221,17:30,CYCLE1_DAY4,24 H,9.459436104,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1547,97RSYC,12-May-22
C1071022,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,12:10,CYCLE1_DAY1,0 H,32.30693264,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1172,104RSYC,22-May-22
C1071022,10901010,182,PF-06863135,T,6518877856,6.51888E+11,20211217,18:59,CYCLE1_DAY1,6 H,280.72867,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1171,104RSYC,22-May-22
C1071022,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,9:46,CYCLE1_DAY8,0 H,63.98299532,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1157,107RSYC,24-May-22
C1071022,10901010,182,PF-06863135,T,6518805050,6.51881E+11,20211223,16:00,CYCLE1_DAY8,6 H,499.7504751,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1156,107RSYC,24-May-22
C1071022,10901010,182,PF-06863135,T,6519057380,6.51906E+11,20211230,14:55,CYCLE1_DAY15,0 H,38.45081871,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1695,109RSYC,25-May-22
C1071022,10901010,182,PF-06863135,T,6519057382,6.51906E+11,20220113,14:40,CYCLE2_DAY1,0 H,655.3727208,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1696,109RSYC,25-May-22
C1071022,10901010,182,PF-06863135,T,6519231708,6.51923E+11,20220310,15:10,CYCLE4_DAY1,0 H,40.1462152,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1904,81RSYC,4-May-22
C1071022,10901010,182,PF-06863135,T,6518807260,6.51881E+11,20220526,14:39,END_OF_TRT,,410.4008105,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1985,122RSYC,29-Jul-22
C1071022,10901010,182,PF-06863135,T,6517433531,6.51743E+11,20220217,12:00,UNPL,9001 H,737.309682,NG/ML,,Visit revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1694,109RSYC,25-May-22
C1071022,10901010,182,PF-06863135,T,6518877867,6.51888E+11,20211218,13:25,CYCLE1_DAY1,24 H,306.5824789,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1175,104RSYC,22-May-22
C1071022,10901010,182,PF-06863135,T,6518828370,6.51883E+11,20211220,8:45,CYCLE1_DAY4,0 H,798.4613237,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1163,108RSYC,24-May-22
C1071022,10901010,182,PF-06863135,T,6518877875,6.51888E+11,20211221,14:33,CYCLE1_DAY4,24 H,695.8655642,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1180,87RSYC,13-May-22
C1071022,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,10:35,CYCLE1_DAY1,0 H,878.7997189,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1944,112RSYC,25-Jul-22
C1071022,10031016,183,PF-06863135,T,6517473906,6.51747E+11,20211228,18:22,CYCLE1_DAY1,6 H,861.7713874,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1945,118RSYC,27-Jul-22
C1071022,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,12:30,CYCLE1_DAY8,0 H,170.5931233,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1946,123RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6516580389,6.51658E+11,20220106,18:30,CYCLE1_DAY8,6 H,869.7731219,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1947,123RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6519134602,6.51913E+11,20220112,14:34,CYCLE1_DAY15,0 H,448.9282936,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1948,122RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6519134603,6.51913E+11,20220119,13:25,CYCLE1_DAY22,0 H,134.7018937,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1626,85RSYC,10-May-22
C1071022,10031016,183,PF-06863135,T,6516580401,6.51658E+11,20220126,12:34,CYCLE2_DAY1,0 H,655.3281853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1625,85RSYC,10-May-22
C1071022,10031016,183,PF-06863135,T,6518620857,6.51862E+11,20220323,8:30,CYCLE4_DAY1,0 H,518.7604372,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1949,124RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6518620861,6.51862E+11,20220615,10:30,CYCLE7_DAY1,0 H,354.1796087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2097,137RSYC,18-Nov-22
C1071022,10031016,183,PF-06863135,T,6519134615,6.51913E+11,20220907,10:44,CYCLE10_DAY1,0 H,933.1147796,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2082,129RSYC,21-Oct-22
C1071022,10031016,183,PF-06863135,T,6519134617,6.51913E+11,20221109,9:05,END_OF_TRT,,504.0575657,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2149,139RSYC,22-Mar-23
C1071022,10031016,183,PF-06863135,T,6518620867,6.51862E+11,20211231,15:13,UNPL,9001 H,585.1852601,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1950,124RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6517472378,6.51747E+11,20211229,11:05,CYCLE1_DAY1,24 H,960.3663551,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1951,122RSYC,29-Jul-22
C1071022,10031016,183,PF-06863135,T,6517751599,6.51775E+11,20220104,16:23,CYCLE1_DAY4,24 H,233.3130371,NG/ML,9,Visit and time point revised; label lines may not match,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,,,
C1071022,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,13:56,CYCLE1_DAY1,0 H,310.624289,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1952,112RSYC,25-Jul-22
C1071022,10031015,184,PF-06863135,T,6518620835,6.51862E+11,20211220,21:00,CYCLE1_DAY1,6 H,493.3402803,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1953,122RSYC,29-Jul-22
C1071022,10031015,184,PF-06863135,T,6518620840,6.51862E+11,20211228,13:38,CYCLE1_DAY8,0 H,271.1420596,NG/ML,,Visit revised from C7D1,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1955,124RSYC,29-Jul-22
C1071022,10031015,184,PF-06863135,T,6519134604,6.51913E+11,20220113,16:03,CYCLE1_DAY22,0 H,11.58065886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1954,122RSYC,29-Jul-22
C1071022,10031015,184,PF-06863135,T,6519134609,6.51913E+11,20220217,13:10,CYCLE3_DAY1,0 H,500.0099151,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1627,85RSYC,10-May-22
C1071022,10031015,184,PF-06863135,T,6517751589,6.51775E+11,20220316,10:45,CYCLE4_DAY1,0 H,988.5362334,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1894,81RSYC,4-May-22
C1071022,10031015,184,PF-06863135,T,6519134618,6.51913E+11,20220411,13:28,END_OF_TRT,,394.609141,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1956,124RSYC,29-Jul-22
C1071022,10031015,184,PF-06863135,T,6517473938,6.51747E+11,20211221,13:15,CYCLE1_DAY1,24 H,443.3182014,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1957,122RSYC,29-Jul-22
C1071022,10031015,184,PF-06863135,T,6517472380,6.51747E+11,20211224,14:29,CYCLE1_DAY4,0 H,11.32823584,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1958,126RSYC,1-Aug-22
C1071022,10031015,184,PF-06863135,T,6517473950,6.51747E+11,20211225,15:44,CYCLE1_DAY4,24 H,80.62770056,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1959,124RSYC,29-Jul-22
C1071022,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,14:48,CYCLE1_DAY1,0 H,96.33719478,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1389,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756837,6.21676E+11,20211220,22:30,CYCLE1_DAY1,6 H,880.7601995,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1388,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,14:27,CYCLE1_DAY8,0 H,4.118532241,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1393,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756839,6.21676E+11,20211227,20:36,CYCLE1_DAY8,6 H,452.7972087,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1392,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756841,6.21676E+11,20220103,15:21,CYCLE1_DAY15,0 H,931.4337747,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1869,80RSYC,4-May-22
C1071022,11301003,185,PF-06863135,T,6216756843,6.21676E+11,20220110,15:00,CYCLE1_DAY22,0 H,968.1509662,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1870,80RSYC,4-May-22
C1071022,11301003,185,PF-06863135,T,6217542182,6.21754E+11,20220117,14:00,CYCLE2_DAY1,0 H,713.5695733,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1872,80RSYC,4-May-22
C1071022,11301003,185,PF-06863135,T,6217339265,6.21734E+11,20220215,15:15,CYCLE3_DAY1,0 H,72.47984484,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1871,80RSYC,4-May-22
C1071022,11301003,185,PF-06863135,T,6217542186,6.21754E+11,20220315,11:00,CYCLE4_DAY1,0 H,795.4990853,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1884,80RSYC,4-May-22
C1071022,11301003,185,PF-06863135,T,6216756849,6.21676E+11,20211221,16:32,CYCLE1_DAY1,24 H,65.58621766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1395,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756851,6.21676E+11,20211223,11:04,CYCLE1_DAY4,0 H,408.4431714,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1397,95RSYC,13-May-22
C1071022,11301003,185,PF-06863135,T,6216756852,6.21676E+11,20211224,12:22,CYCLE1_DAY4,24 H,717.9700059,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1398,108RSYC,24-May-22
C1071022,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,11:27,CYCLE1_DAY1,0 H,105.7439381,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1689,102RSYC,20-May-22
C1071022,10901008,186,PF-06863135,T,6518877857,6.51888E+11,20211231,18:45,CYCLE1_DAY1,6 H,392.25062,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1688,106RSYC,23-May-22
C1071022,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,10:20,CYCLE1_DAY8,0 H,55.31791669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1683,101RSYC,13-May-22
C1071022,10901008,186,PF-06863135,T,6518805052,6.51881E+11,20220107,16:31,CYCLE1_DAY8,6 H,14.36827487,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1684,101RSYC,13-May-22
C1071022,10901008,186,PF-06863135,T,6519019918,6.51902E+11,20220114,15:24,CYCLE1_DAY15,0 H,83.99833184,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1691,106RSYC,23-May-22
C1071022,10901008,186,PF-06863135,T,6517433528,6.51743E+11,20220120,14:23,CYCLE1_DAY22,0 H,548.5136715,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1682,101RSYC,13-May-22
C1071022,10901008,186,PF-06863135,T,6520346778,6.52035E+11,20220203,14:14,UNPL,9001 H,385.324604,NG/ML,,Received as 6518828369-07,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1687,106RSYC,23-May-22
C1071022,10901008,186,PF-06863135,T,6518805053,6.51881E+11,20220101,12:40,CYCLE1_DAY1,24 H,742.8802837,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1685,101RSYC,13-May-22
C1071022,10901008,186,PF-06863135,T,6518877871,6.51888E+11,20220103,11:29,CYCLE1_DAY4,0 H,548.3015943,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1690,106RSYC,23-May-22
C1071022,10901008,186,PF-06863135,T,6518805058,6.51881E+11,20220104,11:25,CYCLE1_DAY4,24 H,568.7000673,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1686,106RSYC,23-May-22
C1071022,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,13:30,CYCLE1_DAY1,0 H,17.36471831,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1698,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6517433456,6.51743E+11,20220103,20:20,CYCLE1_DAY1,6 H,890.6235205,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1697,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,12:02,CYCLE1_DAY8,0 H,271.7491766,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1700,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6517433458,6.51743E+11,20220111,18:37,CYCLE1_DAY8,6 H,495.3064846,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1699,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6519138599,6.51914E+11,20220118,12:01,CYCLE1_DAY15,0 H,11.91719927,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1706,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6519057381,6.51906E+11,20220125,13:00,CYCLE1_DAY22,0 H,710.9206928,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1704,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6519138601,6.51914E+11,20220201,14:20,CYCLE2_DAY1,0 H,462.975404,NG/ML,10,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1707,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6517433551,6.51743E+11,20220222,11:36,END_OF_TRT,,378.9484886,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1702,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6518805055,6.51881E+11,20220104,14:20,CYCLE1_DAY1,24 H,827.7083329,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1703,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6519057385,6.51906E+11,20220106,14:25,CYCLE1_DAY4,0 H,99.24834005,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1705,109RSYC,25-May-22
C1071022,10901011,187,PF-06863135,T,6517433537,6.51743E+11,20220107,15:45,CYCLE1_DAY4,24 H,937.3246145,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1701,109RSYC,25-May-22
C1071022,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,11:26,CYCLE1_DAY1,0 H,534.5172672,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1642,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6519136767,6.51914E+11,20220106,18:31,CYCLE1_DAY1,6 H,624.1908159,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1641,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,7:40,CYCLE1_DAY8,0 H,122.345643,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1644,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6519136771,6.51914E+11,20220113,18:52,CYCLE1_DAY8,6 H,749.1178926,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1643,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6518722091,6.51872E+11,20220120,14:51,CYCLE1_DAY15,0 H,689.4724282,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1639,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6519136778,6.51914E+11,20220127,14:42,CYCLE1_DAY22,0 H,173.7033553,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1648,100RSYC,23-May-22
C1071022,10321006,188,PF-06863135,T,6518722095,6.51872E+11,20220203,13:59,CYCLE2_DAY1,0 H,135.5495347,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1640,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6518150042,6.51815E+11,20220303,14:30,CYCLE3_DAY1,0 H,791.1338177,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1896,81RSYC,4-May-22
C1071022,10321006,188,PF-06863135,T,6517559965,6.51756E+11,20220623,13:56,CYCLE7_DAY1,0 H,663.2857211,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2031,128RSYC,21-Oct-22
C1071022,10321006,188,PF-06863135,T,6518807507,6.51881E+11,20220923,11:25,CYCLE10_DAY1,0 H,136.3185374,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2109,131RSYC,9-Nov-22
C1071022,10321006,188,PF-06863135,T,6518807505,6.51881E+11,20221215,11:09,CYCLE13_DAY1,0 H,227.2130666,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2135,139RSYC,22-Mar-23
C1071022,10321006,188,PF-06863135,T,6519136790,6.51914E+11,20220107,13:01,CYCLE1_DAY1,24 H,616.8528256,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1645,85RSYC,10-May-22
C1071022,10321006,188,PF-06863135,T,6519136793,6.51914E+11,20220109,9:45,CYCLE1_DAY4,0 H,997.0847882,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1646,100RSYC,23-May-22
C1071022,10321006,188,PF-06863135,T,6519136795,6.51914E+11,20220110,11:09,CYCLE1_DAY4,24 H,331.5487133,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1647,85RSYC,10-May-22
C1071022,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,15:45,CYCLE1_DAY1,0 H,902.375959,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1731,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343086,6.51834E+11,20220107,22:18,CYCLE1_DAY1,6 H,843.1700992,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1730,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,8:55,CYCLE1_DAY8,0 H,300.1328651,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1735,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343088,6.51834E+11,20220117,17:54,CYCLE1_DAY8,6 H,928.6740757,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1734,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343090,6.51834E+11,20220124,8:40,CYCLE1_DAY15,0 H,746.147543,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1733,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343093,6.51834E+11,20220131,8:30,CYCLE1_DAY22,0 H,434.1430669,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1732,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6519452615,6.51945E+11,20220307,9:45,CYCLE3_DAY1,0 H,282.6360893,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1907,81RSYC,4-May-22
C1071022,11281002,189,PF-06863135,T,6520815984,6.52082E+11,20220628,7:11,CYCLE7_DAY1,0 H,515.6775725,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2095,127RSYC,19-Oct-22
C1071022,11281002,189,PF-06863135,T,6520815985,6.52082E+11,20220920,10:30,CYCLE10_DAY1,0 H,20.00247923,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2101,132RSYC,10-Nov-22
C1071022,11281002,189,PF-06863135,T,6520815987,6.52082E+11,20221213,7:35,CYCLE13_DAY1,0 H,170.3132396,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2136,139RSYC,22-Mar-23
C1071022,11281002,189,PF-06863135,T,6522253824,6.52225E+11,20230307,7:54,CYCLE16_DAY1,0 H,660.2522771,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2207,142RSYC,18-May-23
C1071022,11281002,189,PF-06863135,T,6522253826,6.52225E+11,20230530,7:25,CYCLE19_DAY1,0 H,721.2367897,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2269,144RSYC,27-Nov-23
C1071022,11281002,189,PF-06863135,T,6522253825,6.52225E+11,20230825,7:26,CYCLE22_DAY1,0 H,462.2364861,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2306,147RSYC,29-Feb-24
C1071022,11281002,189,PF-06863135,T,6522253827,6.52225E+11,20231201,8:08,CYCLE25_DAY1,0 H,217.0403387,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2334,149RSYC,27-Mar-24
C1071022,11281002,189,PF-06863135,T,6525647210,6.52565E+11,,,CYCLE28_DAY1,0 H,855.9164922,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 2375,152RSYC,9-Apr-24
C1071022,11281002,189,PF-06863135,T,6518343098,6.51834E+11,20220108,16:25,CYCLE1_DAY1,24 H,631.1573836,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1728,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6518343101,6.51834E+11,20220110,14:10,CYCLE1_DAY4,0 H,294.7704529,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1729,72RSYC,7-May-22
C1071022,11281002,189,PF-06863135,T,6519452620,6.51945E+11,20220111,14:53,CYCLE1_DAY4,24 H,296.7023196,NG/ML,,,SERUM,PF-06863135,PHARMACOKINETICS,PPD LABORATORY SERVICES; INC,ICD 695; version 1; Total Electrochemiluminescence (ECL) Assay,ELECTROCHEMILUMINESCENCE IMMUNOASSAY,0.5,NG/ML,RSYC 1736,72RSYC,7-May-22
